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ABSTRACT 
The biohacker movement is an important and modern form of activism. This study 
broadly examines how positive-activist-oriented biohackers emerge, organize, and 
respond to social crises. Despite growing public awareness, few studies have examined 
biohacking's influence on prevailing notions of organizing and medicine in-context. 
Therefore, this study examines biohacking in the context of the 2016 EpiPen price-
gouging crisis, and explores how biohackers communicatively attempted to constitute 
counter-narratives and counter-logics about medical access and price through do-it-
yourself (DIY) medical device alternatives. Discourse tracing and critical case study 
analysis are useful methodological frameworks for mapping the historical discursive and 
material logics that led to the EpiPen pricing crisis, including the medicalization of 
allergy, the advancement of drug-device combination technologies, and role of public 
health policy, and pharmaceutical marketing tactics. Findings suggest two new 
interpretations for how non-traditional forms of organizing facilitate new modes of 
resistance in times of institutional crisis. First, the study considers the concept of "pop-up 
maktivism" to conceptualize activism as a type of connective activity rather than 
collective organizing. Second, findings illustrate how activities such as participation and 
co-production can function as meaningful forms of institutional resistance within 
dominant discourses. This study proposes “mirrored materiality” to describe how 
biohackers deploy certain dominant logics to contest others. Lastly, implications for 
contributions to the conceptual frameworks of biopower, sociomateriality, and alternative 
organizing are discussed.  
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CHAPTER 1: 
INTRODUCTION AND RATIONALE 
         The United States has not-so-affectionately been referred to as “Pill Nation” 
because of its complicated and unhealthy historical relationship with prescription drugs. 
According to a 2017 report, the number of prescriptions filled in the United States has 
risen by more than 85% since 1997 (Carr, 2017). In fact, the Centers for Disease Control 
and Prevention reports that almost a half of all Americans are taking at least one 
prescription drug, and almost a quarter take three or more prescription drugs each day 
(Centers for Disease Control and Prevention, 2017).  
Despite the prevalence of medication dispensing, the price of pharmaceutical 
drugs in the U.S. is twice that of most other developed nations (Kesselheim, Avorn, & 
Sarpatwari, 2016), and prices continue to rise. Not surprisingly, from 2013 to 2015, the 
amount of money Americans spent on pharmaceutical drugs rose by 20% (Kesselheim et 
al., 2016). In 2016, while sales for pharmaceuticals reached $450 billion in the United 
States, medical-related expenses were the greatest contributor to poverty in the country 
(U.S. Census Bureau, 2017). In fact, that same year more than 10 million Americans fell 
below the poverty line due to medical-related expenses. Increasing drug prices coupled 
with increased prescribing fill pharmaceutical bank accounts while draining those of 
everyday Americans. Given that the U.S. Federal Reserve (2018) reports that 44% of 
Americans do not have enough money in their savings accounts to cover an unexpected 
$400 expense, increased financial strain related to pharmaceutical costs can have a 
significant impact on individual life. Not only are Americans affected finically, many 
face the potential decision to forego purchasing a medication they rely on to survive. 
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Thus, the implications for access to affordable medicine truly can be the difference 
between life and death.  
Despite growing public and legislative concern over pharmaceutical pricing in the 
U.S., power remains lopsided and routinely favoring pharmaceutical companies. 
Pharmaceutical companies have a long history of using clever marketing tactics and 
engaging in questionable ethical practices. Despite its prevalence, very little 
organizational communication research examines pharmaceutical (mis)behavior (for 
exceptions, see Davis, Cross, & Crowley, 2007; Lyon, 2007; Lyon & Mirivel, 2011). 
Given the social influence pharmaceutical companies have over individual life, more 
research is needed to explore how dominant discourses and logics of pharmaceuticals 
continue to recirculate and reemerge over time (Lyon, 2007).  
Lyon and Mirivel (2011) note that “the convergence of medical care and financial 
profit is not entirely new nor without communicative consequence” (p. 53). 
Communication scholars have been called to more thoroughly “investigate public health 
issues,” including “problems of access, skyrocketing costs, and quality in medicine” 
(Zoller, 2010, p. 482). Healthcare policies and protocols impact a variety of social 
systems, including government agencies, organizations, economic systems, families, and 
individuals (Birkland, 2005). Despite the field of medicine having been originally 
developed for public welfare, access to care (including affordable access to necessary 
pharmaceuticals) is complicated by a variety of economic, regulatory, corporate, and 
sociohistorical pressures in the United States. 
Medicine has become privileged; medical “professionals” are determined by 
specialties and granted certificates of knowledge authority; medical logics dictate how 
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and where the development of new medical knowledge can be produced (and by whom); 
and medical technologies shape how individuals think about and interact with their social 
and individual bodies. As a result, the discourse of medicine is strongly institutionalized 
(Barbour, 2010; Murphy & Eisenberg, 2010; Murphy, Eisenberg, Wears, & Perry, 2008; 
Scott, Ruef, Mendel, & Caronna, 2000; Thornton & Ocasio, 2008).  
Further, health and medicine are political. Medicine today largely functions under 
capitalistic logics that preserve economic-political sovereignty (Nadesan, 2008). 
Government regulations and medical device oversight are intended to protect individuals 
from receiving care that could lead to greater harm or do not provide substantially better 
outcomes than having no care at all. The question of who gets to interpret policy-related 
systems and engender trust in the medical space is an important issue that organizational 
communication scholars should (re)consider (Canary & McPhee, 2009). Health should be 
considered political in nature in part because access to medicine and medical care has 
become privileged (Bambra, Fox, Scott-Samuel, 2005). In this study, I will closely 
examine how certain medical logics become preferred and how the medical and scientific 
discursive formation of allergy and allergy treatment become constituted. The power of 
knowledge and authority is political; it situates historical values, interests, and norms 
while hiding and silencing others (Lyon & Chesebro, 2011). 
One of the most prominent recent examples of pharmaceutical price-gouging is 
Mylan’s EpiPen, an epinephrine auto-injector sold to millions of Americans each year as 
an emergency option for treating anaphylaxis. As the price of EpiPens reached over $600 
in 2016, physicians, politicians, and everyday citizens demanded explanations. How 
could a drug-device combination (that had not fundamentally changed since its first 
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market release in the late 1980s) increase in price more than 500% in the nine years since 
Mylan had owned the distribution and marketing rights to the devices? Mylan assigned 
blame to the complexity of the healthcare marketplace and American healthcare system, 
while congress, the public, and investigative journalists placed blame on corporate greed. 
In the United States, EpiPen price increases through 2016 had legitimate financial 
implications for millions of Americans. Further, lack of affordability presented risks to 
Americans who came to rely on EpiPens as a simple medical alternative to death.  
 This case, however, is not simply about EpiPen pricing or pharmaceutical 
(mis)behavior. While the dominant socio-political conversation focused on which 
government agencies, organizations, and bad actors were to blame, a relatively unknown 
biohacker group responded to the growing crisis by creating an affordable and legal do-it-
yourself (DIY) epinephrine auto-injector. The group named their device the EpiPencil. 
Soon, other at-home makers, hackers, and even members of the medical community 
began developing alternative kits and devices at a fraction of the price of EpiPens. As 
awareness spread, medical authorities, government agencies, patient advocacy groups, 
and journalists alike urged the public not to build their own DIY auto-injectors. In the 
end, individuals responded through creating/making, both as a way to solve a social 
problem and to challenge dominant institutional logics. As a result, they contributed to a 
counter-discourse around ownership of medical knowledge and notions of access and 
price. 
A close examination of this case is interesting, in part, because it marks one of the 
first times that biohackers received broad mainstream media attention. The DIY activities 
and discursive practices of biohackers are interesting sites of observation for analyzing 
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both material resistance and discursive contestation. This study of biohacker 
making/producing illuminates the role of social connected action and alternative 
organizing during times of crisis. In doing so, it expands organizational communication 
literature on social action through material production by considering how making can 
constitute new counter-logics and new bio-political discursive practices to contest 
dominant discourses of power. Although notions of organizational resistance are central 
to previous scholarship in organizational communication, few studies have focused on a 
close analysis of alternative or resistive forms of organizing in action (Kuhn, 2010). 
Analysis of the relationality between discourses and new material meanings requires new 
methodological approaches that incorporate a variety of modes for examining the 
materiality of objects in action (Rose, 2012) across social, organizational, and (in this 
case) biological contexts.  
Issues of power, including questions of “who gains and who loses?” (Flyvbjerg, 
2001), are central to critical research. Case studies are especially well suited to situate 
issues of power within context-dependent knowledge (Flyvbjerg, 2001) and illustrate the 
ways in which situational social issues can both reveal hidden substances of the human 
experience and lead to theoretical generalization. Only then will an understanding of the 
politics of representation be useful. Because power is discursively situated, a story/case 
can allow the researcher to explore various discourses in rich context. Cases also create 
opportunities for focusing on multiple oft-competing discourses by drawing attention to 
counter-narratives and by acknowledging their existence, even if they are fragmented, 
quiet, or disrupt canonical stories (Lindeman-Nelson, 1996). Finally, critical narrative can 
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create space for discourses that are embedded, which gives a tangible and meaningful 
grasp to case aspects that are talked about but do not do the talking. 
In sum, the EpiPen pricing crisis provides a rich scene for case study analysis. 
Examining how various narratives, competing logics, and material productions unfolded 
in time and place and across multiple levels of discourse is a problematic of practical and 
theoretical importance. Biohacking is a timely and relevant social movement that, in the 
context of the EpiPen crisis, presents a unique angle by which a critical analysis can 
demonstrate the role and function of large institutional logics, corporatized politics of 
everyday health, and implications about the modes of material resistance. 
Dissertation Preview 
  The primary purpose of this study is to elucidate how the biohacking counter-
movement in the EpiPen crisis served as a transformative force within entrenched 
ideologies of preferred knowledge and authority. This case illustrates various forms of 
resistance discourses through new material resources and discursive constructions. To 
understand these phenomena in context, I engaged in various types of data collection and 
analysis, including discourse tracing (LeGreco & Tracy, 2009).  
  Chapter 2 reviews past literatures related to biohacking, discourse, biopower, and 
critical organizational communication theory and presents the study’s focal research 
questions. Chapter 3 overviews data collection, organization, analysis methods, and 
procedures used in this study. Chapter 4 presents core findings from data analysis and 
answers the aforementioned research questions. Chapter 5 concludes with a discussion of 
implications for this research across theoretical and practical contexts, study limitations, 
and future research extensions and directions. 
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CHAPTER 2: LITERATURE REVIEW 
CONTEXTUALIZING BIOHACKING WITHIN DISCOURSE, BIOPOWER, AND 
ORGANIZATIONAL COMMUNICATION THEORY 
As discussed in the previous chapter, the goal of this research project is to 
examine and analyze biohacker responses to EpiPen price-gouging by considering how 
various forms of resistance potentially contest dominant discourses of health, medicine, 
and the governance of both. This study will examine notions of social action and 
resistance through a critical post-structural lens and focus on counter-narratives through 
both discursive and material logics. The following literature review first situates this case 
in the context of previous research on biohacker collectives and alternative organizations. 
Then, I contextualize biohackers in relation to frameworks of discourse, biopower, and 
communicatively constituted organizing. 
This is primarily a study about biohacking. Thus, I begin this review by 
operationalizing biohacking. The rest of the chapter unfolds by situating biohacking and 
biohacker activities with various conceptual and theoretic frameworks that guide this 
research study. 
Biohacking and Discourse 
The advent of biohacking originated from a 1988 Washington Post op-ed titled 
“Playing God in your Basement” (Schrage, 1988). Schrage, then-professor at the 
Massachusetts Institute of Technology, penned that just as previous open-source 
subcultures grew around computer technologies like microchips and software, a future 
coterie of amateur “hackers” would also grow around the development of biologic 
science and technology. In the four decades since, biohacking has indeed emerged as a 
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global movement of “amateurs conducting life sciences outside of traditional professional 
settings such as university and corporate labs” (Delfanti, 2012, p. 163).  
Today the movement consists of various permutations (e.g., garage biology, do-it-
yourself biology, citizen biology, biopunk) that are not necessarily synonymous or 
consistent with each other (Meyer, 2016). However, biohacking generally subscribes to 
an ethos of promoting open and decentralized ownership of and access to scientific 
knowledge, technologies, and participation—tenants also shared among other hacker 
cultures (Levy, 2001). Not so different than your grandfather stitching up his own thumb 
after cutting it, biohackers maintain that many of today’s medical procedures could be 
more accessible and just as successful if individuals were empowered to play a larger role 
in their own care. For the purposes of this study, do-it-yourself (DIY) biology and 
biohacking are used interchangeably. 
Pang (2016) notes that prior to the 19th century, “almost all science was done by 
amateurs” (p. i). Over time, however, as scientific knowledge became institutionalized, it 
centralized in universities, graduate training programs, and formal research institutions. 
The result was the formation of specialized knowledge sets and new systems of expertise 
that left the public separated from their care. Critical post-structuralism informs this 
specialization of knowledge. It does so by providing a discursive framework that explains 
which types of knowledge come to be constituted and institutionalized and, further, how 
power becomes historically situated within this knowledge. 
Discursive Constructions 
Discourse refers to enduring group-level thoughts, beliefs, assumptions, and 
systems of knowledge within social contexts (Alvesson & Karreman, 2000). Also 
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referred to as master narratives or grand narratives (Boje, 2001), Discourses (with a “Big 
D”) refer to historically embedded “constellations of talk, ideas, logics, and assumptions 
that [come to constitute] objects and subjects” (Fairhurst & Putnam, 2004, p. 8). 
Organizational communication scholars distinguish between “small d” discourse (i.e., the 
localized talk, texts, and social practices of members of a group) and “big D” Discourse 
(i.e., broad and enduring systems of thought) (Alvesson & Karreman, 2000; Fairhurst & 
Putnam, 2004). Taken this way, discourse is the “medium” by which talk and text 
contribute to the (re)production of enduring Discursive forms. Therefore, discursive 
formations are inherently organizing and communication phenomena (Fairhurst & 
Putnam, 2004). 
Discursive formations constitute certain social realities, privilege certain forms of 
knowledge, create social order and modes of discipline, and embed power through their 
(re)production (Foucault, 1994). First, discursive formations constitute and construct 
certain social meanings through their enactment and, therefore, essentially function as 
social “truths.” Critical scholars acknowledge that discourses have authority and agency, 
establish the internalization of certain norms, form various types of social order, and 
subject ways of “believing and behaving across social life” (Nadesan, 2014, n.p.). The 
power of discursive forms comes from the ways in which the norms and behaviors 
become taken-for-granted assumptions, normalized, and preferred (Foucault, 1978). Over 
time, enduring Discourses (re)constitute power and authority through their repeated 
deployments and, in doing so, constitute organizational and institutional rules (i.e., 
logics). Thus, Discourses are generative and productive and are substantiated through 
their naturalization and normalization. At the same time, they also constrain what is (seen 
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as) possible or alternative. That is, that which is “ruled in” also conversely determines 
what norms, talk, and logics become “ruled out” (Hall, 1997). As certain forms of 
knowledge gain legitimacy, they come to be unquestioned, appearing value-neutral and 
apolitical, and make it unthinkable to do anything else (Deetz, 1992). Unlike traditional 
notions of power as a repressive or constraining force, power lies in the (re)production 
and enactment of knowledges (Nadesan, 2014). Discursive formations, therefore, 
“subject and produce the world” (Deetz, 1992, p. 59). Thus, discursive formations gain 
power through their invisibility.   
This study is primarily concerned with Discourses of medicine, including medical 
governance and regulation. Indeed, Discourses of medicine “transform our understanding 
of self, knowledge, technology, and work as well as the larger institution of medicine” 
(Deetz & McLellan, 2009, p. 125). The production of new medical knowledge functions 
as a mechanism that orients and governs health in certain ways. Further, medicine has 
become a for-profit endeavor that uses corporatized models of operation, where corporate 
logics have come to function as clinical authority. 
Discourses of Medicine: The Medical Gaze and Medicalized Self  
Medical knowledge has become a pervasive form of discipline for how (social 
and individual) bodies are treated, both medically and non-medically. Scientific 
technologies and Discourses of the body created new body politics in the 19th century 
(Nadesan, 2008). Industrialization led to greater population density in urban areas, which 
led to urban squalor and the more-likely spread of infectious disease. To protect the labor 
force (thereby ensuring industrialized efforts and productivity continued), new 
governmentalities were enacted (e.g., the institution of new public health authorities, 
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sanitation measures, infrastructure). Urban medicine efforts soon accompanied urban 
sanitation efforts, which resulted in biopolitical conceptions of the body as a source of 
illness and potential site of contamination. Medical authorities became responsible for 
stopping the spread of disease, as well as serving as a form of societal health security. 
Scientific focus on infectious disease and epidemiology soon came to politically govern 
public health. As a result, public health officials and medical authorities engaged in 
medical policing (Foucault, 1978), creating public policy, and developing new health 
protocols. 
Foucault (1978) proposes that 19th century biopower operated through a medical 
gaze, whereby medicine was seen as the “regime of truth” (p. 133). As such, medical 
knowledge became the preferred instrumentality for medical welfare; however, the 
discourse of medicine also came to frame issues of social and moral health and hygiene 
as well. For example, logics of immunity (i.e., a rationalized perspective focused on 
resistance to certain pathogens) as a medicalized concept has become politically 
naturalized and embedded beyond biomedical contexts (Jamieson, 2015). Scholars point 
to discursive logics of immunity that position the body as a battleground, a place by 
which to eradicate unwanted organisms, both political and biologic. For example, 
scholars like Martin (1990, 1994) and Napier (2003) suggest that logics of immunity are 
both biologic and political and that they situate the body in military metaphors of “war, 
defence [sic], battle and invasion,” which creates an image of the body as “only capable 
of interacting with others in violent or antagonistic ways” (Jamieson, 2015, p. 3). 
Immunity logics also evoke biopolitical enactments that begin to devalue certain lives, 
which, like disease, poses large-scale threats to the health or maintenance of a certain 
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way of life. For example, asylum seekers, refugees, and the brain dead have all 
historically been considered risks to social health and political freedom (Lemke, 2011).  
The medical gaze, thus, contributed to a kind of “therapeutic state” whereby non-
normative behaviors, desires, thoughts, habits, or emotions became the focus of intense 
institutional problematization (Nadesan, in press) and medicalized intervention. Notions 
of diagnoses and treatment also trickled into the identity of mainstream society and 
created a kind of “therapeutic state” in which anything not normalized was seen as a 
personal ailment in need of therapeutic governance and remedy to be fixed by individual 
discipline. Individualism, as a result, was stripped away and replaced with a social 
orientation toward an idealized individual. By identifying human behaviors and affect in 
terms of their pathologies, the medical community has created new technologies of the 
self to manage the psyche and attempt to eradicate unwanted social and individual 
behavior (Nadesan, 2008; Rose, 1990). Scholars have argued that pharmacology is a 
pervasive form of biopolitics. Biopower is thus disseminated through individual practices 
of mental hygiene (Nadesan, 2008). 
Groups like biohackers are susceptible to immunity logics because they operate 
outside of the institutional norms of Western science and medicine and, thereby, present 
the possibility of a threat to national health, both physically and mentally. From this 
standpoint, their activities are categorized as social deviance rather than making for the 
social good. Biohackers find themselves labeled by a biologic dystopian mythos that 
frames them as infiltrators of society’s biological and technical hardware (bodies) and 
software (minds) (Thomas, 2004). For example, Google—the world’s most used search 
engine—defines biohacking as “the activity of exploiting genetic material experimentally 
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without regard to accepted ethical standards, or for criminal purposes” (Google, n.d.). 
This negative popular framing is not unique to biohacking; other techno-social logics 
have emerged through the same medicalized perception. Internet attacks and malware are 
primarily referred to as “viruses” and “worms”; computers become “infected.” 
Television, the internet, video gaming, and cell phone use have all generated discourse 
around their “addictive” properties and have been framed and treated as public health 
concerns (Thomas, 2004). 
The rise of the medical gaze also brought the rise of pharmaceutical and 
medicinal self-regulation (Coombs & Holladay, 2011). In fact, “during the last two 
decades of the twentieth century, a cognitive and pharmaceutical discourse of engineering 
and optimizing one’s neurological state for optimization slowly supplemented, and then 
replaced, the psychological discourse of personal adjustment, fulfillment, and self-
actualization” (p. 161). A growing dependency on medicalized logics has introduced new 
discursive forms that treat non-medical aspects of life in medicalized ways. 
Diffusing Knowledge: Distributing Authority and Expertise  
The biohacker movement in this case finds itself situated within the dominant 
Discourses of medicine and science, complete with the various forms of institutionally 
derived disciplines, enacted policies, constituted protocols, and preferred forms of 
expertise (Nadesan, 2014). One of the more powerful ways “professional” science 
demarcates itself from that of “amateur” science is through the mapping of scientific 
spaces and territories, especially where professional science happens and, by comparison, 
where amateur science is therefore relegated to (Meyer, 2013). Gieryn (1999) notes that 
science defines itself through cultural maps and boundaries of authority and power; 
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“white lab coats, laboratories, technical journals, norms of scientific practice, linear 
accelerators, statistical data, and expertise” (p. x) all draw edges around what constitutes 
science work. Thus, biohackers take up territories in domestic places like the home 
kitchen or garage and public places, like coffee houses, libraries, or online. Myer (2013) 
notes that the contiguities of “boundary work” create spaces for contestation about 
expertise and professional authority, value of contributions, and epistemic validity and 
quality. In other words, biohackers attempt to extend the physical and epistemological 
boundaries of science through their participation and production and, in doing so, also 
challenge privileged perspectives of scientific inquiry and engagement. To counter the 
formal organizing of “professional” science, in the past 10 years biohackers have 
attempted to draw new boundaries and forms through the creation of formal organizing 
bodies and collective organizing groups (e.g., DIYBio.org), the development of open-
source community policies and codes of ethics, the establishment of physical community 
laboratories known as hackerspaces, and the use of virtual network collaborations. 
Further, the DIY community produces technologies that function as strategies for 
emancipating closed systems of knowledge and production. This includes regulatory 
restrictions on the dissemination of certain information (e.g., the pirate radio collective 
movement attempted to “free the airwaves” through low frequency rogue radio outside of 
Federal Communications Commission licensure), countering corporate intellectual 
property protections (e.g., open-source code software like Linux/UNIX as an alternative 
to proprietary, corporate-owned computer operating systems protected by intellectual 
property patents), and contesting privileged forms of expertise (e.g., the “copyleft” 
movements that undergirded the development of technology platforms such as 
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Wikipedia, to oppose copyright content) (Ratto & Boler 2014, p. 36). Creating open 
technologies to more broadly decentralize and emancipate institutionally-held knowledge 
contests aspects of power and authority by redefining, reclaiming, or expanding the 
discursive and physical mechanisms that traditionally define or restrict participation. By 
resituating (or de-situating) the territories and boundaries of institutionalized and 
corporatized production and embracing values like open participation, biohackers engage 
in activities that attempt to (un)discipline technology and make alternative logics of 
ownership, participation, and expertise boundless (Ratto, 2014).  
Through this study, I aim to consider how exclusionary practices of 
institutionalized knowledge and organizing are contested in a specific case of biohacking 
and, conversely, how inclusionary practices enacted by biohackers challenge certain 
institutional logics. In doing so, this examination will trace various contestable discursive 
and material boundaries and consider the mechanisms used to preserve or disrupt logics 
of institutional power. The study asks: 
RQ1: What institutional logics and dominant discourses are present in this case?  
To answer this research question, I will consider how various historical corporate, 
institutional, and governmental discursive forms (and apparatuses) have contributed to 
certain embedded logics of power and authority.  
Additionally, to be able to observe how discourses of power become hegemonic, I 
will consider:   
RQ2: What discourses are contested by biohackers and, conversely, which are 
not? 
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In their quest to emancipate scientific knowledge and decentralize its power, biohackers 
practice a unique type of activism that blends positive social action with material 
intervention. 
Hacktivism, Critical Making, and Maktivism 
Due to its operation on the contiguities of “traditional” science and technology, 
biohacking exists on the fringe, “between traditional manufacturers and users, between 
policy makers and community members” (Dunbar-Hester, 2014, p. 77). Biohacking 
functions as a form of social activism that attempts to create social change through its 
“making,” in order to “increase egalitarian social relations by eroding boundaries 
between experts and laypeople” (Dunbar-Hester, 2014, p. 75). Hacktivism (a portmanteau 
that combines the word “hacking” with “activism”) (Milberry & Anderson, 2009) 
describes the act of hacking as a strategy for both technical/scientific and political 
engagement, as well as a mode of increasing political participation. Making is a form of 
political action that permeating new forms of agency through diffused technologies 
(Dunbar-Hester, 2014).  
Contrary to other “black hat” (i.e., criminal or exploitative) forms of “hacking” 
(e.g., cyber terrorism) that are also politically motivated, biohackers largely engage in 
acts of positive social deviance by producing and developing new capabilities that 
function as artifacts of change for social good (Myer, 2013). DIY (or maker) culture also 
attempts to “intervene in dominant modes of social life” (Ratto, 2014, p. 228). Making as 
a form of positive social action and engagement is conceptualized as a kind of critical 
making (Ratto, 2014). For example, DIY feminists in the 1990s engaged in grassroots 
organizing, cultural activism, and resistance to the traditional information production and 
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commercialization through the production of feminist zines, print and digital publications 
that addressed topics that dominant culture typically avoided like domestic violence, 
sexual liberation, and female health. Zines functioned as discursive and material forms of 
resistance and participation against (and outside of) dominant forms of publishing, 
women’s oppression, commercialization, and institutional production mills of knowledge 
(Mann, 2014). 
Critical making and hacktivism together reflect a unique type of social action that 
combines maker agency (human and material deployments) to function as forms of 
political participation. In other words, material production comes to represent social 
activism and resistance through the process of innovation and making in the public 
sphere. Taken together, scholars have proposed the concept of maktivism to represent the 
intersection of critical making that toes the lines between free and proprietary, open-
source and closed-source, privileged and emancipated, and breaking down barriers 
through creation (Mann, 2014). Maktivists are broadly “white hat” because their activism 
ultimately strives to create solutions through their engagement, rather than exploit or 
destruct. To date, few studies have considered maktivism in context. Further, maktivism 
is primarily focused on the material agency of production and has not explored the 
discursive embeddedness of resistance through maktivism. This study aims to examine 
the ways maktivism, resistance, and collectivity emerge in the context of this case by 
considering how maktivism is enacted through political, technical, and discursive 
production. 
Further, Ratto (2014) notes the “need for scholars to attend to the materiality of 
our sociotechnical environment” (p. 228) and calls for more research that considers the 
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production of technical work accompanied by critical social analysis. This study 
examines the production of new and alternative medical devices developed by 
biohackers. In doing so, this case illustrates how resistance may be enacted through 
material and discursive production, particularly as a form of organizing. Thus, this study 
asks: 
RQ3a: How is material activism (i.e., maktivism) performed in the case of 
responses to the EpiPen crisis? 
RQ3b: What does material resistance specifically look like in a case of 
biohacking? 
Alternative Organizing and Resistance 
 Most organizational communication research on alternative forms of organizing 
focuses on the ways that alternative organizations resist traditional corporatized logics 
and practices. From this standpoint, alternative organizing rejects dominant 
organizational structures and promotes alternative approaches, such as distributing 
power, hierarchy, and resources (Buzannell, 1995; Cheney, 1995; Cheney & Cloud, 
2006; Cheney & Munshi, 2017); resisting models of ownership in favor of greater 
cooperation; and rejecting traditional organizational values (e.g., profit making) 
(Koschmann, 2011). The literature on alternative organizations also emerges as a 
counterpoint to the status quo (Buzannell et al., 1997). Indeed, alternative organizing 
often defines itself “at least somewhat in opposition to the ‘mainstream’” (Cheney, 1995, 
p. 171). Organizational communication scholarship has attended to certain forms of 
alternative organizing, particularly organizations that are fringe, hidden, shadowed, and 
otherwise secret/clandestine, including analysis of militia organizations like ISIL (Islamic 
19 
State of Iraq and the Levant) and al-Qa’ida (Bean & Buikema, 2015; Bruscella & Bisel, 
2018; Schoenborn & Scherer, 2012; Stohl & Sthol, 2011) and computer hacker groups 
like Anonymous (Dobusch & Schoeneborn, 2015).  
 For the purposes of this study, alternative organizing literature has explicated 
certain issues and mechanisms, including how institutional legitimacy has been attempted 
or achieved (Bean & Buikema, 2015), how communication artifacts and channels (e.g., 
mediated technologies) facilitate concealment and revealing, and how issues of visibility 
and invisibility of public image have been managed (Wolfe & Blithe, 2015). That said, as 
it stands, the existing literature has done less to explore broader territories of resistance 
and social action as a form of collective, or more ambiguous forms of loosely connected 
organizing, which this study has the potential to contribute to or extend. 
Riad (2005) suggests that “resistance can operate from within power; individuals 
can exercise power to resist certain elements…but then appropriate other elements of it in 
different contexts” (p. 1533). Indeed, historical research on resistance in organizational 
communication has typically been examined at the organizational level and focused on 
how resistance is demonstrated within organizations (e.g., Alvesson & Willmott, 1992; 
Bain & Taylor, 2000; Ball, 2005; Contu, 2008; Courpasson, Dany, & Clegg, 2012). 
However, Munro (2016) notes “an emerging literature has begun to look outside the 
boundaries of the workplace for sources of resistance that are developing on the 
periphery,” particularly through “counter-hegemonic networks by social movement 
organizations” (p. 570). For example, in his study on how Wikileaks resists hegemonic 
surveillance systems and corporate secrecy, Munro (2016) concludes that Wikileaks was 
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able to resist certain systems of state and corporate power through its ability to mobilize 
and become constitutive through its rhizomatic networked structure. 
Deetz (2008) suggests that resistance to social, corporate, or other 
institutionalized dominance can happen through various forms of contestation but posits 
that resistance is often conceptualized in terms of its pushing back against dominance. 
Indeed, resistance scholarship primarily presents resistance as tension: resist domination 
through “difference” and “otherness” or give into domination. Although some research 
has suggested that deployments like appropriation can function as resistance (Riad, 
2005), participation and imitation continue to be seen largely as subjective to dominant 
modes and logics of power. Historically, scholarship paints resistance as a reaction to 
power, through in notions of “struggle” and “conflict” (Deetz, 2008). However, it would 
be interesting to see if biohacking might provide an example for how activities like 
imitation and participation from peripheral group actors (like biohacker communities) can 
function as meaningful and powerful forms of resistance. Therefore, I will consider: 
RQ4: What does this case illuminate about participation (e.g., coopting, imitation) 
as a function of meaningful resistance? 
Sensitizing Theoretical and Conceptual Frameworks 
The previous section provided a background and context on relevant literature and 
scholarship on the biohacker movement. The next section overviews several guiding 
theoretical constructs and critical perspectives that help situate the research project more 
broadly in the context of medicine and pharmaceuticals in the United States. Although 
these areas of literature do not foreground specific research questions, they serve as 
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sensitizing theoretical-conceptual lenses through which the case was analyzed and 
explained. 
Biopower: Anatamo Politics and Biopolitics 
Rather than other manifestations of direct, absolute, or repressive form of power 
used throughout history, institutionalized power is instead indirect, “dispersed throughout 
daily life in the form of laws, social norms, and personal habits” (Nadesan, 2014, n.p.). 
He termed such anonymous forces disciplines to describe the ways institutionalized and 
ritualized practices orient or discipline certain types of thinking and behaving. Western 
liberalism, he contended, governed bodies and life through two forms of power: 
biopolitics and anatamo politics.  
Biopolitics emerged as a concern for the “health and welfare of the population as 
a political and scientific problem space” (Nadesan, 2014, n.p.). Specifically, the 
development of medical and scientific knowledge in the 18th century became a dominant 
Discourse and resulted in the development of new technological, scientific, social, and 
medical innovations that constituted a medical and clinical view of life and the body. 
Biopolitics aimed to “optimize the vitality of the population through knowledge, 
technology, and interventions aimed at promoting life expectancies, health, reproduction, 
and mental hygiene” (Nadesan, 2014, n.p.). Biopolitics brought with it the 
institutionalization of new expert knowledges and health authorities, government 
policies, and broadly disseminated hygiene protocols (Foucault, 1963). 
Anatamo politics, on the other hand, refer to “technologies of power” that 
discipline, orient, and/or normalize individual lives and bodies toward aims of capital 
accumulation and the maintenance of nation-state sovereignty. Anatamo politics exploit 
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humans for their productive means and orient bodies and behavior toward disciplines that 
attempt to optimize human output, primarily through educational, medical, and corporate 
forms (i.e., the shape certain objects take) and logics (i.e., the meanings and purposes 
from which they are formed). To date, little communication research has examined the 
role of biopower in specific medicines and/or medical devices, including examining how 
their material construction and discursive genealogy shape their governance and 
biopolitical power. This study will attempt to do this by focusing on epinephrine auto-
injectors as both the archetype and artifact of analysis. I will consider the institutionalized 
disciplines and techno-logics present in the Discursive formation of anaphylaxis and 
anaphylaxis management. 
Biopower through corporate subjectivities. Nineteenth century liberalism and 
20th century neoliberalism ushered in new forms of economic and political sovereignty—
where the economic, the political, and the cultural increasingly overlap and invest in one 
another (Lemke, 2011, p. 68). Capitalistic logics have thus become the prevailing 
Discourse in the 21st century Western world, with corporate entities replacing 
governmentalities as the primary holders of economic and biologic governance (Deetz, 
1992; Nadesan, 2008). Corporate meanings, logics, and values come to direct the way 
everyday citizens understand, think about, and act in everyday life (McLellan, 2017). By 
influencing the ways people think, talk, and see themselves, corporations subtly shape the 
taken-for-granted knowledge and values of societies (Deetz, 1992). Over time, strategic 
corporate logics influence the way people experience the world and see themselves, 
particularly in private aspects of their lives. For example, organizational ideologies have 
become situated protocols for our lives. Organizational communication scholars have 
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primarily considered the ways corporate and industrial vocabularies, values, tools, 
technologies, and forms of organizing dominate the possible ways of knowing available 
to individuals and how the presence of corporate logics become unquestioned over time 
(McLellan, 2017). Indeed, as organizational logics become more ubiquitous, “everyday 
language gradually becomes commercialized” (Deetz, 1992, p. 18). For example, we 
regularly attempt to “manage” our personal time and perform cost-benefit analyses for 
personal decisions. Corporate logics have also come to shape our orientation toward work 
and health. For example, Nadesan and Trethewey (2000) argue that women shape 
themselves into enterprising subjects, constantly attempting to resolve competing 
tensions between enacting corporate traits that are historically masculinized while also 
maintaining their female identities. Other scholars point to the ways healthcare has 
become colonized by institutional systems of consumerism and consumption (du Gay, 
1996; du Gay & Pryke, 2002).  
Over time, corporations have come to replace other social institutions (e.g., 
religious, family, educational, community, and governmental) as the primary source of 
meaning and sensemaking. The larger corporate discursive form has contributed to 
techniques in self-management and orienting behavior toward a consistent and preferred 
way of being, thus expanding the reach of technologies of the self. For example, 
discourses of managerialism have contributed to new economies of management-related 
training and career ambitions, as well as new conceptions about how workers see 
themselves and “manage” themselves. Trethewey (2001) examined how women workers 
identify with the grand narrative of “midlife” and found that organizational discourses of 
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midlife are represented as something that must be “managed” effectively, rather than a 
natural part of one’s aging or career longevity. 
The rise of the modern corporate form has created discourses of power that have 
resulted in various forms of disciplinary (or self-orienteering) control toward corporate 
logics, such as individual optimization (Nadesan, 2014). By viewing all biologic function 
in terms of its pathology, the medical community has created new technologies of the self 
to manage the psyche (Nadesan, 2008). Pharmaceuticals, for example, have become an 
easy way to normalize behavior via legally sanctioned products. In fact, “during the last 
two decades of the twentieth century, a cognitive and pharmaceutical discourse of 
engineering and optimizing neurological states slowly supplemented, and then replaced, 
the psychological discourse of personal adjustment, fulfillment, and self-actualization” 
(Nadesan, 2008, p. 161). Additionally, over-the-counter medications or prescription drugs 
are often discussed as ways to “manage” or mask sickness in order to return to work 
(McLellan, 2017). Pharmaceutical drugs and medical devices, therefore, provide benefits 
to public health, while simultaneously contributing to the corporate economic model. For 
example, new economies around biologic material, including the consumption of human 
tissue, blood, and organs (Waldby & Mitchell, 2006), promotes new forms of biocapital. 
Scholars and medical professionals have suggested that “the social construction of 
illness” has been replaced by the “corporate construction of disease” (Moynihan, Heath, 
& Henry, 2002, p. 886). Further, pharmaceutical interests shape public health by 
engaging in practices like disease mongering, which is attempting to profit off of social 
fears about disease (Payer, 1992). Pharmaceutical companies specifically engage in 
attempts to broaden the boundaries of illness, both by amplifying certain illnesses to the 
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public through marketing tactics disguised as public awareness and also through pushing 
medicines to treat those illnesses. Disease mongering has converted individuals from 
patients to medical consumers (Applbaum, 2006). The effect is that society becomes 
conditioned to think in terms of medical treatments, which oftentimes leads to over-
diagnosing and overtreatment driven by both medical professionals and patients 
(Moynihan et al., 2002).  
Pharmaceutical biopower. Pharmaceutical companies have gained significant 
authority over American lives. Albeit limited, several communication scholars (e.g., 
Coombs & Holladay, 2011; Davis et al., 2007; Deetz, 1995; Johnson, Sellnow, Seeger, 
Barret & Hasbargen, 2004; Kohn, 2004; Lyon, 2007; Lyon & Mirivel, 2010, 2011; Tracy, 
2004) have studied pharmaceutical companies in various contexts. Because of the degree 
to which pharmaceutical companies can directly affect our daily lives, communication 
scholars have a responsibility to study the ethicality of their communication with the 
public (Lyon, 2007; Lyon & Mirivel, 2011). Lyon (2007) studied how Merck publicly 
responded to evidence that one of their drugs, Vioxx, was linked to tens of thousands of 
deaths over a four-year period in the early 2000s and that the company intentionally 
withheld knowledge of the risks of the drug from the public and shareholders. Lyon 
suggests that Merck used systematically distorted communication tactics to deceive their 
shareholders, first by conducting research that was more consistently aligned with 
market-driven needs and shareholder interests rather than clinical. Lyon and Mirivel 
(2011) also analyzed the tactics used by Merck trained sales representatives to avoid 
conversations about the potential risks when engaging with doctors. The company, the 
authors concluded, behaved with a moral obligation to its stakeholders rather than to 
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patients or to the public. Capitalism-driven market pressures and practices routinely 
privilege profit over individual health and, in some cases, human life (Law, 2006; 
Scheibel, 1996).  
Although the relationship between government regulation and corporate interests 
is socially narrated as tenuous, Nadesan (2008) suggests that the rise of the neoliberal 
enterprise and the move toward neoconservative governmentalities has given way to 
modern day economic-political sovereignty, a relationship that favors corporate 
expressions of sovereignty but does not erase the need for political sovereignty. Since the 
rise of the “corporation,” biopower over health has shifted from state authority to 
corporate authority (Nadesan, 2008). The relationship between the state and private 
industry is mutually serving and symbiotic, often referred to as the medical-industrial 
complex (Ehrenreich, 2016). Organizational communication scholars should consider 
ways their research might provide a public service, particularly in instances where 
research can illuminate the problematic ways in which institutional organizing affects 
public life and wellbeing (Lyon, 2007). Indeed, this can be seen in a recent study that 
found that all 210 pharmaceutical drugs approved by the FDA from 2010 to 2016 
originated out of government-funded research (Cleary, Beierlein, Khanuja, McNamee, & 
Ledley, 2018). The authors suggest this represents a complementary relationship, insofar 
as the public-sector funds research and scientific evidence for the development of new 
drugs and then hands the research to the private sector to develop and market the drugs 
for use. However, this highlights a complicated relationship with how public health 
becomes (economically and axiologically) valued, distributed, and governed. Publicly-
funded research is commodified and sold back to the very people who both already paid 
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for it and require it to live. Moreover, it is sold back reformulated with new 
biocapitalistic meanings, values, and medical-industrial forms of power. 
Medical governance, distribution, and cost are all of considerable importance for 
critical communication research in many ways. First, they present a rationale by which to 
examine the role of pharmaceutical drugs through a lens of biopower. Second, they 
explain how and why non-normative groups like biohackers may be targeted, excluded, 
or silenced by the dominant Discourse. And third, they provide a framework by which to 
consider how politics of the body influence the rise of dynamic social issues. This study 
will attempt to consider the complex role biopower and biopolitics play in the EpiPen 
crisis’ unfolding. Specifically, this study will consider how the dominant Discourse 
around pharmaceuticals resulted in perceptions about viable medical alternatives like the 
EpiPencil as more dangerous to public health than the highly acknowledged unethical and 
leeching practices of pharmaceutical companies. Fundamentally, biohackers do not 
function to operate within corporatized pharmaceutical organizing. Their participation 
does not intend to profitize or compete along institutional logics. In their organizing, they 
do not intend to sustain traditional forms of organizing. Rather, they constitute a unique 
organizational position whose discursive and material outputs function as a way of 
(dis)organizing.  
Communicatively Constituted Organizing (CCO) 
Organizational communication scholars turn to various theoretical frameworks for 
considering how communication creates, sustains, and ends organizing (Schoeneborn & 
Vasquez, 2017). Rather than treating organizations as places where organizational 
activity merely occurs, some scholars argue “the properties of language and interaction 
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produce actual organizing” (Fairhurst & Putnam, 2004, p. 13). In other words, organizing 
arises through an interplay of texts, conversations, and social practices (Taylor & Van 
Every, 2000) that produce various ritualized talk, behaviors, and resources that make up 
and sustain organizing. Communicative Constitution of Organizations (CCO) is the 
metatheoretical framework used by organizational communication scholars to 
conceptualize the processes and various aspects of organizing as communicatively 
constituted. Additionally, multiple perspectives about what constitutes organizing exist 
within the CCO framework. This study borrows from several schools of thought but most 
often engages the Montreal School perspective due to its more fluid definition of 
organizing as co-orientating and emergent (Cooren, Kuhn, Cornelissen, & Clark, 2011; 
Cornelissen & Kafouros, 2008). 
Scholarship building upon CCO and its development has historically been 
theoretical with few studies contributing to its deployment and application in context 
(Koschmann, 2011). The field has additionally made calls to better understand core 
components of CCO (like agency) in-context through observable cases of analysis rather 
than as an a priori understanding. CCO has, to date, lacked clear distinctions between 
“organizations” and other forms of social collectives like networks, communities, or even 
social movements. Dobusch and Schoeneborn (2015) suggest that CCO should be 
expanded to assess a variety of other social groups, such as loose and fluid networks 
made up of organizations and groups, by focusing on their “organizationality.” Indeed, 
not only should other organizing forms like social movements be considered for their 
organizationality, but we can also valuably examine how various social actor groups—
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organizations, social movements, and governmentalities—influence and interplay with 
each other in specific contexts. 
Applied CCO research has typically contained instances of organizing, 
particularly how acts of organizing unfolds within specific organizations. These studies 
tend to focus on the processes within a specific organization and do less to examine 
larger social or institutional contexts. An analysis of the biohacker movement as a 
referent social and connected action has the potential to illuminate how certain actors 
behave in response to other referent contexts or other social actors, like organizations or 
social constructions. How biohackers frame and are framed by social constructs like 
bioethics and institutionalized talk influences how organizing occurs. This research will 
explore how CCO can explain the biohacker community attempts to legitimize in the 
context of a crisis, how the counter-narratives and materialities produced by individuals, 
social collectives, and connected groups can act as forms of resistance and contestation, 
and how institutionalized talk and text emerge in response to counter-logics. These 
biohacker goals are often pursued through material production. 
Matter and meaning as constitutive. Much the same way maktivism can focus 
on the material production of social movements, CCO literature has also made the 
material turn toward the agentic nature of materiality as a constitutive function of 
organizing (Ashcraft, Kuhn, & Cooren, 2009). Scholars argue that social constructs like 
values, principles, or ideas are not necessarily less material than physical objects and that 
the social and material world are intrinsically intertwined in action (i.e., the possibility for 
action-in-use is inscribed in a particular object’s existence, but its properties for action 
only emerge through its use). As a result, a focus of materiality is concerned with how the 
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social and material world are entangled (Leonardi, 2011). The “materials of bodies, 
sweat, machines, factories, cubicles, wages, benefits, exhaust fumes, timber and effluent 
[can] help explain why and when workers constitute their own organizing, display 
resistance, or fail to do so” (Cheney & Cloud, 2006, p. 505). That is, objects like 
technology, texts, and bodies are entangled within communication processes and carry 
various forms of meaning. Materials, in this case, are not merely artifacts but shape 
meanings for organizational members that orient behavior, thought, and activity. As 
Montreal School scholar Francois Cooren explains, “artifacts have a big role to play in 
the communicative constitution of an organization. They matter a lot. They count. They 
display agency to the extent that they ‘make a difference’” (Schoeneborn & Blaschke, 
2014, p. 298, emphasis in original). Indeed, the material turn is a shift toward exploring 
how matter makes itself known and is experienced, focusing on how materials come to 
represent and do more than what they are materially comprised of/from. 
Research on materiality has primarily focused on the role, function, and use of 
communication technologies within organizations. Scholars argue that material and social 
action, taken together, create new possibilities for action, to fundamentally change 
organizational or social structure, enact new routines, and create new alternatives 
(Leonardi, 2011). To understand the ways materials are agentic and constitutive of 
various comportments, including objects that resist, protest, and participate politically, 
this study will examine the sociomateriality of both the EpiPen and DIY epinephrine 
auto-injector alternatives.  
Reed (2010) suggests that, in general, CCO has fallen short of considering the 
material, discursive, and relational power in larger political contexts. There is a need for 
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research that focuses on specific material cases in the contexts of various constituting 
authorities beyond a single organization, including institutional authority, political 
authority, and competing corporate logics. Because social institutions are continually co-
constructed not only through everyday communication but also through space, place, and 
time, material resources should be considered central to the research; therefore, there is a 
need for research that explores how meaning and matter become materialized in larger 
sociohistorical contexts. Critical perspectives using CCO as a framework attend to the 
function of power and order, including notions of expertise, hierarchy, access to 
information, and ability to author artifacts of control, in the process of organizing and 
consider how materials constitute forms of authority (Cooren, Fairhurst, & Huet, 2012; 
Taylor & Van Every, 2014), as well as how they provide opportunities or create barriers 
for contestation.  
Issues of power are central to critical organizational communication research and 
can borrow from multiple perspectives in order to arrive at diverse and meaningful 
conclusions while also keeping critical perspectives at the forefront of CCO research. 
Notions of resistance are central to CCO research; however, rarely have concepts of un-
structuring or alternative organizing been considered (Kuhn, 2010). By studying 
alternative forms of organizing and social actors, like biohackers, this current study may 
contribute to the advancement of this literature. Despite a great deal of generative 
theoretical research on CCO and the role of materiality in organizing, several questions 
about the constitutive nature of organizing remain unanswered. This research aims to 
understand how organizing happens in the context of the EpiPen crisis. By examining 
research in context, I intend to intersect multiple critical theoretical frameworks to 
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consider how notions of organizing, biopower, and sociomateriality function in this 
study. 
Summary 
 This chapter contextualizes biohacking within multiple conceptual, theoretical, 
and socio-historical domains. Biohacking is a subculture that operates outside of the 
formal institutional boundaries of science and medicine. Biohackers participate in 
epistemological discourses of science and medicine yet simultaneously reject many of the 
dominant logics of corporate, political, and authoritative medicine. The movement is one 
of activism and making and engaging in sociomaterial forms of resistance. Organizational 
communication theory and scholarship have explored various aspects adjacent to 
biohacker culture, including notions of alternative organizing and resistance. 
Additionally, a critical post-structural lens provides an appropriate perspective for better 
elucidating biohackers as actors in the larger context of biopower and the economic-
political governance in the United States. This chapter presented multiple research 
questions to consider how a study of biohackers can contribute to various organizational 
communication literatures. The next chapter overviews the methodological approaches 
and procedures used to collect and analyze data. 
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CHAPTER 3: 
METHODS AND PROCEDURES 
Organizational communication research has a rich metatheoretical tradition of 
collecting, categorizing, and analyzing data across multiple discursive and organizational 
levels. Drawn from structuration theory (Giddens, 1984), multilevel analysis attempts to 
highlight/demonstrate the tensions between agency and structure in human organizing 
(Ashcraft et al., 2009). Because identities and relationalities are, at once, constructed 
across the individual level, the organizational level, and the institutional level, multilevel 
data ordering is often used as a way to delineate how functions of micro, meso, and 
macro orders interplay across space and time (Barbour, 2017). However, multilevel data 
analysis often attempts to categorize data into groupings that are not neat or discrete 
(Barbour, 2017). Further, communication phenomena have long and tangled histories, 
and the relationship between agency and structure is continually fluid and recursive. 
Whether data are categorized across hierarchical levels of social order (i.e., micro, meso, 
macro) or parallel discursive levels depends on the need and goals of the study at hand. 
This dissertation attempts to categorize data across, through, and in-between institutional, 
organizational, and group level discursive contexts. Therefore, this study borrows from 
and combines multiple approaches to data collection, organization, and analysis found 
within organizational communication research. 
Methodological Underpinnings 
The following section provides an overview of the various methodologies used to 
systematically identify, historically situate, and meaningfully categorize the data used in 
this study.  
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Critical Case Study 
Case study research provides a framework for looking at the specific ways 
organizational activities unfold. Critical cases are a nuanced approach for examining how 
social forces (e.g., power) influence individual behavior, aspects of organizing, and larger 
more enduring social constructs (Flyvbjerg, 2001). Critical cases also provide a context 
for solving and generalizing social issues that can lead to social transformation. Context-
based research helps situate multiple (oft-competing) voices in a particular context by 
depicting them in ways that both provide rich description and equally represent 
multivocality rather than a single master voice of authority (Tracy, 2007). Thus, a 
situated critical case study presents the opportunity to “track the passage of certain 
d/Discourses and the closure of others” (Broadfoot, Deetz, & Anderson, 2004, p. 198). 
Issues of access and health are important to examine in contexts and cases where 
notions of the body influence (and are influenced by) discourses of power, health, money, 
and science. Given the prevalence and influence pharmaceutical care has over how 
bodies are governed and disciplined, organizational communication scholarship can 
provide a practical lens for engaging critically with the complexities that influence the 
larger constitution of organizational and institutional knowledge within society. Crises 
can provide a specific context for examining how technologics subject new material 
interactions and collective meanings. Looking at the variety of potential biopolitical, 
bioethical, and critical organizational implications of the EpiPen crisis provides a unique 
context for contributing to health communication research, organizational communication 
research, and critical inquiry.  
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Discourse Tracing 
Discourse tracing is a useful method for organizing and analyzing data relative to 
a particular issue, case, or historical event. Discourse tracing attempts to map discursive 
changes across time in order to illuminate how various discursive practices interact, 
influence, and contest throughout time (LeGreco & Tracy, 2009). Certain discourses 
produce authoritative texts and routinized practices, reify social logics, and create new 
meanings, but they also silence, dismiss, or delegitimize other possibilities. Discourse, 
therefore, is how knowledge becomes structured, collectively accepted through the logics 
of that knowledge (i.e., the rules and facts that are seen as naturalized, the taken-for-
granted assumptions that underlie structures of knowledge), and given power within a 
social order through its (re)production in talk and text (Foucault, 1972). 
Tracing the “formation, interpretation, and appropriation” of certain discourses 
can elucidate how certain social and institutional systems come to be and persist in-
context (LeGreco & Tracy, 2009, p. 1519). Critical-interpretive scholarship emphasizes 
the role of discursive power, including how discursive constructions create meanings that 
lead to preferred ways of knowing (Lyon & Chesebro, 2011). Discourse tracing has been 
used as a methodological approach for investigating how rhetorical acts circulate various 
contexts and systems and how power becomes historically situated through such moves. 
Further, discourse tracing allows for data collection and analysis of multivocality 
(LeGreco & Tracy, 2009) by preserving the “little stories” in a particular case that may 
have become silenced, hidden, or historically forgotten (Boje, 2001; Deetz & McClellan, 
2009). Because discourses are historically situated, continually (re)constructed, and 
circulate across various contexts, I used purposeful sampling (Tracy, in press) to “choose 
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data that fit the parameters of the project’s research questions, goals, and purposes” 
(Tracy, in press, n.p.). Selection criteria included setting parameters of sociohistorical 
context, identifying a precise timeframe for the case, and limiting the case to certain 
discourses and actors. The following sections outline the methodological decisions and 
data management strategies I utilized to identify, gather, categorize, and code the data 
included in the parameters of this study.  
Rupture point. Discourses circulate across various contexts and permeate various 
contiguities without clear start or end points. Therefore, my goal was to identify a 
meaningful starting point from which to scope the “case” at hand. Drawing from 
discourse tracing, I first attempted to identify a rupture point (i.e., an event of 
significance that changes or signals a shift in the discursive organizing of a group or 
society, such as a sudden rise in costs or a natural disaster that results in a disruption in 
daily routines) (LeGreco & Tracy, 2009). Born out of Foucault’s (1972) notion of 
discursive formations, rupture points help a researcher scope their research project by 
identifying a moment of significance from which observable discursive changes or new 
discursive constitutions can be mapped and analyzed. For example, the terrorist attacks 
on September 11, 2001, “signaled a clearly defined shift in discourses about airport 
security and the eventual development of the Transportation Security Administration” for 
Malvini Redden’s (2017, p. 3) research on the constitution of new body politics through 
airport security pat-downs. However, rupture points do not necessarily need to be the 
main focus of the study. For example, Malvini Redden (2013) did not specifically study 
the events of 9/11 but instead used the event as a “jumping off point [from which] to 
focus on subsequent discursive practices” (Malvini Redden, 2017, p. 3).  
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Although this case study primarily centers around the discursive practices 
following EpiPen pricing in 2016, it is also a case of alternative discursive practices of 
resistance to historically dominant discourses of accessibility, ownership, and cost of 
medicine. The discursive and social conditions that EpiPen pricing grew out of predate 
and extend beyond the primary scene of the case. Thus, this case is situated within the 
realm of various discursive formations without neat time and space boundaries, which 
have been historically situated through enduring discourses. Although this is a study of a 
singular issue, the use of a rupture point should be thought of less as a singular event and 
more as the result of various logics that culminated in new divergences. 
 What is the rupture of this particular case? In 2015, issues of pharmaceutical 
price-gouging received international attention when Martin Shkreli, then-founder and 
CEO of Turing Pharmaceuticals, unapologetically raised the price of Daraprim (a drug 
that was also effective at combating toxoplasmosis related to the AIDS virus) from 
$13.50 per pill to $750 per pill (a 5,000% increase) a month after he purchased the 
exclusive rights to sell the drug (Daraprim Price Hike, 2018). The price hike drew 
immediate and overwhelming attention from politicians, journalists, health advocacy 
groups, and shocked citizens (Calderwood & Adimora, 2015). Almost overnight, 
pharmaceutical pricing became a public issue. However, when called in front of a senate 
committee hearing, Shkreli refused to answer questions and publicly mocked the 
members of congress who had questioned him on social media. Shkreli also unabashedly 
acknowledged that the price hikes were solely to make the company’s shareholders 
money. While profit has always been the cornerstone of United States capitalism, never 
before had a company been so unapologetic about price exploitation. Shkreli was dubbed 
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“the most hated man in America” by the national media, which further fueled a growing 
populist narrative around greedy Big Pharma executives who load their bank accounts 
while everyday Americans struggle to afford medications that keep them alive. 
 This immediately preceding event provides an important context for why EpiPen 
pricing became amplified throughout 2016 and 2017. Heightened political interest in, and 
media attention toward, pharmaceutical pricing, combined with a strong public memory 
of corporate pharmaceutical greed, directly contributed to the ways in which EpiPen 
pricing gained attention and drew such derision. Martin Shrkeli is not the focus of my 
study; however, the series of public events surrounding him represent a historical turning 
point from which the specific case in this study (the EpiPen pricing crisis) 
chronologically and situationally emerged. The course of events leading up to the scope 
of this case represent a rupture (or divergence) from the traditional dominant and 
authoritative discursive practices. Further, the preceding events represent a type of 
divergence that more closely mirrors a boiling point. Said another way, Shkreli was the 
fuse that lit the stove burner, mass media attention and public opinion turned the heat up, 
and soon Mylan found itself in the proverbial pot of hot water for its similar pricing 
tactics. For this study, the EpiPen price hike serves as a point of departure (forward and 
back) from which to analyze the specific conditions of the case at hand.  
 To validate an accurate rupture point, I mapped the height of online public interest 
around “EpiPen,” “epinephrine,” and “anaphylaxis” using Google Trends (n.d.), which 
illustrates the historical frequency of searched terms and phrases on Google.com dating 
back to 2012. In all instances, online interest and coverage around the EpiPen price crisis 
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peaked in August 2016 (see Figure 1)—immediately following the rupture point 
described above. 
  
Figure 1. Historical searches for case related terms over time. Retrieved from Google 
Trends, n.d., Epinephrine, EpiPen, Anaphylaxis, Retrieved September 19, 2018, from 
https://trends.google.com/trends/explore?date=2012-01-01%202018-01-
01&geo=US&q=Epinephrine,EpiPen,Anaphylaxis. In the public domain. 
 
Biohacker material-discursive practices. One of the reasons this case is ripe for 
analysis is that it marks the emergence of new discursive moves and modes of resistance 
in situ. Although the EpiPen is the central context of this case, this is not merely a case 
study of pharmaceutical bad behavior. Rather, it is a study of the ways alternative 
discourses emerge in times of crisis, how resistance is enacted and materialized, and how 
social change can constitute new meanings and challenge preferred ways of being and 
knowing (Lyon & Chesebro, 2011). Although the biohacker community has received 
some academic attention (e.g., Delfanti, 2012; Dunbar-Hester, 2014), few studies have 
attempted to observe and analyze the enacted discursive practices of the biohacker 
community implanted in action. Indeed, this case is one of the few (and certainly early) 
examples of the biohacker community moving from fringe conversations (on the internet 
and in small social circles) to the dominant narrative, in response to a social crisis. Thus, 
the discursive practices of biohackers in response to a social crisis provides a case ripe 
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for analysis. And the rupture point functions primarily as a point of departure from which 
to map the “formation, interpretation, and appropriation” of various discourses over time 
(LeGreco & Tracy, 2009, p. 1519) and consider how certain discursive fields become 
situated, hidden, contested, or transformational in context—something I turn to next. 
Discursive fields. Discourse tracing typically attempts to categorize data into 
three discrete levels of analysis: micro-level data tends to focus on localized talk and 
individual practices (Fairclough, 1995); meso-level discursive practices include analysis 
of data focused on group-level (e.g., team, organizational) practices, interactions, and 
processes that have become routinized and formally codified (say, through organizational 
policy); and macro-level data functions to reveal enduring systems of thought and 
normative social practices spanning across institutional contexts (for example, in laws or 
ideological norms) (LeGreco & Tracy, 2009). This type of categorization is useful for 
studies that attempt to examine instances of discursive activity within a single scene. As 
mentioned previously, Malvini Redden (2013) employed discourse tracing as a method of 
mapping the ways the creation of the Transportation Safety Administration (TSA) led to 
body screening procedures and policies that changed the treatment of bodies in public 
spaces (specifically airports and security screening lines). Malvini Redden mapped the 
ways post-9/11 macro-level discourses of fear and safety became enacted agency (meso-
level) pat-down policies and constituted new authorities over travelers’ bodies and 
identities (micro-level). Similarly, LeGreco (2007) studied the effects of food politics on 
adolescent attitudes and behaviors toward food. Her study traced the ways federal and 
state laws (macro) became interpreted and applied in school cafeterias and lunchrooms 
(meso) to further define students’ attitudes and behaviors toward food (micro). In both of 
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these studies, the foci were on micro-level interactions in relationship to the interpreted 
enactment of meso- and macro-level moves.  
Although this study looks across multiple levels of discourse, the 
micro/meso/macro distinction can also be problematic for several reasons. First, 
discourse tracing is a categorically messy form of analysis. Way (2012) reminds that “in 
practice, levels of discourse do not operate in a vacuum or separate from one another, but 
are highly dependent upon one another and deeply intertwined” (p. 55). Discourse tracing 
can also result in data categorization issues. For example, macro-level data, which 
evidences enduring systems of thought and taken-for-granted assumptions, can be 
observed through macro-, meso-, and micro-level data sources. Given the “robust and 
sometimes unwieldy dataset” (Malvini Redden, 2017, p. 2) appropriate for discourse, 
data categorization specific to the unique demands of the case at hand should be 
developed. Further, my particular study diverges from traditional discourse tracing 
because the primary focus of this case is not localized micro-level behaviors and talk. 
While this study focuses on biohacker collectives, its focus is not on the interactions or 
local talk of biohackers. To resolve these differences, this study will diverge from the 
multilevel micro/meso/macro distinction typical to discourse tracing and instead 
categorize texts, talk, artifacts, and practices by types of discursive actor(s) and 
discursive fields.  
To define and categorize by discursive fields (i.e., groupings) and data within 
each field, I used the following orienting questions: 1) what systems (actor groups) 
contributed to creating the kind of knowledge necessary to lead this case to its rupture 
point; 2) what institutional structures and materialities preserved certain historical 
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discourses over time; and conversely, 3) what voices/actors shaped the norms and 
practices that had become embedded into the social fabric of the case at hand; and finally 
4) what materialities were deployed to dispute historically dominant discourses? These 
questions provide a frame of reference that deviates from the traditional discourse tracing 
by focusing on both discursive formations before the rupture point as well as the 
discursive moves following the rupture point. Doing so extends the scope of the case at 
hand and situates the case in a larger socio-material context. 
From these questions, I identified the following primary actors responsible for, or 
involved in, the creation, proliferation, preservation, and disruption of prominent 
discourses within the rupture point: 
● Government actors: e.g., senators, government agencies, and the enactment of 
government policy 
● Organization-level actors: specifically, Mylan, its tactics, and influence over other 
meso-level actors to advance the development and dependency of the EpiPen in 
the allergy community 
● Industry actors: including consumer advocacy groups, medical professionals, and 
legal experts (derived from data collected) 
● Broad public opinion and representations of public opinion in mass media: and  
● Biohackers: including the texts and artifacts produced and enacted as a way of 
resisting dominant discourses 
These categorizations allow for a more precise extrapolation of how various actors’ 
interests, logics, and knowledge(s) become situated in various discursive formations 
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(Foucault, 1972) and how various discourses converge, diverge, and compete over 
discursive practices over time (Fairclough, 1995). 
Data Gathering 
As noted previously, discourse tracing can be a messy endeavor. To create an in-
depth description and chronology of the case and to accurately capture the various 
discursive practices across various actors, I included a variety of data types, sources, and 
methods of collection (Denzin, 1978). Because the primary crisis in the EpiPen case was 
related to the cost of EpiPen devices and to establish an accurate chronology of events, I 
began by collecting historical data relevant to EpiPen pricing using internet searches, 
historical newspaper archives, news reporting, and data sources from Mylan. Then, I 
traced a chronology of news coverage of the EpiPen crisis from historical newspaper 
archives and internet searches, using key terms. From there, I reviewed various types of 
data across all actor groups, including texts (e.g., publicly available documents, laws), 
talk (e.g., online conversations and discussion boards, transcripts of interviews), and 
practices (e.g., data on buying habits, citizen petitions), and other artifacts (e.g., images, 
videos). Data were gathered from mass media and news reports, corporate press releases, 
publicly available congressional documents, state and federal laws, legal briefs, online 
discussion boards, YouTube videos, social media data, medical guidelines, data retrieved 
through Freedom of Information Act (FOIA) requests, and other publicly available online 
data sources. During my initial data discovery, I collected and reviewed 57 unique data 
sources, including 2,775 single-spaced pages of text, 24 hours of transcribed video, and 
22 images. 
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I continued to collect and immerse myself in open data collection until I felt I had 
reached maximum variance sampling (Tracy, in press) to ensure that usually overlooked 
and marginalized data are considered for inclusion. I determined initial data collection 
complete when I was able to notice consistent patterns across the data. I approached 
initial data gathering with the goal of establishing requisite variety (Weick, 2007). 
Data Validity and Purposeful Reduction  
During my initial data collection, I cast a wide net with the goals of including a 
polyphony of voices, mapping the larger context for the case, and ensuring that the data 
adequately illuminated issues of power and conflict (Flyvbjerg, 2001). Doing so provided 
me with a large set of disparate data. However useful, casting such a wide net naturally 
resulted in some data that were hard to validate/substantiate, may not have had data 
validity, or may not have been useful for analysis.  
For example, I looked for data specific to “public complaints about EpiPen 
pricing.” One of the sources from my initial data collection included an online citizen 
petition asking congress to “Stop the EpiPen price gouging” on the website 
Petition2Congress.com. Another was a list of all complaints submitted to the Federal 
Trade Commission (FTC) about Mylan and EpiPen pricing. Although the online citizen 
petition to congress was signed by over 145,000 individuals and was mentioned in 
multiple news reports as evidence of public discontent, my review of the data suggested 
that the source was not necessarily valid for analysis. For instance, I had no way to verify 
the actual number of unique individuals who signed the petition (e.g., individuals could 
sign the petition multiple times and as often as they wanted). Similarly, a review of each 
of the 95,000 public comments added to the petition revealed that the same people had 
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left comments multiple times, and some of the responses seemed be added for the 
purposes of internet trolling (i.e., comments that are meant to intentionally sow discord, 
distract from the primary purpose, or provoke others). And although the website the 
petition was hosted on appeared legitimate, there was no way to verify that the petition 
responses had ever been shared with any government agency or congresspersons. Thus, 
the petition was heuristically useful (and therefore remained as a part of the data set) but I 
deemed it was not valid enough to use for data coding. On the other hand, citizen 
complaints about Mylan and the EpiPen submitted to the FTC were obtained from a 
reporter who had retrieved them from a FOIA request. The latter data source provided the 
same level of insight but with more validity for coding. 
 For my entire data set, I applied the same rigor of assessing what ways the data 
were valuable and valid and then engaged in purposeful reduction (Tracy, in press) to 
only include data that provided the most benefit to further analyze by using specific 
discriminating criteria. 
Primary Data 
 Primary data were categorized by “type” of data, with a consideration for both the 
producer of the data and the format of the data (See Appendix A). The following section 
provides descriptions for each of data types included in this study. 
Institutional texts. As part of my primary data considerations, I used the 
definition of “text” to mean that which is written and codified with a consideration for 
what those texts do (i.e., what unfolds as a result of the enactment of a text) (Taylor & 
Van Every, 2000). Institutional texts refer to artifacts that create the structures of 
discourse fields, in this case medicine (and more specifically the medicalization of 
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anaphylaxis-related care). For the purposes of this study, primary texts were limited to 
those that were constitutive or contractual in nature (Cooren, 2004), signified agreement 
between two or more of the actor groups, or was produced by an actor group in direct 
response to another actor group present in this case. Institutional texts, as defined in this 
study, are those that are meant to be declaratory or agentic (created to be authoritative, 
constitute particular options, advance the interests of a particular group, and/or establish 
an official stance). I also chose to prioritize official and formal texts that were created by 
actor groups across the various discursive fields used in this study. These texts include 
official press releases, official statements by company spokespersons, transcriptions of 
official legal or congressional testimonies, state and federal laws, publicly available 
company policies, patents, legal documents, website content authored by the organization 
and more. Most of the data were available online through government and corporate 
websites or archival data searches. 
News reporting. Mass media reports are useful data sources for analyzing 
enduring social and institutionalized ways of thinking. Cooren’s (2010, 2012) notion of 
ventriloquism (which treats communication as the constitution of many authors and 
voices through a speaker) provides insight into not only what an author is explicitly 
saying but also “all the things that might be speaking through” that person (Cooren & 
Sandler, 2014, p. 238). Thus, ventriloquism “problematizes the question as to who or 
even what is speaking, or more generally, saying or doing something in a given situation” 
(p. 230). Løvgaard & Strand (2014) suggest that news writers and reporters act as 
“puppet actors” who express enduring systems of thought and preferred ways of knowing 
through their reporting. They note that discourse is not what is said, but rather “discourse 
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is what ‘decides’ what is meaningful to say” (Løvgaard & Strand, 2014, p. 263). Media 
reporting serves as a function for gathering broad public opinion, as media are known to 
simultaneously shape public opinion while representing it. As such, I considered the key 
points and issues journalists and reporters were attempting to inform the public about 
through their writing and identified what institutionalized constructions (e.g., the news, 
medicine, etc.) were present. I also considered what discursive constructions and 
enduring frames of reference (e.g., deference to expertise, neoliberal ideologies, broad 
social apprehensions, etc.) led the author in determining what was included in each text 
and, conversely, what was left out or disregarded. 
Therefore, news media were considered a primary data source for analysis and 
coding for both what is being said or written in the article and for what the article says 
and reveals about how problems are framed, what solutions are considered/available, and 
where authoritative voices may shape how decisions are made and whose interests are 
taken up. To delineate and prioritize mass media texts, including news articles, reports, 
and journalistic coverage, I chose to focus on texts that were primarily about the EpiPen 
crisis, biohacker responses to EpiPen pricing, or articles that specifically mentioned 
Mylan, EpiPens, or biohackers. Further, I prioritized news stories that included quotes or 
statements from experts or authoritative voices, including consumer advocacy groups, 
government agency spokespersons, medical professionals, university professors, and 
legal experts. These second-hand quotations are both a matter of convenience—gathering 
perspectives and voices of individuals across various groups—and reveal what voices are 
shared and what perspectives are validated through ventriloquizing.  
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While gathering media sources, I attempted to collect stories from a variety of 
outlets, including international, national, local, and industry-specific sources. Primary 
news media were gathered from internet resources like web searches, website archives, 
historical newspapers articles, and online news reports. Because media companies in the 
United States are often classified in terms of their political bias, I also attempted to 
include representation of sources across the political spectrum to get a broad sweep of 
perspectives and interpretations. In all, I gathered 66 primary news sources for analysis. 
Materialities. This study primarily centers around discourse produced through 
medicalized devices, specifically epinephrine auto-injectors and the medical components 
that make them up. Thus, this study is concerned with the relationship between 
materialities and discursive constructions. Material storytelling considers materials not 
simply as objects but also as sites of enactment (Sørensen & Strand, 2014). For example, 
rather than focusing on a “chair,” material storytelling considers the way(s) a chair 
functions as a form of inter-activity. Sørensen and Strand (2014) suggest that objects 
(apparatuses) hold constitutive agency; therefore, this study includes various material 
apparatuses as primary data and considers them in terms of their material-discursive 
constitutions. That is, this study analyzed how materials function as sites of enactment 
(e.g., how materials become enacted and function to create various types of inter-
activity). Primary material data included multiple epinephrine auto-injectors, do-it-
yourself options, and on-the-market products. I also analyzed the sites where material and 
discursive inter-activity occurred, particularly the spaces and places where materialities 
like the EpiPen and EpiPencil were invited and, conversely, where they were not allowed. 
For example, the primary mechanism for demonstrating how to make a do-it-yourself 
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epinephrine auto-injector occurred on YouTube; therefore, this study analyzed the ways 
in which devices were represented, deconstructed, reconstructed, and used in YouTube 
videos. Using material-discursive modalities of analysis, this study will be able to 
consider what aspects of hegemonic and discursive power materialities hold in the case, 
particularly related to where contestable boundaries lie.  
Visual artifacts. Cooren and Sandler (2014) suggest that individuals 
ventriloquize and are ventriloquized by more than just talk and conversation, including 
anything that might be deemed as “animating, moving, preoccupying, interesting, or 
enthusing” talk and conversations (p. 238). Therefore, this is a study of things that 
materialize through discursive and material productions. Photos/images are a central form 
of cultural studies that can illuminate the subjectivities and context-dependent meanings 
created by and through their production over time (Margolis & Pauwels, 2011). Because 
images are useful to consider the primary materialities created by relevant discourses, as 
well as the primary discourses created by the relevant materialities, visual materials for 
analysis include historical photos, instructional online videos, instruction manuals, 
technical diagrams, and analysis of the production of devices through images and videos. 
Although all videos were transcribed for textual/content analysis, I took screen 
captures—still images from moments within the video—for visual analysis. Additionally, 
as part of this study, I obtained the materials needed to make a do-it-yourself EpiPencil as 
well as an EpiPen, in part to analyze the material similarities and differences. I 
documented my material analysis through photos, which also served as primary data for 
this study.  
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DIYBio interviews. I originally became interested in the biohacker movement 
several years before beginning this particular case study. Approximately one year before 
data collection on this project began, I had been conducting research on a biohacker 
collective known as DIYBio, a governing consortium that provides resources to local 
self-organized chapters spread across the world. While studying the organizational 
structure of the DIYBio groups, I developed relationships with nine biohacker 
communities across the United States. From my communications and relationships with 
the communities, I negotiated six semi-structured explorative responsive interviews 
(Rubin & Rubin, 2005). Questions focused on how members identify as “biohackers,” 
how they make sense of their role as non-expert citizen scientists, and what hopes and 
fears they have for the future of biohacking. Interviews were approved by the Arizona 
State University Institutional Review Board (IRB). All interviews were audio recorded, 
transcribed, and thematically coded. In all, the interviews resulted in 44 single-spaced 
typed pages of transcripts. While none of the interviews or subsequent conversations I 
had with the DIYBio groups specifically attended to the EpiPen crisis, my relationship 
with DIYBio attenuated me to an awareness of the EpiPen case as it unfolded. Further, 
the interviews provide interesting context that is useful for interpreting the case at hand. 
As such, in the analysis that follows, I reference excerpts from these interviews to 
provide perspectives and voices of the biohacker community. 
Expert source: Four Thieves Vinegar. To more clearly understand the 
motivations and enterprising logics that guided the actions of the primary biohacker 
collective—Four Thieves Vinegar—in this case, I contacted the collective’s spokesperson 
and conducted a private expert interview for analysis. The ASU IRB-approved interview 
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provided a first-hand perspective about multiple issues. These included why the 
collective chose to respond to EpiPen prices and make their own device as a display of 
resistance, what intentions they had for the public using the device as a viable alternative 
to the EpiPen, and how they made sense of their desired and realized role in the larger 
discourse around medical access and cost. The interview was conducted virtually via 
video conference software, recorded, and then transcribed, which resulted in 10 pages of 
single-spaced text for analysis. The data were then uploaded to Dedoose data analytics 
software for analysis. 
Data Analysis 
Data analysis followed an iterative-abductive approach (Tracy, in press) that 
moved back and forth between data collection, analysis, asking specific/guided questions 
of the data, gathering more data as needed, and reviewing additional literature in order to 
best explain the phenomena observed.  
Chronological Ordering  
Consistent with discourse tracing, I first organized the primary and non-primary 
data in a chronological order of events, using the August 2016 rupture point (described 
earlier in this chapter) as the point of departure, both forward and backward (see 
Appendix B). Data ordering motivated my initial mapping of the dominant discourses 
that moved throughout time and space, and illustrated ways various actors’ material-
discursive moves and tactics were enacted. Chronologizing the data allowed me to 
examine whether the data I had collected was sufficient to map a rich history of events 
relevant to the case and create meaningful coherence of the data. 
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As a result of chronological ordering, I also collected additional data that 
broadened the historical timeframe and background of the case. Additional data included 
rhetorical moves and communication events (i.e., discursive enactments) that further 
illuminated various discourses and actors. For example, I chose to include data that dated 
back to the pre-marketplace origins of epinephrine auto-injectors. Doing so allowed me 
to consider the a priori logics that moved throughout the discourses in the case at hand, 
particularly related to medicalized knowledge and the genealogy of allergies and 
anaphylaxis. This theoretical sampling (Tracy, in press) of additional data resulted in my 
identifying and analyzing 66 new data sources. In all, 134 primary data sources were 
coded and analyzed (Table X). Twenty-two data sources were not coded, but were 
retained for heuristic value, context, and insight. 
Table 1 
Summary of Primary Research Data 
Type of Data Number of Sources (Pages) 
Institutional Texts 11 government texts (234); 
11 Mylan texts (37); 
7 pharmaceutical industry texts (143);  
5 consumer/patient advocacy organization texts (49); 
5 medical professional maker texts (116);  
4 medical industry texts (56); 
5 biohacker texts (20) 
News Reporting 38 news sources (178) 
Materialities 3 epinephrine auto-injector devices; 
1 EpiPencil 
Visual Artifacts 32 images;  
7 videos (28 transcribed) 
Interviews 4 DIYBio Interviews (20); 
1 Expert Source—Four Thieves Vinegar (15) 
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Data Synthesis  
As described earlier, data were collected and then prioritized as primary and non-
primary data as a means of practicing purposeful reduction. Non-primary data remained 
in the dataset for their heuristic value and for building a clear picture of the relevant 
events of the case but were not used for further coding or analysis. Primary data, in 
contrast, were synthesized for interesting, significant, and frequent codes (Saldaña, 
2015). Data synthesizing is an important practice for developing a “working skeleton” for 
the data analysis (Tracy, in press). Preliminary data synthesis provided guidance for 
identifying sensitizing concepts and themes. For example, I created themes pertaining to 
the regulation of medical device development, including issues of safety, regulatory 
processes, and guidelines around quality and use; commonly expressed concerns and 
fears, like those regarding safety, access, price, lack of oversight, and deviance from 
established medical protocols); and overarching issues in need of fixing, such as free 
market enterprise, healthcare affordability, importance of access for emergency response, 
and deference toward authority. 
Primary Cycle Coding  
During initial thematic data synthesis, and in line with recommendations from 
discourse tracing (LeGreco & Tracy, 2009), themes emerged by my asking specific 
questions of the data or creating questions my data could answer. Questions were guided 
by my research goals of elucidating the ways discourses move between, across, and 
among actors; how power becomes embedded in dominant discourses; and how 
resistance and dissent are enacted during social crises. To consider aspects of power, I 
considered: 1) who was speaking, 2) how authority was represented, and 3) who was 
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authorized to speak. Additionally, I borrowed from Flyvbjerg’s (2001) suggestions for 
critical case study research by considering who would benefit and who would lose from 
the represented perspectives.  
This case primarily centers around discourses of health, money, and science and, 
more specifically, how institutional organizing affects public life and personal wellbeing. 
Therefore, I was especially attuned to analyzing texts and artifacts addressing issues of 
health, cost of care, access, and quality of care across the data sets. Further, because this 
is also a case of counter-narratives and dissent, I also analyzed for the ways in which 
discursive and material dissent were enacted and considered what solutions are seen as 
legitimate, which are not, and why.  
For each theme, I then created a codebook to further categorize data by codes. 
Within the codebook, I wrote a description of each code and listed poignant examples 
from the data. For example, I coded for “FearAnaph,” which refers to data that express 
fears and concerns about the risks associated with anaphylaxis; “Use-Admin,” which 
refers to talk and text about use of the EpiPen as a preferred “fool-proof” technology (i.e., 
ability to administer epinephrine quickly, consistently, and safely); and “MedEnterprise,” 
which refers to instances where medicine and medical technologies are talked about in 
terms of their free-market enterprising roles and values. As with my themes, I also looked 
for sub-codes within my codes that expressed multiple perspectives of voices relative to 
each code. For example, when coding for how issues of “access” were framed, I sub-
coded for how institutional actor groups and agencies addressed access (e.g., “Mylan 
emphasized that it has expanded access to EpiPens by distributing them for free at 
schools”), as well as sub-coded for how counter-voices framed access (e.g., 
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“Pharmaceutical technology, like software, should be open-source and accessible.”). 
These codes were useful in teasing out the nuanced ways the problems were framed, 
institutionalized, and constructed, as well as how actors talked about and attempted to 
address those problems. Primary cycle coding also elucidated contestations, including 
what discursive constructs could and could not be contested within the dominant 
discourses. 
Phronetic Iterative Analysis  
Consistent with a phronetic iterative approach to analysis, “which alternates 
between emic, or emergent, readings of the data and an etic use of existing models, 
explanations, and theories” (Tracy, in press, n.p.), I used primary cycle coding as a 
preliminary step toward further organizing and synthesizing my data into larger 
interpretive concepts. Specifically, I next engaged in a process known as analytic casing 
(Ragin, 1992), which allows for taking a topical focus (i.e., a case) and analyzing a 
complex dataset in a way that raises up the findings to larger abstractions, such as 
theoretical concerns, methodological contributions and expansions, broader social 
concerns, and more. Observations about the EpiPen crisis, for example, “cases up” to 
larger empirical and theoretical issues regarding medicalized knowledge, biopolitics, 
institutional resistance, and sociomateriality. Therefore, secondary data analysis included 
using broader conceptual frames and methodological approaches to data categorization 
and synthesis.  
To help in casing up, particularly as it is related to how enduring 
institutionalizations of medical knowledge and governance of the body in the context of 
allergy, I next turned to Rose’s (2012) guide for discursively analyzing a “history of the 
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present.” In applying Rose’s methodology, I looked for the following frames present in 
the data: 
● Problematizations: This refers to the way “problems” are presented and 
framed, often in relation to various (moral, political, economic, military, 
etc.) concerns. Building from primary cycle coding, I looked for how the 
authority groups I previously identified problematized issues in the case 
(i.e., issues of access, cost, and safety). I further considered what tactics 
have historically been used to preserve or guard against those issues. 
● Explanations: This refers to operative concepts, such as how certain 
domains of evidence are designated, how criteria of proof are offered, and 
how forms of visibility, preference, remarkability, and calculability are 
granted to certain explanations but not others. To analyze for these 
explanations, I identified data that suggested the ways medicalized 
preference was given to measuring and evidencing how things like 
“safety,” “quality,” “reliability,” and other preferred functions of 
medicalization have been qualified and used as evidence for preserving 
dominant discourses. 
● Technologies: This refers to how certain technologies, protocols, or 
treatments are constructed or deployed as a means of judgment, including 
what techniques are offered or employed to intervene, “reform,” or “cure” 
the problem at hand. I identified the various technologies seen as modes of 
treatment (e.g., legislation reform, medical treatments, etc.) to fix the 
problem by analyzing what was being proposed as a “solution frame” for 
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the problem by each of the various actors and examining what tactics and 
technologies of control were employed to solve the problems. 
● Authorities: These refer to the ways certain expertise function as modes of 
authority, the ways certain procedures are used to acquire and maintain 
authority, and whose interests are advanced as a result of expert authority 
opinion. Authorities were previously identified and categorized during 
data gathering and analysis; however, a second consideration for new 
observations was given. 
● Subjectivities: These refer to the those who are subjected to/by the 
prevailing discourses or traditional governance models of behavior and 
thought. To analyze these, I looked for terminology that frames or attacks 
individuals as creators of new forms of being and knowledge, particularly 
in the ways the biohacker communities were framed. Subjectivities for this 
study were also analyzed with special consideration for the sociomaterial 
artifacts, particularly as they related to forms of testing, privileged 
treatments, and regimens of acceptability (i.e., what individuals must do to 
themselves, what practices or regimes they should follow, and how they 
should conduct themselves). Subjectivities provided a lens to consider 
how new discursive formations of do-it-yourself technology were shut 
down and how biohacker responses to traditional forms of allergy 
treatment were still subjected to allergy governance. 
● Strategies: These refer to certain actor groups’ aspirations and goals for 
governance and treatment, including the connections and associations with 
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political, organizational, and systematic logics. To analyze strategies, I 
explored the ways bodies, allergy, and treatment have been historically 
and systematically governed and become governed, particularly through 
the policy, agreements, and an ethos of self-care. 
These dimensions allowed me to conceptually 1) identify the problem-spaces carved out 
by authorities, 2) consider how certain solution frames were legitimized and enacted 
through various technologies and strategies, and 3) analyze the ways subjectivities have 
come to be governed. In total, this approach painted a history of the present that revealed 
the ways epinephrine auto-injectors function as a material-discursive formation to govern 
allergy and considered how various discourses circulated among the various actors in this 
case. 
Summary 
Chapter 3 provided an overview and outline for the methodological choices made 
to identify, gather, organize, and make sense of data as part of this case study. A 
combination of phronetic-iterative and critical-interpretive approaches, including 
discourse tracing and critical case study analysis, provided the framework for the analysis 
techniques used that ensured processes were appropriate, credible, and rigorous. In the 
next chapter, I will highlight the primary findings from data analysis.  
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CHAPTER 4: 
EPIPEN AS A HISTORY OF THE PRESENT:  
DISCURSIVE AND GENEALOGICAL TRACING 
The previous chapter provided a detailed overview of the methodological 
approaches used to collect, organize, prioritize, and analyze data for this study. Discourse 
tracing (LeGreco & Tracy, 2009) first recommends identifying a critical rupture point 
from which to map the discursive moves of various competing discourses. The rupture 
point in this case served as a reference point from which to “case.” Discourse tracing first 
requires chronologizing the relevant events in the case. Chronology is useful because it 
can show how various texts and conversations move throughout discursive fields in 
context. Thus, the first part of this chapter provides a chronology of the case. 
The primary section of this chapter answers RQ1 by considering what discursive 
formations and institutional logics shape the case. To answer this question, I borrow from 
Foucault’s (1977) notions of genealogy as “histories of the body” in order to trace what 
historical systems, structures, and logics have come to produce certain domains of 
preferred knowledge, relationships of power, and new forms of subjectivity on society. 
Logics are codified and embedded “rules” that produce objects of power, such as texts, 
knowledge, artifacts, principles, protocols, laws, and more. The next section then traces 
the logics of medicine, specifically allergy and allergy governance, and logics in 
government-developed medical technologies. This chapter then re-situates the EpiPen as 
the dominant logic for allergy governance by analyzing various medical, corporate, and 
political strategies, tactics, and biopolitical enactments. 
 
60 
Chronologizing the Case 
According to an economic analysis of wholesale epinephrine auto-injector prices 
over time, the original average wholesale price of a single EpiPen auto-injector in 
1986/87 was approximately $35.59, or about $82 USD today, calculating for inflation 
(Westermann-Clark, Fitzhugh, and Lockey, 2012). Shortly after the EpiPen’s original 
commercial market release, the Associated Press (Siegel, 1988) published articles 
appearing in newspapers around the country describing the three primary options 
available for patients needing a prescription for emergency epinephrine: 1) The newly-
available EpiPen, described as a “pre-loaded, push button syringe that looks like a 
fountain pen” (p. 8A), would cost patients $20–$30; 2) Patients who preferred to use the 
market alternative Ana-Kit (i.e., a small red emergency kit that included a syringe pre-
filled with a double dose of epinephrine, several diphenhydramine tablets, and a couple 
rubbing alcohol towelettes–see Figure 2), could expect to pay “between $17 and $22” (p. 
8A); and lastly, 3) price-conscious customers could simply purchase glass ampules of 
epinephrine for around $5 per vial and draw their own epinephrine using syringes that 
cost $.20–.50 cents each. 
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Figure 2. Ana-Kit produced by Hollister-Stier beginning in the 1970s–80s and 
discontinued in the 1990s. Reprinted from Wellington County Museum & Archives 
Collections Catalogue, n.d. Retrieved September 28, 2018, from 
https://wcma.pastperfectonline.com/webobject/0FCB13F8-0F68-4EF0-B1EF-
545747234270. In the public domain. 
 
Although the cost of the drug epinephrine has not changed in more than three 
decades—a single vial today still costs around $5—the price of epinephrine drug delivery 
devices, most notably the EpiPen, have skyrocketed. In fact, at the height of the EpiPen 
pricing crisis in mid-2016, EpiPen wholesale acquisition cost hovered between $600 and 
$700. From their release in 1987 until 2007, EpiPen prices had remained reasonably 
affordable. However, in 2007, when Mylan purchased marketing and distribution rights 
for the devices, EpiPen prices began to increase. According to a congressional report on 
the price of EpiPens, in 2017 an EpiPen cost about $100 wholesale. By 2012, the cost of 
a 2-pack—in 2009 Mylan stopped offering the option to purchase a single EpiPen— had 
risen to $218. By 2014, the cost was $350, and by 2015 the price increased to $460. And 
by the summer of 2016, at the peak of public outcry, the price averaged $608 (Reviewing 
the Rising Price of EpiPens, 2016). In the nine years Mylan oversaw EpiPen distribution, 
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prices increased more than 500%. For comparison, the annual inflation rate in the U.S. 
over the same period of time is 1.78%, and the total/cumulative inflation rate over that 
same nine-year period of time is 15.8%. To put it more clearly, the price of a single 
EpiPen prescription was 30 times more than the annual inflation over the same nine-year 
period of time. Moreover, Mylan had established a dominant hold on the market by 
supplying more than 90% of all U.S. epinephrine-based prescriptions. By 2016, 
epinephrine auto-injectors had become standard practice, and EpiPens had become the 
preferred brand. 
Public concern for EpiPen pricing traces back to as early as 2012 when 
Westermann-Clark, Fitzhugh, and Lockey published a letter in the Journal of Allergy and 
Clinical Immunology that cited evidence that a growing number of their patients were no 
longer able to afford to EpiPens and other auto-injector devices. The authors suggested 
that the increase in cost was “resulting in a significant economic burden for some patients 
and families” (Westermann-Clark et al., p. 822). In the same letter they reminded doctors 
that “lower-cost alternatives exist” (p. 822), such as reverting back to pre-filled syringes 
(PFS), and noted that they can still be “safely provided to patients who cannot afford 
prescription auto-injectors” (p. 822). EpiPen pricing received very little media attention 
in the year and half that followed.  
Then, in 2014, two non-mainstream articles reignited concerns about EpiPen 
prices. In the first article, appearing in The Valley Advocate (an alternative news outlet), 
the author shared her experience of traveling to Canada to buy an EpiPen (which can be 
purchased over-the-counter) for $94 without insurance as opposed to more than $300 she 
would have to pay out-of-pocket (even with insurance) in the United States (Allen, 2014). 
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The second article, written by a pediatric emergency physician in the Pacific Standard 
(an independent journal focusing on social justice issues), expressed sticker shock over 
the cost of her daughter’s EpiPen prescription. She noted that “increasingly, some have 
no choice but to go without, forced to gamble on their children’s safety” (Arnold, 2014, 
para. 14).  
That same year, overall concern for a trend toward rising pharmaceutical costs a 
led two U.S. congressmen – Democratic Representative Elijah Cummins (ranking 
member of the House Committee on Oversight and Government Reform) and 
Independent Senator Bernie Sanders (chairman of the subcommittee on Primary Health 
and Aging, Senate Committee on Health, Education, Labor and Pensions) –to launch 
investigations into “soaring generic drug prices” (Sanders, 2014, para. 1) for 14 generic 
drugs that had seen marked increases in price. Generic medications (i.e., drugs that are no 
longer protected by drug patents and can be manufactured and sold through names 
outside of the original brand name) are meant to lower medication prices due to the 
possibility of increased market competition. However, Cummins and Sanders concluded 
that while “generic drugs were meant to help make medications affordable,” (Sanders, 
2014, para. 5), certain generic drugs were experiencing “huge upswings” that were 
“hurting patients” (para. 6). In fact, they found that all 14 drugs in their investigation had 
average price increases between 388% and 8,281% (Sanders, 2014). Pharmaceutical 
pricing had become a national issue and was receiving widespread media and political 
attention. Drug pricing had become one of the most important platform issues for 
candidates in the 2016 presidential election, following a growing public concern for 
growing drug prices (DiJulio, Firth, & Brodie, 2015; Kirzinger, Wu, & Brodie, 2016; 
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Rovner, 2016) and a growing public distrust in pharmaceutical companies (Snyder Bulik, 
2018).  
In July 2016, multiple mainstream media articles cited that “some allergy 
sufferers are going to extraordinary—and dangerous—lengths as an alternative to paying 
through the nose for EpiPens” (Tuttle, 2016, para. 6). According to the authors, some 
parents chose to have their children rely on expired devices, while others turned to 
“riskier DIY alternatives” such as purchasing manual syringes and having them “filled 
with the epinephrine at a doctor’s office” (Swetlitz, 2016, para. 7). As media attention on 
EpiPen pricing increased, so too did political attention. Twenty senators joined together 
in writing to Mylan CEO Heather Bresch to express their “concern with the repeated and 
significant price increases” (Sanders et al., 2016, para. 1) for EpiPens and noted that the 
device “has become so exorbitantly expensive” that the price is putting U.S. citizens “in 
jeopardy” (para. 3). Concern was consistent across democratic-republican party lines. 
Senator Amy Klobuchar (chair of the Senate Judiciary Antitrust Committee) requested 
that the Federal Trade Commission (FTC) investigate possible antitrust violations by 
Mylan (Klobuchar, 2016). Senators Chuck Grassley (of the Senate Judiciary Committee), 
Susan Collins, Claire McCaskill, and Richard Blumenthal also sent inquiries to Mylan 
about EpiPen pricing arrangements and anti-competitive pricing arrangements. Senators 
sent inquiries to the Federal Drug Administration (FDA) to question its process for 
approving other possible alternative epinephrine administration devices (Grassley, Leahy, 
Klobuchar, Blumenthal, & Johnson, 2016). Finally, in the summer of 2019, Bresch was 
set to appear before a congressional committee to explain her company’s pricing 
practices. The EpiPen quickly became the epicenter of drug-pricing practices in America. 
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Medical Professionals Response 
With mounting frustration that the Mylan congressional hearing would follow an 
all-too-predictable pattern of finger-pointing, outrage, and CEOs enduring “a day of 
public villainy [to] explain that high drug prices are sometimes-unfortunate cost[s] of 
innovation” (Zaitchick, 2018, para. 2), as had happened with previous inquiries into 
pharmaceutical companies, and with media reports expressing concern about the lack of 
affordable options available to patients, a handful of medical professionals intervened. 
According to medical professionals, if price was the issue, historical protocols and logics 
were readily available and cost-effective alternatives. Medical professionals were trained 
to administer medicine through a syringe and then manually inject it into a patient’s 
thigh. Before epinephrine auto-injectors, the vial-and-syringe method was the preferred 
protocol. Therefore, a number of medical professionals returned to old methods of 
delivery as a cost-cutting alternative. 
For example, in 2013, King County Washington emergency medical technicians 
(EMTs) switched from emergency response protocols using EpiPens to vial-and-syringe 
protocols due to rising EpiPen prices. EMTs were retrained to treat anaphylaxis using 
“Check & Inject Kits” (see Figure 3), which the department produced itself (Husain, 
Nolan, Latimer & Eisenberg, 2017). Further, King County began selling their kits to 
other local first-response departments across the country as a way to curb pricing. Check 
& Inject kits cost $15 each while EpiPens cost more than $300 per pen. 
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Figure 3. From “King County (Wash.) EMS saves $334,000 annually by switching to IM 
delivery of epi by EMTs,” by S. Husain, J. Nolan, A. Latimer, and M. Eisenberg, 2017, 
Journal of Emergency Medical Services. Copyright 2017 by the Journal of Emergency 
Medical Services.  
 
Eastern Kentucky University’s Emergency Medical Care program also responded to 
rising EpiPen prices by advising that all EMTs in the state would be required to 
administer epinephrine via syringe and encouraged other states and fire departments 
across the country (which often have small operating budgets for medical supplies and 
often rely on volunteer first-responders) to move toward syringe-delivered epinephrine 
training as well (Fifer, 2016). 
In September 2016, a United States-based surgeon with a popular YouTube 
channel published a video introducing a modified protocol: a vial-and-syringe solution 
using an ampule of epinephrine, syringe, and needle incorporated into a “3D printed 
activation container” (McLellan, 2016). In the video description, the doctor states, “When 
the EpiPen skyrocketed to $600 we were shocked just like you. […] In only 6 days we 
dreamed, designed and 3D printed the new Epi Injector solution which costs less than 10 
dollars for all components” (para. 1; see Figure 4). Despite claiming to share the open-
source design file online, the specs were not released.  
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Figure 4. Screenshots of 3D Printed Epi Injector under $10. Adapted from 3D Printed 
Epi Injector under $10 – Version 1.2 [video], in YouTube, n.d. Retrieved October 11, 
2018, from https://www.youtube.com/watch?v=3OJOHt_nGjs. In the public domain. 
 
In response to issues of price, medical professionals turned to their training and 
knowledge to modify traditional logics and, in one example, extend old protocols into 
new materials. 
However, the majority of outspoken medical professionals suggested that patients 
could revert to using pre-filled syringes filled either by a doctor in a doctor office or at 
home. Yet as more news articles cited doctors recommending the syringe-and-vial 
method as an alternative, other medical experts returned to focusing on the potential risks 
to patient safety. Food Allergy Research & Education (FARE) organization’s chief 
medical officer suggested that “anyone using [the vial and syringe] approach would 
require extensive medical training to do it effectively and safely, without contamination 
or accidental intravenous injection” (FARE, 2016, para. 2). Other industry authorities 
expressed concerns that if “your child is suffering from an allergic reaction [...] you don’t 
want to read the instructions in that moment. You just have to know how to use it” 
(Keshavan, 2016, para. 15). Indeed, the medical community broadly agreed that patients 
needed affordable access to epinephrine; however, they disagreed on what protocols 
should be considered “safe” and “reliable.” Despite vial-and-syringe protocols being 
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standards just decades before, patients had grown accustomed to auto-injectors and had 
come to rely on the speed and simplicity of a device that could quickly administer it at 
the click of a button. Manual medical administration had become reserved for medical 
authorities. Thus, logics of auto-injection and convenience had come to normalize and 
replace older medico-administrative logics. However, these logics would also be 
challenged, as price and access persisted as a dominant social issue. 
Biohackers Intervene 
In 2016, I was in the second year of my PhD program and had become interested 
in the DIY biology and biohacker movement. Independent of this study, I began 
interviewing members of local DIYBio communities across the country. In revisiting 
these interviews for synthesizing concepts, multivocality, and perspective, I found quotes 
that aptly foretold the change that was emerging in the biohacker space relative to EpiPen 
pricing. During one of my interviews, I asked Thom, a biohacker in Raleigh (who was 
also previously a chemist for a pharmaceutical laboratory), whether he believed the 
DIYBio community could ever truly change the ways large institutions like 
pharmaceutical companies operate. His response was telling: “DIY is probably never 
going to supplant or take over the role of Big Pharma.” Big Pharma, he suggested, “will 
hopefully be forced to reform by our ability to open up technologies and bring 
competition.” In another interview I conducted with Heather, the head of a DIYbio 
community in Denver, I asked what she thought it might take for the biohacker 
community to become more broadly known and understood. Her response was candid: 
the community has to make waves. “If it doesn’t make waves, it doesn’t become a 
movement,” she suggested. Although EpiPens and EpiPen pricing never came up in our 
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conversations, biohackers around the country were looking for an opportunity to make 
waves—to contribute to a problem that could disrupt the discourse of medicine and 
science, and lead to positive change. The EpiPen pricing crisis became that opportunity. 
While Mylan tried to explain the cost away, biohackers moved to disrupt cost away 
through maktivism. 
In September 2016, a biohacker collective by the name of Four Thieves Vinegar 
Collective published a video on YouTube advertising a DIY epinephrine auto-injector for 
under $30. They called their device the “EpiPencil.” The video featured a man, who 
identified himself as “Dr. Michael Laufer, chief spokesman for the collective.” According 
to the collective’s website, Laufer was not a medical doctor but rather held a Ph.D. in 
mathematics. In the video, he wore thin wire-framed glasses and a leather motorcycle 
jacket. He appeared to be in his mid-30s, and was recording the video in what appeared to 
be a dorm room, the walls a neutral off-white color and barren. Against the wall behind 
him was a small, unmade bed, next to which was a mini-refrigerator. The video unfolds 
as follows: 
After introducing himself, he holds up a plastic blue cylindrical device with a 
label affixed to it that closely resembles the label on an EpiPen (see Figure 5).  
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Figure 5. Screenshot of Michael Laufer presenting the EpiPencil. Adapted Epi Pencil 
[video], in Internet Archive, n.d. Retrieved July 19, 2017, from 
https://archive.org/details/EpiPencil_201801. In the public domain. 
 
He then begins to overview the various off-the-shelf components used to make the 
EpiPencil auto-injector. The plastic cylinder, he notes is an auto-injector “designed for 
needle-phobic diabetics.” Once fully assembled, the video then cuts to a recording of him 
sitting in a chair at a dining room table, his pants draped down just above his ankles. He 
is wearing the same leather jacket atop. As he looks at the camera, with the EpiPencil 
pressed against his exposed thigh, he instructs to “Press it in, press the button.” He then 
pushes the release lever on the device. As his face grimaces, he lets out a loud groan. He 
then looks back toward the camera while slowly pulling the discharged device away from 
his leg, and affirms “yeah, it hurts.” In addition to the instructional video, Four Thieves 
Vinegar published online instructions, a parts/purchase list, and a public statement 
(written in the style of a political resolution). The statement proclaimed that “auto-
injectors and epinephrine are technology which belongs to the world” (Four Thieves 
Vinegar, 2016).  
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Shortly after the release of this video, other biohacker groups and DIYers began 
offering epinephrine auto-injector alternatives online. ProgressTH (an international 
design lab) released a statement announcing the development of a 3D concept for an at-
home EpiPen alternative auto-injector, which could be printed for as little as $3 in 
materials (see Figure 6). 
 
Figure 6. 3D printed epinephrine auto-injector concept prototype. Reprinted from Epipen 
goes from $300 to $30 to $3 with Opensource and 3D Printing, in ProgressTH, 2016. 
Retrieved July 19, 2017, in http://www.progressth.org/2016/10/epipen-goes-from-300-
to30-to-3-with.html. Copyright 2016 by ProgressTH. Reprinted with permission. 
 
Their press release encouraged individuals to “roll up their sleeves and create with their 
own two hands the change they want to see in the world.” (ProgressTH, 2016). They 
declared that “if Mylan refuses to create an affordable EpiPen, and other companies 
refuse to provide other life-saving essentials at affordable costs, we must create them 
ourselves” (para. 12). Other auto-injector designs and design specifications (specs, 
hereafter) also quickly appeared on open-CAD websites, where individuals can share 3D 
computer-aided designs for 3D printing. 
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Unlike 3D-printed models that required users to have software and a 3D printer to 
print devices, or be able to interpret CAD specs, Four Thieves Vinegar’s solution only 
required one to purchase already-available products online. News quickly circulated 
about EpiPen “hacks,” and the response was alarmist: “Please do not hack your own 
EpiPen” (Weil, 2016). The EpiPencil quickly garnered industry responses from patient 
advocacy groups and medical experts about the dangers to patient safety (e.g., the 
potential risk of drawing up too much of the drug, injecting a contaminated dose due to 
improper storage, greater possibility for human error, lack of proper government and 
medical oversight). Popular Science and NPR published articles highlighting the ethical 
risks (d’Adesky, 2017; Hess, 2016). Medical professors and bioethics experts pointed to 
the importance of drug-device regulation. One suggested that the EpiPencil was “new 
version of old quackery” (Hess, 2016, par 6.) and claimed that the hack was ushering in 
the possibility for complete deregulation of drugs. One author suggested that a “DIY 
pharmaceutical revolution is coming—if it doesn’t kill us first” (Brown, 2017, para. 1). 
Eventually, even the FDA weighed in. Although the FDA could not stop biohackers from 
publishing instructions on how to make an EpiPencil or prevent citizens from making 
their own, FDA spokesperson Theresa Eisenman warned against “using unapproved 
prescription drugs for personal use” because the public cannot “have any assurance that 
unapproved products effective, safe or produced under good manufacturing practices” (as 
cited in Leonard, 2016, para. 16). Despite the fact that millions of Americans potentially 
risked being unable to afford emergency epinephrine through FDA-approved devices, in 
many experts’ minds, the risk of a DIY alternative (even one that simply reverted back to 
a historically common protocol pre-auto-injector) was more dangerous. 
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Discursive and Capitalistic Outcomes 
In the end, political economics prevailed: pressure from politicians, the public, 
and arguably biohackers led to some slight marketplace corrections. In December 2016, 
Mylan announced it the release of a generic version of its own device at about half the 
cost (about $340) of the brand name EpiPen (Mylan, 2016a). One month later, CVS (one 
of the nation’s largest retail pharmacy networks) announced that it had partnered with 
pharmaceutical manufacturer Impax to provide its customers with an alternative generic 
epinephrine auto-injector, Adrenaclick, for around $110 for a two-pack prescription 
(CVS, 2017). CVS also announced that the manufacturer would provide a $100 coupon 
for much of its financially insecure population to reduce the out-of-pocket cost to about 
$10 per prescription. Finally, in August 2018, the FDA approved a generic therapeutic 
equivalent (i.e., a drug that can be substituted for brand name prescriptions) (FDA, 2018). 
In evaluating the role biohackers played in this case, it is worth considering the 
discursive effects of their participation. First, this case marks an important moment for 
biohacking as a movement given it received widespread national media attention and 
industry reaction for participating. Although the EpiPencil and other biohacker 
contributions were criticized over concerns for safety, their material and discursive 
enactments had staying power. Even into 2018, news articles and television shows 
continued to discuss the EpiPencil in the context of outrageous pharmaceutical prices and 
price-gouging practices. For example, in May 2018, the daytime television series The 
Doctors (which has been broadcast on local stations across the country since 2008) ran a 
feature highlighting the EpiPencil and its efforts to combat pharmaceutical prices. In the 
segment, the hosts condemn pharmaceutical companies as “gougers” out to “rip people 
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off” and applaud Four Thieves Vinegar for “highlighting a broken system,” yet also warn 
that “DIY and medication shouldn’t be in the same sentence.” Motherboard, a popular 
web and print news platform covering the future of science and technology, also 
published follow-up articles on the EpiPencil (Oberhaus, 2018).  
However, not all engagement was conversational. In January 2018, Laufer took to 
Twitter to announce that “YouTube took down our video, claiming it was dangerous, 
after being up for a year and a half, and something like a million views” (Laufer, 2018). 
Although the video was removed from YouTube, the group re-hosted the video 
elsewhere. When I interviewed Laufer, he informed me that since 2016 the collective had 
received hundreds of “thank you” messages mixed in with some hate mail and death 
threats. 
In the end, an online video, a set of simple instructions, a handful of pre-existing 
medical-grade components, and a print-your-own label were able to enter the national 
conversation and contribute to counter-logics of price and access to essential medications. 
To better understand the forces motivating preferences toward EpiPens and away from 
market alternatives, the next section maps the institutional and dominant Discourses 
disciplining this case. 
Genealogical Perspectives of Allergy and Allergy Governance 
 RQ1 considers what institutionalized logics and dominant Discourses led to the 
case at hand. To answer this question, I turn to a Foucauldian concept of “history of the 
present” (Foucault, 1977). Presentism, or the study of the present is “a kind of historical 
writing that approaches the past using concepts and concerns of the present” (Garland, 
2014, p. 367). A critical history of the present requires revealing how certain values, 
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assumptions, and dominant solution-frames came to be constituted into the present. Thus, 
this section maps a genealogical history of allergy and anaphylaxis, including dominant 
forms of medical and political governance. Genealogy is useful for tracing “how 
contemporary practices and institutions emerged out of specific struggles, conflicts, 
alliances, and exercises of power, many of which are nowadays forgotten” (Garland, 
2014, p. 372)—and is compatible with discourse tracing (LeGreco & Tracy, 2009), as 
described in the methods section.  
Allergies are broadly the result of an overreaction in immune system response to 
allergens found in food, animal venom, plant toxins, medicines, and other environmental 
substances (Centers for Disease Control and Prevention, 2019a). Physiological response 
to allergens can vary depending on the amount of exposure to a particular toxin and one’s 
level of immune system response. Severe allergic reaction can trigger anaphylaxis, which 
causes swelling in the submucosal tissues (e.g., tongue, mouth, and throat), rapid loss of 
blood pressure (due to circulatory constriction of blood vessels), and tightening of the 
airways in the lungs (Tupper & Visser, 2010). Thus, the effects of some allergic reactions 
can be life-threatening. Despite the risk, however, anaphylaxis is a relatively rare 
autoimmune response. In fact, in the United States, anaphylaxis only results in the death 
of around 250 people in the U.S. per year (or .86 deaths per million people) (American 
Academy of Allergy, Asthma & Immunology, 2014). Of death-related fatal allergic 
reactions, most are caused by pharmaceutical drugs like antibiotics, followed by venom 
(as a result of stings from wasps, bees, or other insects), and then food-related allergies 
(American Academy of Allergy, Asthma & Immunology, 2014).  
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Yet, within the public psyche, the perception of prevalence of allergy and 
anaphylactic risk, particularly by/from food, is significant. Fear of allergy from food and 
food-byproducts containing nuts, lactose, eggs, soy, wheat, and fish have indeed 
increased over the past century. This can be seen in the removal of certain foods from 
shared public spaces including the removal of in-flight peanut snacks on airplanes and 
school lunchroom policies substituting peanut butter for other types of nut butter. Even 
the rise of allergy-focused consumer advocacy and patient advocacy groups indicates the 
prominence of food related allergy awareness.  
Although allergy has been present throughout human history (Ring, 2014), allergy 
has developed into a unique modern-day malady (Jackson, 2006). The development of 
epidemiological medicine (i.e., the study of how pathogens and disease spread and 
disseminate across a population or geographic area), public health policies related to 
environmental politics and disease control, and changing cultural perceptions about 
medicine, health, and environmental pollution have all contributed to today’s dominant 
discourse of allergy treatment and governance. 
Medicalization of Allergy 
The greatest contributor to the rise of allergy science emerged from the 
development of epidemiologic studies at the turn of the 19th century (Jackson, 2006). 
Epidemiology is the modern-day medical approach to studying the ways pathogens (e.g., 
viruses, bacteria, etc.) are spread and dispersed across populations. The development of 
epidemiologic knowledge shifted attention from the localization of diseases in the body 
to the spread of diseases across populations. This epistemological shift created new 
technologies and logics of the collective body, such as new public health protocols, 
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medical therapies, and political acts to control the spread of diseases and viruses both 
within the body and within the larger population. For example, 19th and 20th century 
development of epidemiologic-based medicines such as vaccinations (Lahariya, 2016) 
and broad antibiotic use became prominent protocols for infectious disease prevention 
and treatment (Aminov, 2010). Epidemiologic knowledge also brought new broad public 
health initiatives aimed at monitoring and preventing the spread of communicable 
disease, and the U.S. federal government began allocating more federal resources to 
public health initiatives. Soon new government programs sprang up that were aimed to 
preserve the health, safety, and security of the entire population. For example, in 1946, 
the Communicable Disease Center was created with a mission of reducing the spread of 
transmittable diseases like malaria (Centers for Disease Control and Prevention, 2019b). 
As medical, scientific, and political groups dedicated more resources to 
pathogenesis, new technologies and methods in the early 20th century allowed scientists 
to begin monitoring the movement of pathogens and focus on environmental conditions 
that facilitated infectious processes. As a result, the science of allergy and immunology 
emerged. Allergy pathogenesis focused on the various originations of allergy, including 
physiological responses to chemicals and the environment (Jackson, 2006). 
Epidemiological knowledge and the development of new technologies and information 
used to better track seasonal illness—combined with advancements in atmospheric 
physics in the early 20th century—led to goals of tracking and measuring the paths and 
quantity of airborne pathogens around the world, including more scientific approaches to 
measuring regional pollen counts (Jackson, 2006). 
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As public health expanded from localized sites to more geographic and 
environmental sites, scientists and politicians alike also expanded their interest in how 
environmental factors contribute to the spread of diseases. Water quality, air quality, food 
safety, and sanitation all became scientific areas of study. Decades of unregulated factory 
emissions led to dramatic decreases in air quality across the U.S. for much of the 19th 
and early 20th century. Further, decades of poor air quality contributed to a rise in 
respiratory-related illnesses over the same time period. Combined with a focus on the 
environmental and financial impacts of population health, scientists and government 
actors became increasingly interested and concerned with the link between air quality, 
pollution, and health (Environmental Protection Agency, 2019). In response, in 1970, 
President Richard Nixon established the Environmental Protection Agency (EPA), and 
Congress passed the landmark Clean Air Act Amendments to establish air quality 
standards and regulate factory pollution production. 
With more attention dedicated to tracking and monitoring environmental changes 
in pollution, scientists began to notice rises in annual global pollen levels around the 
world. With greater attention came growing concern that motivated international 
scientific communities to issue stringent warnings that if modern air trends remained 
unchecked half the world would be suffering from an allergy in the 21st century 
(Jackson, 2006). The increase in allergy-related diagnoses led some to label allergy a 
global epidemic (Platts-Mills, 2016; UCB Institute, 2005). The scientific community 
agreed that “the potential impact of this explosion of allergies on health, happiness and 
longevity was clear: allergic reactions could severely compromise the quality of life and, 
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in some instances, kill” (Jackson, 2006, p. 216). Allergies had become both an individual 
medical problem as well as a population health concern.  
With a greater focus on environmental factors on public health, environmental 
science in the 1960s and 1970s also began to take up the call for addressing public health 
concerns. Armed with new knowledge about the effects of industrial production and a 
growing awareness of the presence of the invisible toxins and health-related allergens in 
water, air, and food, “allergy” became a household word. As allergy became more 
ubiquitous, so too did social anxieties about its symptoms (Jackson, 2006).  
Ubiquity and Debate of Allergy in the Modern Lexicon  
In the late 20th century, a new faction of medical interpretation known as clinical 
ecology attempted to challenge the narrow definition of allergy held by the medical 
community. Clinical ecologists took up “anti-modern sentiments” to both medicine and 
commercial-industrial production of the 20th century and espoused modern medicine as a 
public health threat itself (Jackson, 2006). Environmental medical professionals preferred 
broader definitions of allergy that focused on myriad symptoms that could result from 
exposure to various environmental factors, including foods and toxins (Jackson, 2006). 
While traditional medical science defined allergy in terms of its metabolic calculability 
(i.e., a measurable increase in immunoglobulins in response to an environmental agent), 
clinical ecologists debated for broader definitions. Allergies, they suggested, are both 
biologically symptomatic and psycho-symptomatic. As a result, “allergy” became a 
diagnosis for a variety of acute and longer-term social and medical ailments. Indeed, one 
might be inflicted by food and chemical “sensitivities,” contributing to a new focus of 
food allergy for both traditionalists and clinical ecologists. Toxins,  
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Epidemiological and environmental concerns for sanitation and cleanliness also 
strengthened associations of allergy with dirt, poverty, and deprivation. Combined with 
broadening associations of allergy-as-sensitivity, allergy emerged as a “culturally 
constituted mark of social distinction” and social status (Jackson, 2006, p. 208). 
Ultimately “allergists were unable to resist popular appropriation of the term. In the 
closing decades of the twentieth century, allergy was increasingly employed to signify a 
bizarre assortment of physical idiosyncrasies, personal antipathies, psychological 
aversions, marital disagreements, personal conflicts, and international tensions” (p. 213). 
Thus, its diagnosis and meaning circulated across medical and social contexts. 
Cultural attitudes and anxieties shaped by medicalization of allergy, fears about 
environmental contributors to health, and new social connotations and appropriation of 
allergy into non-medicalized contexts has led to a diffusion of allergy as serious and 
metaphoric, as individual and social, and as mild and life-threatening. Further, the history 
of allergy has led to the 21st century treatments and governance of allergy. 
Allergy Treatment and Governance 
Health and medicine are governed both through political and medical activities. In 
the 21st century, Western medicine follows four primary treatment traditions: 1) 
preventive care, 2) curative care, 3) palliative care, and 4) managed care. Each of the 
following overarching approaches situates unique tactics and discourses of practice. 
Preventive care includes medicine and science that attempts to prevent illness from 
occurring, including preventative medicine (e.g., vaccines) and disease eradication (e.g., 
smallpox, malaria). Curative treatments are those that can cure a disease or illness with 
the use of medicines, such as antibiotics, treatments such as chemotherapies, and medical 
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procedures such as surgeries. Palliative care involves treatments that attempt to improve 
quality of life (primarily through means to reduce suffering) for individuals with 
diagnoses for which there is no curative treatment and will ultimately lead to death. 
Unlike preventive, curative, and palliative care (which all involve the conclusion 
of a therapy or treatment), managed care is sometimes used as a catchall to describe the 
practice of medicine that attempts to control or manage onset symptoms and side effects 
of various types of illness, diseases, and chronic or ambiguous pathologies. Therapy 
protocols for allergy typically rely on management tactics, including maintenance and 
suppression tactics that rely on medications to counteract, relieve, or prevent the effects 
of allergy reaction. These management tactics rely on logics of immunity (i.e., 
medications that pharmacodynamically influence immune system response). Immuno-
logics can enhance (e.g., adrenal steroids), suppress (e.g., antihistamines), or desensitize 
(e.g., immunotherapy) immune response.  
In the modern era, allergy emerged as a threat to both public and private life. 
Although allergies are treated through all three immunity management tactics, severe 
allergy has come to be primarily governed by epinephrine, a drug that both enhances and 
suppresses immune response to severe allergy, which is discussed in more detail in the 
next section. 
EpiPen: The Emergence of a Powerful Combination Device 
Epinephrine is a synthetic version of adrenaline. For over 100 years, epinephrine 
has been used as a first line against the effects of anaphylaxis by relaxing muscles in the 
airways and restricting blood vessels in the body to raise the blood pressure during an 
allergic reaction or asthma attack (Ram, Hoare, Arroll, and Hoare, 2012). Since its 
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discovery at the turn of the 19th century, epinephrine has a long and storied past as a 
pharmaceutical drug. Epinephrine was first found to be stable in its concentrated 
chemical form outside of the body by a Japanese biochemist named Jokichi Takamine 
(Arthur, 2015). In 1903, Takamine (1903) was granted a U.S. patent for his isolation 
techniques and would eventually license the patent to Parke-Davis, one of the largest 
pharmaceutical firms in the U.S. at the turn of the century, to synthesize and manufacture 
epinephrine. To be effective, epinephrine needs to quickly enter the bloodstream, so it 
must to be administered via intramuscular injection. Historically, epinephrine has been 
kept in small dark glass vials (epinephrine is light-sensitive) and can be withdrawn and 
administered using a needle and syringe. 
This primary method of medical delivery stayed consistent until 1971, when 
Hollister-Stier Laboratories released the Ana-kit, an anaphylaxis emergency treatment kit 
that included a pre-filled syringe (PFS) (Hollister Stier, 2019; previously pictured in 
Figure 2). The product was originally marketed as an emergency insect (bee) sting kit. 
The Ana-kit was small and portable, which made it more convenient and compact for 
medical professionals (doctors, nurses, and EMTs). 
Auto-injectors: A Military-Industrial Venture 
At the height of the Vietnam War, the U.S. Government wanted more effective 
defenses against biochemical nerve agents for soldiers in battle. Previous antidote 
delivery devices were made of stainless steel, which would affect the chemical stability 
of some anti-nerve agents. Officials at the Pentagon desired a device that was made out of 
glass, could be more easily transported, and was an expedient method of medication 
delivery (Department of Defense, 2000). In 1973, the Pentagon contracted with Survival 
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Technology, Inc. to come up with a “quick injection” device. From 1973–1977, engineers 
at a medical equipment company Survival Technology (notably Sheldon Kaplan, George 
Calkins, Stanley Sarnoff, and Lawrence Dalling) patented technologies for a series 
“hypodermic injection devices”—technologies that would eventually become name the 
Pralidoxime ComboPen and AtroPen auto-injector (Kaplan, Calkins, Sarnoff, & Dalling, 
1977; Sarnoff & Calkins, 1975; see Figure 7). 
 
Figure 7. Military field-nerve agent antidote kit, including AtroPen and ComboPen. 
Reprinted from Mark I NAAK, in Wikipedia, n.d. Retrieved December 11, 2018, from 
https://en.wikipedia.org/wiki/Mark_I_NAAK#/media/File:Auto-injector. In the public 
domain. 
 
In 1983, Meridian Medical Technologies, the pharmaceutical manufacturer, saw 
an opportunity to use the “quick injection” technology used in the ComboPen and apply it 
to the consumer market. This is notable as the EpiPen served as the first drug-device 
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combination on the market and became fundamental in shaping an entire marketplace of 
drug-device combinations. In fact, today the FDA has multiple categories for 
combination devices in the marketplace today. Meridian patented the combination drug-
device (epinephrine-auto-injector) and called it the EpiPen (Meridian Medical 
Technologies, Inc., 1987). Four years later, in 1987, the FDA approved the EpiPen for 
commercial use (Chowdhury, 2011). 
Over the next 20 years, ownership of the EpiPen and its intellectual property was 
sold and licensed many times. Manufacturer Meridian Medical was eventually acquired 
by King Pharmaceuticals in 2003. King Pharmaceuticals was then acquired by 
pharmaceutical manufacturer Pfizer in 2011. While Meridian was the manufacturer of 
EpiPens through most of the 1990s, the EpiPen was eventually marketed and distributed 
by Dey LP, a subsidiary of international pharmaceutical giant Merck KGaA (Merck’s 
generic operations arm).  
In 2007, Mylan purchased Merck KGaA for more than $6 billion. With the 
purchase, Mylan acquired marketing and distribution of the EpiPen, as well as exclusive 
rights to the EpiPen. EpiPen is not the only epinephrine auto-injector. Over the past three 
decades a number of pharmaceutical companies have attempted to develop epinephrine 
auto-injectors; however, the EpiPen has been the most successful and has cornered more 
than 90% of the auto-injector market since and accounted for 40% of Mylan’s profits 
since 2015 (Koons & Langreth, 2015).  
What Do We Learn from a Historical Tracing? 
The origins of epinephrine and auto-injectors is causally important to 
understanding how EpiPens came to dominate the logics and politics of allergy 
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governance. These findings can extend our understanding of the politics of immunity as a 
function of biopower. This section then analyzes two prominent logics emerging from 
genealogical tracing: immunity logics and military-medical logics. 
Immunity Logics 
Cohen (2009) suggests that immunity as a (Roman) political discursive construct 
(i.e., to be freed or immunized from punishment) has come to infect biological and 
medical discourses and knowledge. The study of allergy, for example, is firmly situated 
within a science of immunology, with immunity logics presupposing notions of a 
biologic “self-defense” (Jamieson, 2015). In explaining how politics become biologic, 
Jamieson (2015) suggests that “immunity is perceived as moving across different 
discursive domains, and, as such, it transforms our biology insofar as it transforms 
medical discourses and practices” (p. 15). Both the scientific development of 
epidemiology as epistemological study of the body and the environment, as well as the 
modern biopolitical immuno-logics of public health and disease spread, emerge from 
modern biopolitical immunologics. Thus, they emerge from historical political discourses 
of immunity. Biopower, for example, can explain how immunity logics have become 
naturalized as both biological in nature and as a taken-for-granted “regime of truth” 
(Foucault, 1963). Immunity politics are typically framed in terms of prevention and 
eradication, with goals of curtailing the spread of a (social, medical, biologic) disease. 
However, the primary and preferred method of treatment for allergy is based on 
management therapy rather than inoculation or vaccination. To survive an allergic 
pathogen, the prevailing response is to suppress anaphylactic response through synthetic 
medical materials (like epinephrine). 
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Immunity logics are at the center of the EpiPen. Although epinephrine is not an 
inoculation, genealogically examining the history of allergy alongside a politico-medical 
history of epinephrine auto-injectors reveals interesting embedded logics of immunity. 
Applying concepts of immunity logics and biopower (e.g., Martin, 1990; Cohen, 2009; 
Jamieson, 2015) helps illuminate how the EpiPen came to dominate cultural and political 
logics and discourse. Indeed, allergy is firmly rooted in the scientific knowledges of 
immunologics. As the discourse of allergy spread, so too did its localization. No longer 
was allergy something that was only found in dangerous substances like venom and 
poison; allergy was all around, potentially infecting us through our food, water, and air. 
Sensitivities to allergy, both in terms of our noticing/awareness and our lack of ability to 
self-defend against such, contributed to the development of new safety protocols in the 
form of antidotes, specifically giving the body a boost of adrenaline to be able to self-
defend against anaphylaxis. 
Military-Medical Logics 
The notion of a “defended self” is also attributable to political power, particularly  
in historical aspects of Roman law and military logics. Auto-injectors emerged from the 
military-industrial complex and resulted in both the production of new material forms and 
discursive forms. Auto-injectors developed as a wartime need, to protect troops on the 
battlefield from unsuspecting biologic or chemical agents. Growing out of the same 
biologic-political discourse that weaponized the atomized world (through nuclear war), 
wartime logics also discursively weaponized biology. To provide wartime defense 
against new forms of bio-warfare (through biologic nerve agents), the scientific and 
military community looked to develop new biologic technologies of antidote self-
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defense. Antidotes provided a last line of self-defense on the battlefield. However, these 
discursive logics transferred into medical logics as auto-injectors moved from the 
battlefield of war to the battlefield of everyday life. 
 Indeed, we see the logics of military-medical materially, discursively, and 
metaphorically injected into the logics of anaphylaxis governance through auto-injectors. 
Material meanings are markedly embedded into the design and administration of auto-
injectors (see Figures 8 and 9 below). Consumer versions of auto-injectors initially 
looked very similar to wartime devices. However, this similarity is not artificial. With the 
commercialization of auto-injectors, military discursive logics also followed. Allergies 
quickly shifted from seasonal irritations to life-threatening pathogens. The rise of clinical 
ecology propelled the ubiquity of allergy and anaphylaxis. Allergies inherited both 
cultural and medical bio-logics and became both culturally ambiguous and 
epidemiological (medically substantiated). Allergy was truly environmental and posed 
danger to one’s health and safety in all aspects of life. Thus, allergy needed treatments 
that were equally potent at resisting the onset of attack and relied on military protocols 
and wartime metaphors. Auto-injectors borrowed from immunity logics by offering a 
“last line” of self-defense should one’s immunity become compromised. 
 We can see the ways “allergy” has been shaped by dominant historical discourses 
of environmentalism, epidemiology, and clinical ecology, particularly how advocacy 
groups like FARE and the Allergy & Asthma Network talked about recommended 
methods of treating allergy at the time of this case. For example, by 2016 consumer 
advocacy groups promoted epinephrine as a “first line of treatment – always” for any 
allergic reaction (Allergy & Asthma Network, 2016, p. 33). FARE also advocated for 
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using an EpiPen, even if a person is uncertain whether they are actually having an allergic 
reaction or simply having sensitivities such as “itching” or “feeling something bad is 
about to happen, anxiety, or confusion” (cited in Fugh-Berman & Batt, 2016). According 
to Fugh-Berman and Blatt (2016), “FARE’s treatment plan [even] includes an option to 
administer epinephrine to a highly food-allergic person who is having no symptoms and 
who is unsure whether or not they ate something they were allergic to” (para. 6). The 
Asthma & Allergy Network encouraged patients to use epinephrine over other allergy 
medications (e.g., antihistamines like Benadryl, which is readily available without a 
prescription and at a fraction of the cost), even for mild allergies and allergic reactions 
(Allergy & Asthma Network, 2016). Although antihistamines risk carrying side effects 
like dizziness, upset stomach, and constipation, they are relatively mild compared to the 
far more serious side effects that can be induced by epinephrine, including irregular 
heartbeat, fainting, stroke, trouble breathing, chest pain, and possible overdose resulting 
in death (Mayo Clinic, n.d.). Yet consumer advocacy groups continued to encourage 
over-prescribing and over-use of EpiPens.  
The EpiPen is a discursive paradigm of allergy and anaphylaxis governance 
within a prevailing modern medical problem-frame of allergy as a biologic, deadly, and 
hiding in every corner of our mundane lives, infiltrating our basic needs (food and air). 
To combat this threat, the EpiPen is the fail-safe tactic. Therefore, it must be available for 
deployment at a moment’s notice and carried on one’s person. The EpiPen has risks, yet 
those risks get represented in a calculus of lives saved, so they tend to be de-prioritized in 
public health and legislation that encourages the use of EpiPen by making public spaces 
like schools have them available. While this might not be objectionable on some levels, it 
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illustrates the logic of governing out-of-control allergies (obscures some fundamental 
risks, particularly if people use them more than once), documented by more aggressive 
standards of use by consumer-advocacy groups. Thus, allergists, patients, politicians and 
international healthcare agencies struggling to loosen the grip of allergy on modern 
societies have adopted conflicting strategies (Figures 8 and 9).  
 
Figure 8. Pralidoxime ComboPen and AtroPen Auto-injector developed for the United 
States Military, which would eventually become a design that inspired the EpiPen. 
Reprinted from Getty Images, n.d. Retrieved December 11, 2018, from 
https://chemm.nlm.nih.gov/antidote_nerveagents.htm. Copyright by Greg 
Mathieson/Getty Images. Reprinted with permission. 
 
 
Figure 9. Early version of EpiPen that closely resemble the design of Figure 8. Reprinted 
from Getty Images, n.d. Retrieved January 26, 2019, from 
http://fortune.com/2016/08/22/mylan-epipen-price-hike-monopoly/. Copyright by Bay 
Area News Group/Getty Images. Reprinted with permission. 
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Indeed, consumer products even pass along the instructions and protocols, 
particularly in terms of instructions for use. For example, the administration steps are 
nearly identical for administration. EpiPen users and nerve agent auto-injector users are 
first told to pull off the grey safety cap, push the injector “firmly” or “hard” against the 
thigh, and then hold device in place for 10 seconds (see Figure 10 for comparison). In 
future EpiPen product enhancements, the grey cap was eventually replaced with a blue 
cap, and the injection end was outfitted with an orange cap (to denote which end houses 
the needle). The speed of epinephrine delivery also increased from 10 seconds to three 
seconds. 
 
Figure 10. Visual instructions for administering nerve agent auto-injector (left) and 
EpiPen (right). Left adapted from ATNAA, in Drugs.com, n.d. Retrieved February 11, 
2019, from https://www.drugs.com/pro/atnaa.html. In the public domain. Right adapted 
from Childcare First Aid, in Allens Training, 2015. Retrieved February 11, 2019, from 
https://www.allenstraining.com.au/f.ashx/downloads/Childcare-wkbk-pt2-Anaph-
3MAR15.pdf. In the public domain. 
 
 Tracing the EpiPen from government-funded injection device to commercial 
product is historically important because it reveals significant material-discursive 
constructs and logics that shaped attitudes, ideas, talk and materialities around allergies 
91 
and their treatment. Since its development, epinephrine has become the primary solution-
frame to manage against the threat of anaphylaxis. The epinephrine-as-solution frame 
comes from historically tracing discourse around allergy as a modern-day malady and 
medicalized fears of anaphylaxis emerging and continuing military intentionalities and 
logics. We also see how consumerism and the biopolitics of medicine extends to 
consumers through various discursive forms, the socialized meanings that are built into 
auto-injectors. 
Mapping the medical treatment of allergy across historical contexts is useful to 
situate the discursive formation of allergy. Logics of epidemiology, the governance and 
treatment of allergy, and biopolitical contexts reveal how allergy and anaphylaxis has 
become (re)constituted through medical and technological deployments. This context 
provides insight into how allergy has become normalized, commercialized, economized, 
weaponized, and further regulated through industry and governmental enactments and 
how anaphylaxis and epinephrine have become sociomaterially constituted into 
discourses of medicine, health, and governance.  
Under neoliberal logics, medicine has become an economic endeavor. Thus, the 
EpiPen has also emerged through dominant corporate discursive enactments and 
strategies. The following section overviews an analysis of the specific corporate 
strategies and tactics used to further extend the EpiPen’s role in preserving economic-
political sovereignty (Nadesan, 2008). Epinephrine is an effective intervention for severe 
allergic reaction, and auto-injectors are an effective method of administration. While 
these are not inherently problematic solutions, the EpiPen has become an instrumentality 
of power situated within biopolitical contexts that give it authority over other equally 
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plausible logics and alternatives. Thus, the EpiPen disciplines toward safety. The problem 
in this case instead emerges out of a concern for access. If EpiPens are indispensable in 
the fight against allergy, what happens when people cannot afford them? To better 
understand how EpiPens became instrumentalities of power, this study next turns to an 
analysis of the EpiPen as a corporate politic. 
EpiPen Entrenchment into Private and Public Spaces 
Since 2011, Mylan has used a variety of medico-political tactics to place EpiPens 
in public and private spaces across the U.S. During her prepared congressional testimony 
in 2016, Mylan CEO Heather Bresch implored committee members to understand the 
EpiPen’s numerous positive impacts to health. She explained that the product saves 
countless lives and reduces overall healthcare costs by serving as an “insurance policy” 
against anaphylaxis shock for millions of Americans. She expressed that too much focus 
had been placed on EpiPen pricing and not enough attention on her company’s efforts to 
increase access to the device. Her concern centered on the fact that the company had 
helped stock more than 700,000 EpiPens across 66,000 schools in the United States, “no 
strings attached” (Reviewing the Rising Price of EpiPens, 2016, p. 2). However, during 
the hearing, Senator Tammy Duckworth illuminated that Mylan also reached out to those 
66,000 schools with a contract that allowed them to buy additional EpiPens at a heavily 
discounted rate ($112 as opposed to $600) so long as the schools do not “in the next 12 
months, purchase any products that are competitive to EpiPen auto-injectors” (Reviewing 
the Rising Price of EpiPens, 2016, p. 18).  
In 2012, Mylan also launched the EpiPens4Schools program, a tactic that 
developed partnerships with individuals and groups at the national and state level. One of 
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the most prominent supporters and promoters of the program was the recently appointed 
chair of the National Association of State Boards of Education (NASBE), Gayle 
Manchin, who also happened to be Bresch’s mother (O’Donnell, 2016). Manchin, in her 
new role with the NASBE, began a nationwide campaign known as the “epinephrine 
policy initiative,” which aimed “to help state boards of education as they develop student 
health policies” and “set the stage for [national] policy development (National 
Association of State Boards of Education, 2012, para. 2). Mylan also fostered its 
relationships with consumer advocacy organizations like FARE to promote the need for 
new state and federal legislation requiring public places like schools to keep stock of 
epinephrine auto-injectors. In exchange for their advocacy, Mylan sponsored educational 
events and developed educational materials for NASBE (O’Donnell, 2016). The 
epinephrine policy initiative focused on education about the risks and dangers of 
anaphylaxis and the universal acceptance of epinephrine as a fail-safe drug for 
anaphylactic treatment.  
Their efforts contributed to enacted laws in 12 states across the country that 
required schools to keep epinephrine auto-injectors on premises. It also resulted in the 
passing of the federal “EpiPen Law” in 2013 (Access to Emergency Epinephrine Act, 
2013). The law authorized:  
the Department of Health and Human Services to give funding preferences to 
states for asthma-treatment grants if they: maintained an emergency supply of 
epinephrine (EpiPens), permitted trained personnel of the school to administer 
epinephrine, and developed a plan for ensuring trained personnel are available to 
administer epinephrine during all hours of the school day. (Jarrett, 2013, para. 2) 
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 EpiPens had become so ubiquitous with epinephrine administration that they 
discursively became the only solution. Even in cases where schools had to train personnel 
to administer the drug, those individuals were most likely trained in how to administer 
EpiPens. The “EpiPen Law” used economic-political incentives to encourage public 
spaces to stock EpiPens in exchange for federal grant money. 
As part of its efforts to promote public health, access, and awareness, Mylan also 
paid consumer advocacy groups through sponsorships and donations. Patient and health 
advocacy groups (i.e., groups that “claim to represent the interests of patients with a 
particular condition”) often receiving funding from industry corporate sponsors like 
pharmaceutical companies because these groups are “very effective in spreading industry 
messages that appear free from the taint of industry bias” (Fugh-Berman & Batt, 2016, 
para. 10). And Mylan used its relationship with several in the early-to-mid 2010s to help 
encourage and promote the use of epinephrine in allergy care.  
Mylan’s self-promoted billion-dollar investment to make EpiPens more 
“available” to the public also included efforts to include epinephrine on the “federal 
preventive drug list.” Under the Affordable Care Act of 2010, the federal preventive drug 
list ensures that individuals who are prescribed a drug on the list are free from 
copayment, co-insurance, or out-of-pocket deductible. If successful, Mylan could, in 
effect, continue to charge high prices for EpiPens while hiding the cost at the counter for 
patients and “mute the protests” (Lipton & Abrams, 2016, para. 1).  
Mylan again partnered with consumer advocacy groups like the Asthma & 
Allergy Network and medical professionals to advance lobbying efforts and shift industry 
perception in Mylan’s favor. One of Mylan’s paid consultants, Dr. Leonard Fromer (an 
95 
assistant clinical professor of family medicine at the University of California, Los 
Angeles), published a letter in the American Journal of Medicine that suggests “the cost 
of auto-injectors compared with the costs of emergency department visits and 
hospitalizations associated with failure to treat anaphylaxis appropriately” (Fromer, 2016, 
p. 1250). Given his status as a paid consultant, it is not surprising that Fromer urged 
support for epinephrine auto-injectors by saying that they should be added to the 
preventive drug list “due to at-risk individuals remaining at chronic high risk of 
recurrence” and suggesting that anaphylaxis is “routinely underrecognized and 
undertreated” (p. 1244). Although the preventive drug list ostensibly could be interpreted 
as eliminating financial barriers for patients, Dr. Fromer’s paid consulting work served to 
further embed epinephrine as the primary course of care for the treatment of allergy and 
anaphylaxis. Despite deploying political tactics to make epinephrine auto-injectors 
(broadly) indispensable, the EpiPen had become nearly interchangeable with auto-
injectors, and Mylan intends to keep it that way. 
Despite epinephrine being a generic drug, in 2012 Teva Pharmaceuticals was 
prepared to bring a new generic epinephrine delivery system to market. Teva’s product 
would be in direct competition with the EpiPen. However, according to congressional 
testimony, Mylan and Teva reached an agreement “preventing [Teva] from putting a 
generic on the market until 2015 or earlier under certain circumstances” (Reviewing the 
Rising Price of EpiPens, 2016, p. 34). Committee members pondered aloud about a 
possible anti-competitive “pay for delay” scheme. Then, months before Teva’s settlement 
agreement with Mylan was set to expire in January, 2015, Mylan filed a “505(q) citizens 
petition” on drug safety to the FDA citing safety concerns.  
96 
Within the petition, Mylan claimed to have commissioned a study that found Teva 
devices had a 93% failure rate. According to Carrier and Minniti (2016), citizen petitions 
are meant to give everyday citizens an opportunity voice concerns for a product related to 
its safety or effectiveness. However, industry reporters have found that “citizen petitions 
represent a hidden tool in brands’ toolkit of entry-delaying activity, and when used 
inappropriately force consumers to pay high drug prices while providing no offsetting 
safety benefit” (p. 306). In fact, Carrier and Minniti (2016) found that 92% of citizen 
petitions are actually filed by corporations. They may as well be called “corporate 
petitions.” When asked about the decision to file a citizen’s petition, Mylan responded 
that “we submitted a petition, which is a public process that gives anyone with a view the 
opportunity to voice an opinion by submitting comments, and puts the decision in FDA’s 
hands, where it belongs” (cited in Zhang, 2017, para. 13). And although the FDA 
ultimately denied Mylan’s petition, Teva’s FDA application for market entry was denied 
in 2015 under uncertain circumstances. That same year, the FDA rejected another 
possible alternative device by Adamas. 
 In each of these examples, Mylan attempted to advance the interests of their 
organization through political-medical tactics and used medico-administrative logics to 
advance corporatized goals in the name of health, safety, and access. Taken together, the 
instrumentality of these political acts reflects an economic-political model that preserves 
discourses originating within its walls and deploys historical military and public health 
logics that have been embedded into 21st century neoliberal economic-political 
partnership. Although these tactics circulate across multiple institutions, they use 
common policies and support common solution-frames. The medicalization of allergy, 
97 
the extension of military technologies and logics to defend against allergy, and corporate-
political maneuvers to commodify allergy have resulted in EpiPens as a powerful 
discursive form that has become entrenched into all aspects of life. 
Summary 
Within neoliberalism, discipline and techniques of preferred order converge 
through policies, laws, authorities, and common knowledge and rely on, borrow, and co-
opt institutional expertise. Under neoliberalism, we see that instead of having a 
contentious relationship between the state and corporations, each deploy similar 
authorities and rely on similar knowledge that moves across contexts (in this case of 
health, wellbeing, and medicine). EpiPen has become a prominent object of discipline. 
The medical and military logics that codify the EpiPen have established it as the 
prominent form of allergy governance. Further, the EpiPen has become an object of 
biopolitical significance that extends its reach in the public and private sphere and 
(re)produces logics that have resulted in making it unthinkable to do anything other than 
use it. The next chapter shifts focus back to the case at hand by focusing on the role and 
function of maktivism in responding to the EpiPen crisis that this chapter foregrounds 
and contextualized. 
  
98 
CHAPTER 5: 
MAKTIVISM THROUGH PARTICIPATION, BOUNDARIES OF CONTESTATION, 
AND DECONSTRUCTED LOGICS 
 The previous chapter provided a detailed history of the EpiPen case that focused 
on analyzing the historical discursive formations and institutional logics that created the 
conditions for the case to unfold. This chapter turns toward an analysis of critical making 
and maktivism in the context of biohacker engagement and presents interesting findings 
about how resistance moves through dominant domains of medicine and technology. This 
chapter begins with an analysis of how maktivism can be participatory and resistant. 
Next, I present findings for how participation through maktivism de-constructs certain 
dominant logics and re-constructs others—in particular, how maktivism becomes 
subjected to certain dominant Discourses. Finally, I overview where the primary 
boundaries of contestation existed in this case and which dominant logics were ultimately 
contestable. 
How Can Participation Function as Resistance? 
 RQ3 asks how material activism (maktivism) is performed in this case, with a 
particularly interest in the role of material resistance. As previously discussed, resistance 
is often conceptualized as rejecting dominant preferences. Maktivism, however, provides 
a conceptualization for considering the role of critical making (in this case biohacking) as 
a form of social justice action and intervention. Activism primarily emerges through acts 
of protest. Although maktivism can also function as a form of protest, in this study, we 
see protest and counter-narrative through participatory enactment and problem-solving. 
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Rather than breaking down (as in the case of hacktivism), biohackers produce and 
participate by offering alternative solutions, and with them alternative logics. 
Four Thieves Vinegar is the catalyst for maktivism by biohackers in this case. 
Interestingly, their “hack” does not reject conventional medicine. In fact, Four Thieves 
Vinegar sources the parts to make the EpiPen from already-existing, readily available 
medical-grade parts. In my interview with Laufer, I asked how it was that he came to 
choose the EpiPencil design, and his answer was illuminating. He noted: 
The best counterfeits are not counterfeit. You just use the real thing and 
everything that is used in that is, those are all off-the-shelf parts that are medical 
devices. You know, it wasn’t like “Oh make a needle out of something” or “make 
a syringe.” It was like “Go buy a syringe.” 
Laufer continued. 
There’s sort of an urge in the hacker world to do things in a hacker way, to do a 
work-around just because you can, not because it’s necessarily necessary or even 
the best approach. There’s something that riles up the heart of the hacker when 
you say “I can build it myself. I don’t need infrastructure.” 
Writ large, biohacking commonly deploys tactics of using materials that are already 
available or can be easily “hacked” to construct new technologies. For example, 
biohackers who published examples of hacked PFS approaches turned to everyday 
household materials to lower the cost of their hacks, which evoked the ethos of DIY (see 
Figures 11, 12, 13).  
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Figure 11. Screenshot of a PFS hack using a toothbrush container for a case. Adapted 
from How to Make Your Own EpiPen, in YouTube, n.d. Retrieved September 28, 2018, 
from https://www.youtube.com/watch?v=E9kgX1qtfho. In the public domain.   
 
 
Figure 12. Example instructions for using plastic straws to keep a PFS from inadvertently 
plunging. Reprinted from Epinephrine Auto-injection Alternative, in AltmanMD.com, 
2016. Retrieved February 12, 2019, from http://altmanmd.com/2016/09/epineprhine-
autoinjection-alternative-pre-filled-syringes-a-simple-inexpensive-solution/. Copyright 
2016 by Donald Altman. Reprinted with permission. 
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Figure 13. EpiPen alternative housing design for 3D printer. Adapted from EpiPen 
Cheaper Addition, in TinkerCAD, n.d. Retrieved March 3, 2018, from 
https://www.tinkercad.com/things/jwuZdvuglYM-epipen-cheaper-edition. In the public 
domain. 
 
Laufer commended that sometimes hacker communities use hacks as a way to 
gain credibility within the biohacker community or choose to use alternative materials 
because they evidence or give “cred” (credibility) to the hacker community. While the 
ultimate goal for biohacking is to produce alternative solutions, Four Thieves Vinegar 
focused on making “something that was going to work, something that was simple, 
something that was cheap, something that was accessible, and something that was safe.” I 
make the case that it is interesting and telling that Four Thieves Vinegar’s chose to co-opt 
and appropriate medical devices both to resist traditional convention and to preserve 
much of the medical integrity of the materials and of the counter-narrative. 
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 Unlike other “hacks,” Four Thieves Vinegar’s choice not to use alternative 
materials, such as 3D printed parts, or repurpose non-medicalized components for their 
device was in part a matter of convenience—auto-injector technology, medical syringes, 
and vials are generally available for purchase. However, the group also rejected certain 
logics of hacker culture and, thereby, also resisted the desire to demarcate the 
functionality of the device as having been hacked. Thus, they simultaneously participated 
in biohacktivism and medical problem-solving. Where their maktivism was most visible, 
however, was through their instructional video and the product label (see Figure 14). 
Four Thieves Vinegar presented an alternative to the EpiPen by repurposing the EpiPen 
label and, in doing so, repurposed the EpiPen. By re-presenting the EpiPen label as the 
EpiPencil label, Four Thieves Vinegar co-opted the utility, familiarity, and otherwise 
hidden medical protocologics embedded within it. 
 
 
Figure 14. 2016 EpiPen label (left) and EpiPencil label (right). Left reprinted from 
EpiPen in Med Library, n.d. Retrieved July 22, 2018, from 
https://medlibrary.org/lib/rx/meds/epipen-3/page/3/. Right reprinted from EpiPencil in 
Four Thieves Vinegar, 2016. Retrieved July 22, 2018, from fourthievesvinegar.org/. In 
the public domain. 
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Regarding the label, Laufer stated, “Making the label was specific because part of 
the argument for auto-injectors being good technology or important technology is that 
they can be picked up by somebody who has never seen one before, and they can read the 
label, and [inject].” As if disclosing a secret, Laufer continued, “[the label] is almost the 
same. It’s not really different. // I changed a little bit of the verbiage, and I put our logo 
on it. And that was it.” 
 Four Thieves Vinegar still resisted dominant logics and discursive formations by 
creating a device that utilized off-the-shelf medical parts, included the same preferred 
medication for anaphylaxis treatment, relied on the same medico-administrative logics 
and protocols, and repurposed the logo of the most common and familiar product. 
Through their production and participation, the collective was able to reveal certain flaws 
in the dominant narrative around EpiPen prices and access. Through their participation, 
the collective produced something that is both antithetical to the dominant narrative and 
uses the dominant narrative. By redeploying old materials in new ways, biohackers 
reconstituted new meanings into various materialities. Four Thieves Vinegar took this 
one step further by co-opting medical technologies and medical protocols to constitute 
new meanings and, in the process, reveal hidden absurdities embedded within those 
materialities. These findings have important implications for how we think about 
micropolitical resistance and participation, particularly across and within dominant 
discursive forms.  
This section lays out a case for biohacking as a mode of resistance. The next 
section analyzes the way biohackers’ discursive-material production served to contest 
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dominant discursive assumptions. In doing, the next section provides findings relevant to 
RQ2, which considered what discourses and discusrive logics were contested in this case, 
and conversely which were not. 
Biohacking Resistance to the EpiPen Crisis 
 To answer the question of what discursive logics were contestable in this case, the 
following section summarizes the key discursive-material contestations presented by 
biohackers. This section also includes an overview of what logics biohackers attempted 
to contest, as well as an analysis of which were contestable. Non-contestable discursive 
logics refer both to those that tried to be contested by biohackers and instances where 
biohackers were ultimately subjected to dominant logics despite their resistance.  
Contesting Price 
Cost and affordability are unequivocally at the center of this case. Neoliberal 
logics of price emerged as the central problem-frame and proposed solution-frame across 
all actor groups focused on fixing cost. Across dominant institutions, price functions in 
the neoliberal context of free market enterprise. Government actors, for example, were 
primarily concerned with intervention for the sole purposes of encouraging fair 
marketplace competition and preserving political-economic biopolitical power. Public 
dissent circulated around issues of affordability and the high cost of medical care. 
Finally, critical makers (both medical professionals and biohackers) created alternative 
devices to protest price logics and provide cheaper alternatives. Four Thieves Vinegar 
expressed disdain that “the pharmaceutical industry continues to put profits above human 
life” (Four Thieves Vinegar, 2016).  
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Despite contesting price, it is important to note the conceptual difference between 
price logics of biohackers and capitalistic price logics. The difference is most noticeable 
in the way various actor groups talk about price. For example, at the congressional 
hearing with Mylan, politicians expressed their disinterest in hindering Mylan’s ability to 
turn a profit. In contrast, DIY alternatives function as micropolitical expressions of 
resistance and contest neoliberal logics of price by demonstrating how easy it is to 
remove barriers to price. Syringe-and-vial alternatives, for example, attempt to 
disentangle the price of epinephrine from the price of EpiPens. Auto-injector alternatives 
take it another step in their attempts to disentangle the price of the self-injection 
technology. In doing so, both alternatives challenge core assumptions about price. 
In my interview with Laufer, the Four Thieves Vinegar founder, he explained that 
the collective had explored the possibility of manufacturing epinephrine and realized “it 
was a huge pain.” However, he resituated the problem:  
Getting epinephrine is not hard. It’s everywhere, and it’s fucking cheap. And if 
you have a fear of anaphylaxis, you can ask your doctor to just give you a 
prescription for a vial of it, and you can load it. 
Across the board, epinephrine rarely emerged as the problem. Rather, the problem was 
the need for a dramatically cheaper medical delivery system. In the end, biohackers were 
successful at contributing to counter-logics of price, as they were able to “shame Mylan 
by showing how much it really costs to make an EpiPen” (Sorrel, 2016).  
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Contesting the Pharmaceutical-Industrial Logics 
Mylan primarily framed the problem of price as one of medical-industrial 
constraints rather than that of corporate greed and deployed a number of traditional 
tactics to excuse away their prices. 
The pharmaceutical-industrial ecosystem. Mylan also largely blamed “the 
system” for EpiPen prices. In her congressional testimony, Bresch claimed that “the 
system has been around for decades,” “the system rewards higher prices,” and that 
“Mylan didn’t make the system” (Reviewing the Rising Price of EpiPens, 2016, pp. 48–
49). To illustrate, Mylan issued a press release, in the name of “price transparency,” with 
the hopes of helping to “meaningfully address the U.S. healthcare crisis” (Mylan, 2016b, 
para. 2). Bresch suggested that Mylan only realized $274 per EpiPen prescription, of 
which just $50 could be considered profit (Reviewing the Rising Price of EpiPens, 2016). 
Of the remaining money Mylan saw, $69 went toward paying for the cost of goods (i.e., 
raw materials and manufacturing costs for each pen), and $105 paid for other “EpiPen 
related costs” (likely referring to various miscellaneous expenses related to marketing, 
distribution, licensing, business operations, legal fees, training, lobbying, and sales 
activity). The significant reason for the additional $334 per prescription, she argued, was 
the result of the full supply chain (i.e., pharmacy benefit managers, wholesalers, 
pharmacy retailers, and insurers) driving up the price so they could make their own 
profits. 
The “system is broken” became a dominant discursive boogeyman in this case. It 
most notably showed up in the various instances where the problem-frame was the 
institutional structure itself. While Mylan blamed the downstream supply chain, most 
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blamed corporate greed. Others blamed the FDA for the slowness with which it had 
approved alternative products (Newman, 2016) and for a regulatory environment that lets 
“drug companies push prices as high as possible until there’s public outrage” (Emanuel, 
2016, para. 4). Still others blamed pricing structures and incentives (Ho, 2016). Taken 
together, “the system” came to be a discursive form all its own. The system, in this case, 
is both visible and hidden. That is, it circulates across discursive boundaries of medicine, 
politics, and economic logics. Rather than a coordinated partnership, “the system” was 
portrayed as tenuous rather than a dominant force. Thus, “system-is-broken” emerged as 
both a dominant problem-frame and a scapegoat dominant solution-frame for politicians 
and pharmaceutical companies. Biohackers also agreed the system was broken. However, 
“the system” was not broken because it was dysfunctional like the dominant system 
portrayed. Rather it was broken because it was working just as intended—to profit off 
sick lives and hoard medical care for those who could afford it. 
 In our interview together, Laufer suggested that dominant actors propose that 
when infrastructure is not working “we should fix the infrastructure.” On the other hand, 
he sees the biohacker community as proposing a “work-around” in the meantime rather 
than a complete overhaul without any intermediating steps. He states: 
Yes, we have infrastructure, and yes we should work to make it so that it works as 
we want it to; // “however, if it’s not [working], we don’t have time to sit around 
and wait for laws to be passed, or policy to change, or approval and regulations to 
shift if your life is on the line. You need a stopgap. You need something to fill in. 
Biohackers acknowledge their (lack of) role in “the system” and, in doing so, 
acknowledge that they must offer temporary solutions in extra-infrastructural ways on 
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their way toward creating systematic change. Earlier in our interview, Laufer said that 
Four Thieves Vinegar’s goal is ultimately to not exist as an entity. Biohacker 
interventions, he suggested, indicate/evidence gaps that need filling. The system will only 
ever be fixed when it goes away (i.e., once a critical mass of distributed and emancipated 
health solutions and knowledge exist), and there is no longer need for “hacking” as a 
form of deviance. 
While this notion is utopian, it explains the motivations of biohackers and the role 
of temporality in their participation in social issues. For biohackers, the system-as-broken 
serves as a call that necessitates meaningful response, whereas the system-as-broken for 
others is a convenient inconvenience that sometimes results in corporate price gouging. 
In sum, the system-as-broken has become a powerful discursive apparatus such that even 
moderate responses like biohacking seem radical and that people taking care of their own 
health in non-preferred-systematic ways is a social risk.  
Despite claiming the system is broken, Mylan also relied on a variety of 
systematic tactics to defend its prices. 
Pharmaceutical research and development. Pharmaceutical companies have 
long maintained that the profit they realize from drugs helps to offset the expensive costs 
associated with bringing those drugs to market. Research and development (R&D) costs 
(e.g., biochemical research, clinical trials, market research, FDA approval process, etc.), 
thus, are a common justification for prices, particularly when drugs are still under patent. 
In her written congressional testimony, CEO Heather Bresch claimed that Mylan “must 
invest heavily in research and development and manufacturing in order to produce 
billions of doses and bring hundreds of new products to market every year” (Reviewing 
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the Rising Price of EpiPens, 2016, p. 19). She noted that the “overwhelming majority of 
what we’ve spent [on EpiPens] has been on access and awareness programs” (p. 20). 
However, as previously outlined in this chapter, very little has changed about the EpiPen 
other than its price since Mylan purchased the rights to sell it in 2007. In fact, it is worth 
noting that in 2009 Mylan voluntarily decreased the expiration period of EpiPens, which 
caused customers to purchase them more frequently.   
 However, biohackers successfully contested narratives of R&D through their 
making. By developing alternatives quickly and, in the case of Four Thieves Vinegar, 
doing so by offering a solution that followed similar administrative protocols, critical 
makers emancipated research and development. Further, by bringing previous techno-
logics forward as alternatives, they attempted to juxtapose previous administrative 
techniques with the cost justifications of new, more automated administrative logics. 
These contestations contributed to a growing shift in the public discourse about whether 
pharmaceutical companies can attribute iterative R&D costs to medical pricing. Although 
biohackers discursively and symbolically contested notions of R&D, the larger narrative 
turned to a focus on the cost of safety and convenience. Journalists expressed concern 
that alternatives introduced too much risk. Political contiguities also focused on the role 
of balance between price and public safety. Mylan emphasized the importance of 
ensuring that their devices work every time. Thus, an emphasis on safety and reliability 
superseded the value of offsetting logics of R&D. 
Pharmaceutical patents. Patents are also powerful deterrents in American 
economic-politics that are meant to conceal knowledge (intellectual property). Although 
the federal government is responsible for issuing patents, they brand themselves merely 
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as bookkeepers in such legal matters. A large part of the broad biohacker narrative 
focused on an ethos of “copyleft” and open-technology logics. Biohackers aimed to 
emancipate knowledge by freely publishing instructions, sharing computer-aided designs 
(CAD), and encouraging other DIY makers to create their own alternative devices and 
solutions. Thus, biohackers challenged intellectual property logics through their 
participation.  
When I asked whether Four Thieves Vinegar had concerns about patent 
violations, Laufer suggested that that the EpiPencil uses medical grade parts and that their 
instructions encourage the product be used in the way it is originally intended (i.e., to 
draw up a prescribed medication and inject it intra-muscularly). Further, unlike the 
dominant narrative, which focused on market competition, biohackers were not 
encouraging a product. Rather, they are merely providing information (that should 
already be readily available) to people who might benefit from it. Taken this way, the 
EpiPencil has already inherited certain forms of knowledge and medico-administrative 
meanings that give it credence as both a tool for medical use and for emancipating 
knowledge.  
Four Thieves Vinegar attempted to appropriate old meanings to make new ones 
and reveal taken-for-granted inconveniences about dominant notions of medical access 
and price. By reframing traditional medical-grade parts as a “hack” in response to EpiPen 
prices, the DIY community essentially co-opts materials and their embedded meanings in 
order to reveal cracks in their discursive logics. 
In this section, I discussed how biohackers and critical makers objected to and 
contested economic/capitalist/political logics through their participation in this case. The 
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next section focuses on non-contestable boundaries of biopolitics and medico-
administrative logics. 
Uncontested Boundaries and Medical Subjectivities 
Critical makers, in this case, are primarily concerned with addressing 
institutional/economic barriers affecting individual access to affordable medicine by 
creating intermediary alternatives. However, economic-political logics are only one part 
of the dominant discourses that circulate throughout this case. Next, I overview the 
dominant medico-administrative logics and discursive formations that remain 
unchallenged or become reproduced through biohacker engagement. 
Medical Authority 
DIY makers do not challenge the dominant medical solution-frames of 
epinephrine as the preferred allergy governance chemical, injection as the dominant 
delivery method, or pharmaceutical companies and doctors as medical gatekeepers. This 
is particularly interesting because Four Thieves Vinegar is a self-proclaimed anarchist 
group with a long-term goal of emancipating the production of medicine through DIY 
solutions. In fact, Four Thieves Vinegar’s mission is to promote and enhance the 
development of an “open-source automated lab reactor, which can be built with off-the-
shelf parts, and can be set to synthesize different medications” (Four Thieves Vinegar, 
2016, para. 1). In response to the EpiPen crisis, biohackers could have presented tactics 
focused on alternative medical production and governance, including its development and 
dispensing. 
In an attempt to meaningfully contribute to and democratize medical knowledge, 
biohackers oscillate between participator and activist by situating themselves within 
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certain medical discourses and aligning their solutions to the dominant solution-frame. 
Thus, we see biohackers performing activism through cooperation. This oscillation 
reveals an interesting aspect of biopolitics, one that influences the challenges confronting 
fringe groups desiring to promote the diffusion of institutional knowledge and, in doing 
so, preserve the institutional logics that give it power. Therefore, biohackers 
simultaneously attempt to cooperate and resist, and distance themselves through efforts to 
create practices that are more inclusionary. Consider the following example of discursive 
conflict for the collective. 
Deviance ßà Inclusion Paradox 
The Four Thieves Vinegar collective borrows its name from an allegorical tale 
born out of the European plague outbreak in the late 1500s to early 1600s. As the legend 
goes, four brothers created a potion that prevented them from succumbing to the plague. 
Rather than use their potion to save others, they chose instead to steal from the sick and 
the dead. Eventually the brothers were caught; however, to avoid prosecution they 
offered their potion in exchange for immunity from prosecution. 
In this modern-day context, the biohacker group function as the four thieves, their 
alternative products as the potion, and corporate pharmaceuticals as a modern-day 
plague. The collective’s potion is also two-fold: a cure for medical ailments and a cure 
for the illness that is for-profit medicine. In our interview, Laufer reflected that “those 
four brothers were caught,” but “instead of being executed, they were let free by sharing 
information they had. And in exchange, others got the information that let them live.” 
Emancipating medical knowledge, from Laufer’s viewpoint, “is enough to save lives.” 
Four Thieves Vinegar acknowledges their identity as medical deviants and reenacts 
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immunity logics that have historically framed hackers as epidemiological-like risks to 
society. Despite their emancipatory and democratizing goals, because the collective is 
participating with medicine outside of traditional institutional boundaries, their 
contributions are largely only seen in antagonistic ways (Jamieson, 2015).  
Interestingly, the allegorical tale of the four brothers emerges from pre-
epidemiological Discourse. In fact, community plague doctors believed that infections 
spread through air and infected those who breathed the “bad air” in, a theory known at 
the time as miasmatic theory. Miasmatic theory materialized through certain medical 
protocols, most notably the use of plague doctor uniforms. The plague doctor mask, for 
example, was long and beak-like. To avoid bad air, doctors filled the mask with herbs and 
other aromatic items. The prevailing theory was that the aromatics could trap the disease 
and keep it away from the face (see Figures 15, 16, 17).  
 
  
  
 
Figure 15 (left). Anonymous hacker logo. Reprinted from Emblem of Anonymous, in 
Wikipedia, n.d. Retrieved July 11, 2018 from 
https://wikipedia.org/wiki/Anonymous_(group). In the public domain.  
Figure 16 (center). Four Thieves Vinegar Collective logo. Reprinted from Four Thieves 
Vinegar, 2016. Retrieved July 11, 2018, from www.fourthievesvinegar.org. Copyright 
2016 by Four Thieves Vinegar. Reprinted with permission.  
Figure 17 (right). 17th century plague doctor ensemble. Reprinted from Dr. Beak in 
Wikipedia, n.d. Retrieved July 11, 2018, from 
https://en.wikipedia.org/wiki/Plague_doctor. In the public domain. 
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Although miasmatic theory eventually fell out of favor (in place of germ theory 
and then again by epidemiological science), the Four Thieves Vinegar collective borrows 
from and co-opts a historical tale that illustrates a historical contestation of medicine and 
access that has formed and re-formed over centuries. Through this example, and this case, 
we can see the historical biopolitics of power over time and see historical logics 
portraying biohackers as a possible modern-day version of an ancient battleground over 
health, access, and politics of immunity.  
To further illustrate how the organization oscillates between cooperation and 
activism, consider the collective’s logo. The logo is ominous and draws from historical 
visual representations of both medicine and hacking. Like other computer hacker groups, 
the logo deploys a masked character, one that is wearing the mask of historical medical 
experts (meant to protect the medical doctors from illness) while simultaneously evoking 
a kind of masking consistent with shadowed/hidden organizations like computer hacker 
groups, such as Anonymous. 
Four Thieves Vinegar also operates in similar ways to hacker groups by primarily 
contesting medical logics in non-medical spaces. For example, members participate in 
secret—Laufer notes that in some cases members do not know the identities of other 
members—and communicate through encrypted online chat channels. To fund their 
work, they accept donations through cryptocurrency and display a “warranty canary” on 
their site. Essentially a digital canary in the coal mine, a warranty canary functions as a 
transparency tactic among open-source and hacker communities to disclose whether the 
group has received any formal written order(s) from a government agency or is part of a 
legal process that would prohibit them from being able to say publicly that they had 
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received such an order. Because some subpoenas include secret gag orders as part of a 
federal or state investigation, warranty canaries let biohacker groups discretely defy the 
gag orders. For example, not updating the warranty beyond the specified timestamp, 
removing the warranty from the website altogether is a discrete indicator to the public 
that the group has, in fact, been approached with a formal written order, or that the 
government has sought or obtained access to its information or records. 
Thus, the discursive enactments that shape the Four Thieves Vinegar allegory 
exemplify how historical discursive formations reemerge in modern socio-historical 
contexts. This also reveals how multiple dominant discourses continue to vie for power, 
circulate throughout time and across various contexts, and reconstitute themselves in new 
ways. Politics of immunity can help explain how their deployment of common medical 
protocols and logics in this case represent both cooperation and resistance. Next, I 
highlight another boundary of contestation for biohackers. 
Performing Medicine: Democratization through Demonstration 
Biohacking has historically been enacted through production and performance in 
ways that often blur the line between deviance and participation. Several DIY makers in 
this case enacted participation through demonstration (i.e., creating videos that 
demonstrate an alternative solution). Four Thieves Vinegar does this by deploying a form 
of resistance common in the biohacker community: participating through self-
experimentation. This kind of performative engagement is important to biohackers and 
challenges the boundaries between often cautionary and prohibitive medical logics. For 
example, in 2015, a California biohacker group named Science for the Masses 
documented an experiment that attempted to identify whether injecting certain protons 
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into a person’s eye could produce effects similar to having night vision. They published 
images of their experiment along with an open-source scientific paper via their website 
(see Figure 18). 
 
Figure 18. Biohacker group Science for the Masses demonstrates a potential night vision 
hack using protons. Reprinted from Science for the Masses, n.d. Retrieved March 19, 
2019, from https://scienceforthemasses.org/2015/03/10/ce6-eyedrop-application-and-
testing-photos/. Copyright 2015 by Science for the Masses. Reprinted with permission. 
 
This type of “show and tell” functions to destigmatize scientific experimentation 
by pulling back the proverbial curtain on medico-logics and, thereby, challenging the 
embedded authority of scientific participation. Unlike other examples in this case, Four 
Thieves Vinegar takes biohacking from informative to performative and extends the 
spaces where contestation occurs. Laufer extends the doing of biotechnology into private 
spaces, such as in bedrooms and at dining room tables.  
Although EpiPens had successfully moved into private spaces like the home, 
Laufer extended the development, production, and administration of medical procedures 
into the bedroom and kitchen. By bringing such devices into private spaces, Four Thieves 
Vinegar performed activism by proscribing medicine and techniques and, thereby, 
attempting to normalize injection protocols through alternative materialities, which 
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further contributed to the demystification of medical technologies (Dunbar-Hester, 2014). 
However, the medical expertise and the pharmaceutical industry owned the preferred 
medico-administrative logics, and ultimately YouTube removed the EpiPencil 
instructional video for violating community guidelines. The removal of their video also 
reveals another interesting biopolitical logic relevant to this case—legal disclaimers as an 
object of institutional power. 
Legal disclaimers as biopolitical texts. Wright (2008) notes that legal 
disclaimers “presume an underlying tension of some sort” and that “generally, a 
disclaimer tells some audience that some other text or circumstance does not mean or 
imply what one might otherwise think (p. 88). In January 2018, a year and a half after 
initially releasing the EpiPencil instructional video, Laufer shared on Twitter that 
YouTube had removed the video from its site. According to the email he shared (Figure 
19), YouTube claimed that Four Thieves Vinegar had violated the community guidelines 
for acceptable content by encouraging or promoting “violent or dangerous acts that have 
inherent risk of serious physical harm or death” (see Figure 19).  
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Figure 19. YouTube message to Four Thieves Vinegar regarding the removal of their 
EpiPencil video. Image courtesy of Michael Laufer. 
 
Other DIY epinephrine alternative videos remained on YouTube, so I asked 
Laufer why YouTube removed his. He suggested that it was because he refused to add a 
legal disclaimer or statements noting that a video “is for information purposes only, don’t 
ever do this.” “Fuck that,” he exclaimed.  “I’m sorry, [but we are] encouraging people to 
take control of their own health and encouraging people to, you know, technically 
practice medicine […] on themselves.” He noted that individuals providing legal advice 
to the collective suggested adding a disclaimer to the video because it “offers you some 
protection”; however, he lamented that it is antithetical to their goal of telling people they 
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can make an EpiPencil for themselves. Indeed, all other DIY maker alternative videos on 
YouTube included legal disclaimers.  
 While sites like YouTube mediate the promulgation and propagation of counter-
narratives, in this case we see an example of how certain mechanisms of control create 
boundaries around forms of contestation, including self-experimentation and producing 
knowledge that encourages action. Legal disclaimers function in this case to preserve 
certain dominant discursive logics about how knowledge is privileged, including who can 
contribute, how individuals can participate, and what participation looks like. In other 
words, legal disclaimers allow for the production of “alternative” information within the 
dominant domain as long as there are clearly marked signposts delineating it from 
authoritative knowledge and participation. Thus, legal disclaimers reduce participation to 
aspects of voyeurism and entertainment rather than meaningful co-production of new and 
contestable knowledge. By refusing to play the “post a disclaimer game,” Four Thieves 
Vinegar intentionally resisted certain dominant biopolitical norms. But in doing so, it also 
made it more likely that they would be censured for their critical making. 
 In this section, I presented findings about how biohackers contested institutional-
pharmaceutical and corporate logics and medico-authoritative logics. Next, I will discuss 
biohacker resistance in the context of drug-device combination techno-logics. 
Deconstructing/Reconstructing Materialities and Techno-logics  
 Although medicine is important to this case, the “drug-delivery system” was the 
central problem-frame. As auto-injectors moved from military projects to commercial 
use, the device itself became the prominent historical innovation around which economic 
discursive texts (e.g., patents, administrative logics, and profit) emerged. Thus, these 
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embedded logics continue to circulate through the dominant narrative of corporatized 
epinephrine auto-injectors and alternative DIY productions.  
EpiPens are both “medical” and “devices.” Therefore, they (re)produce both medical and 
technological authority and order. For example, Mylan claims that,  
although it may look simple, [the EpiPen] is actually quite complex. In the event 
of a severe allergic reaction, the more than 15 critical component parts in this 
device must work EVERY TIME ... IN SECONDS ... to deliver medicine to treat 
life threatening symptoms quickly and without fail. (Reviewing the Rising Price 
of EpiPens, 2016, p. 20)  
Indeed, the technology administers the medicine and provides a sense of safety. Although 
the device consists of a syringe and vial, it conceals these components and rejects 
alternatives that are merely syringe-and-vial based. The EpiPen conceals both its 
operations and its medical parts and, in doing so, appears both medical and non-medical. 
Further, instructions on the label are administrative and emphasize the technical 
components of the device. In that way, the EpiPen disciplines users toward its techno-
logic protocols.  
 One of the most prominent ways Mylan maintains its role as a disciplining 
authority is through the deployment of training/practice devices. Prescriptions for 
EpiPens also include a training device, which merely consists of the external material 
components (see figure 20). Each training pen allows a person to practice using the 
device and become familiar with its technologic behavior. Through familiarity with the 
device as a technology and by borrowing from its embedded medical meaning but 
removed from its medical application, trainer pens orient users toward their use. 
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Figure 20. EpiPen training device. Adapted from EpiPen Trainer, in Emergency Training 
Associates, n.d. Retrieved March 29, 2019, from https://etatnt.org/epipen-trainer/. In the 
public domain.  
 
Training pens have come to constitute and normalize EpiPen use by not only shaping 
behavior but also reducing the need for medical expertise and medical involvement. 
Therefore, EpiPens become the medical expertise through their techno-logics. What is 
interesting about this is that EpiPens are, in fact, a do-it-yourself (at-home) device. 
 Biohackers attempted to deconstruct EpiPens by focusing not on the medico-
administrative logics but on the material components, which contested the material 
meaning of the device. To demonstrate, I procured the parts needed to produce an 
EpiPencil (Table 1), and then assembled them following the instructions on Four Thieves 
Vinegar’s website (Figure 21). 
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Table 2  
 
Parts and Materials for Personal EpiPencil Build 
 
Item / Quantity Price From Single 
Use Price 
5 (five) 1ml 1cc sterile (individually 
wrapped) disposable medical-grade 
syringes with luer slip tips 
$5.99 Amazon.com ~$1.20 
10 (ten) 22G 1-inch sterile (individually 
wrapped) single-use hypodermic 
needles 
$8.85 Amazon.com ~$.89 
Auto-ject 2 non-fixed needle injection 
aid device 
$31.94 with 
shipping 
ADW Diabetes 
(online) 
$31.94 
Epinephrine prescription from licensed 
prescriber (5ml vial) 
~$5.00 Healthcare 
provider 
~$1.00 
Total single-use cost $35.03 
 
 
Figure 21. EpiPencil components purchased from the parts list in Table 1. Image 
courtesy of Matt Donovan 
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In my experience as an individual with no medical expertise, I was able to easily 
purchase the necessary medical parts, follow the instructions, and assemble a full-
working EpiPencil in approximately 15 minutes. My experience validated that Four 
Thieves Vinegar was able to demystify medical technology by empowering individuals to 
make their own devices (Dunbar-Hester, 2014). By demystifying technology, DIY 
making is most successful at problematizing material logics.  
Device de-construction became a central aspect of the national conversation. In 
October 2016, a California newspaper published an online news article about two 
mechanical engineers who had disassembled an EpiPen in order to calculate the cost of 
its raw material parts. Based on their engineering backgrounds, the two people involved 
estimated that raw materials cost about $8, to which one of the engineers exclaimed, 
“Now I’m even more outraged at how badly we’re being gouged by the pharmaceutical 
industry” (Seipel, 2016, para. 30). In this case, we can see another dominant discursive 
formation circulate across the DIY maker movement. Privileged notions of technological 
deconstruction and reconstruction emerge from a discursive shift occurring since the late 
20th century away from “traditional public sector values” and toward “entrepreneurial” 
and “enterprising” organizational values (du Gay,1996, p. 156).  
Entrepreneurialism and the Entrepreneurial Imperative 
Born out of a growing discourse around greater global market competition and the 
rapid growth of information technologies, the entrepreneurial imperative embraced 
attitudes and values of “increased economic efficiency” and “improved services at 
reduced cost” over more bureaucratic ethos. Entrepreneurialism offers a strong critique of 
“bureaucratic culture” and positions itself as the solution that focuses on principles like 
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rapid change and the premise that only those organizations that are “ever more 
enterprising will survive and prosper” (du Gay,1996, p. 154). In the deployment of this 
new contemporary discourse, bureaucracy became synonymous with a lack of progress, 
predictability, “waste, inertia, and unnecessary regulation” (p. 153) and likely became the 
“first casualty of such an uncertain environment” (p. 154). 
The move toward privileging an entrepreneurial discourse presupposed that all 
organizational industries, including hospitals, nonprofits, banks, and even government 
agencies, would all have to develop and embrace enterprising norms and entrepreneurial 
tactics to preserve economic prosperity. Supply-side sovereignty, enterprising logics 
presupposed, was the only way to ensure national sovereignty in a globally 
interconnected and accelerated world (Nadesan, 2008). As such, the role of government 
agencies moved from providing goods and services to allocating them through 
commercial enterprises. Entrepreneurial logics also caused shifts in perception and 
attitude about the government’s role in society. The entrepreneurial imperative 
reconstituted the relationship between government and business by moving government 
agencies out of the “business” of operationalized institutions (e.g., prisons, schools, 
healthcare) and into more contract-based relationships with institutions (Freedland, 
1994). Additionally, government agencies came to adopt many of the economic 
principles that undergird the enterprising ethos. As a result, economic logics became the 
principle method for “programming the totality of governmental action” (Gordon, 1991, 
p. 43). The entrepreneurial imperative is convenient because it is often used to present a 
dualism between bureaucratic government and public sector enterprise (du Gay, 2004), 
and often functions as a rhetorical move to scapegoat institutional violations of public 
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trust (such as drug price gouging). However, enterprising logics also frame non-
institutional engagement, particularly when the solution is framed in terms of its 
technological affordances (Delfanti, 2012). 
By contributing to, and participating in, activities that emphasize technological 
alternatives and de-emphasize medico-administrative logics, DIY makers in this case 
chose dominant entrepreneurial forms. This is particularly noticeable in the use of 3D 
printing. Indeed, 3D printing has become synonymous with critical making in recent 
years. 3D printing represents the possibility for emancipating manufacturing as well as 
adoption of technologies that are not currently institutionalized. By deconstructing and 
reconstructing technological materialities, certain DIY makers in this case adopted 
strategies that closely mirror enterprising logics and, as a result, emancipated techno-
logics that demystify technology but rarely produce meaningful social change or 
widespread adoption of alternative techno-logics. 
Summary 
This chapter presented some of the key dominant Discourses in this case across 
various discursive fields. Across each Discourse, biohackers and DIY makers attempted 
to resist and contest certain logics. Biohackers also deployed various discursive and 
material moves to create both counter and participatory narratives. In the end, this study 
presents a nuanced perspective on how critical making functions on the fringe of multiple 
Discourses competing for power. Biohackers are constantly oscillating between issues of 
resistance and participation, deviance and inclusion, and breaking down discursive-
material meanings and building up new meanings. The next chapter provides a discussion 
of these findings including their theoretical and practical implications.  
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CHAPTER 6: 
DISCUSSION, IMPLICATIONS, AND FUTURE DIRECTIONS 
Summary of Dissertation 
 This study set out to better understand the function of maktivism as a fringe 
practice—one that delicately oscillates between the boundaries of inclusionary 
participation and exclusionary resistance within institutions and institutionalized realms 
of knowledge. Turning to critical case study analysis and borrowing from various 
discursive and historical tracing methods (Foucault, 1977; LeGreco & Tracy, 2009), this 
study examined DIY making in the context of epinephrine auto-injectors. The case 
analysis provides a rich illustration of critical intervention in a prominent social issue 
(pharmaceutical pricing and access) while also operating at the intersections of 
technology and medicine.  
First, I identified a modern case where biohackers engaged in critical making as a 
way to intervene in a complex social issue (Ratto, 2014). The 2016 EpiPen pricing crisis 
was ripe for analysis because it marked one of the first times biohackers received such 
widespread response. Further, the crisis provided a “rupture point” from which to analyze 
the discursive and material practices and strategies employed by various actor groups 
over time and map their interactions over time. Borrowing from discourse tracing, I first 
presented a chronology of events relevant to the case, particularly the discursive and 
material enactments across three primary discursive fields: organizational, governmental, 
and maktivist. Then I traced the strategies, discursive productions, and tactics deployed 
by various actors across each field and made particular note of where certain dominant 
logics intersected and diverged. Next, I situated the case within a “history of the present” 
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(Foucault, 1977) by examining the discursive formations of allergy and allergy 
governance. Then, using phronetic-iterative analysis techniques, I analyzed how certain 
discursive forms shaped whether resistance and contestation were possible for DIY 
makers in this case.  
Throughout, the analysis focused on discursive-material production as a form of 
resistance, which provided interesting perspectives about how participation can both 
contribute to and contest dominant logics. These findings, which are discussed 
throughout the rest of this chapter, have particularly important implications for this study 
and for future research.  
Theoretical Considerations 
Although there could be many answers to the overarching question “what is this a 
case of?” this study primarily focused on counter-dominant narratives and competing 
historical tensions/logics. I focused largely on notions of resistance and social action, 
evidenced through modes of discursive and material production and participation. To 
further implicate each of these case aspects, the following section will case up (Ragin, 
1992) by drawing enumerating conclusions to better explain and refine theoretical 
concepts (Eisenhardt, 1989). 
Critical Making and Maktivism 
First, this case demonstrates the role and function of critical making and 
maktivism in action. Maktivism—do-it-yourself activities deployed as a form of 
sociopolitical engagement and critical activism through critical material making (Ratto, 
2014)—is useful for describing biohacker responses to EpiPen pricing and access in 
2016. Social activism is a coordinating and propagating activity. Thus, social issues are 
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often a mobilizing force for activism. Notions of hacking and activism (i.e., hacktivism) 
have previously been described and associated with subversive resistance tactics and 
protesting logics: virtual sit-ins, creating protest websites, and virtually vandalizing 
websites (often referred to as e-graffiti) (Auty, 2004). Critical making, on the other hand, 
has focused on activities that are more largely situated under a hacker ethic of activism 
through positive deviance (e.g., concern for democratizing technology, participatory 
technology, civil society activism, positive political change, social empowerment, and the 
spread of awareness of issues) (Ratto, 2014). This study conceptualizes the DIY makers 
in this case to have participated in activities that are more appropriately described in 
terms of their adherence to critical making. What can this study contribute to the study of 
maktivism? 
Maktivism as a “Pop-up” form of Organizing and Material Action 
Social activism is an inherently participatory activity. As such, social issues and 
crises are often a mobilizing force for engagement. Indeed, this study presents a case of 
biohackers taking up the call to “intervene in social life” (Ratto, 2014, p. 228). In this 
case we see their responses as co-arising and dispersed, emerging in a similar but 
diffused way. Rather than resist for the sake of resisting, DIY makers in this case chose to 
participate as a way of offering solutions to a single emerging problem. Said another way, 
DIY makers were interrelated and coordinated in their response not through organizing 
logics but through problem-solving logics.  
Pop-up as heeding the call. Weick (2001) notes that problem-solving activities 
often develop from heed concepts, which invite individuals to take up, attend to, or try 
something new. Whereas habitual acti
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logics, “in heedful performance, each action is modified by its predecessor” (p. 264). 
Heedful performance has been previously conceptualized as group interrelated activities, 
where group interrelating is both the product and condition of actions of individuals 
(Asch, 1952). Yet, heedful interrelating can also help explain the disconnected yet 
interrelated activities of DIY makers in this case. We can think of DIY makers in this 
case as interrelated by their activities rather than their coordinated engagement (Weick, 
2001). Taken together, maktivism was a heed concept that was taken up as a social call to 
action and interrelated through the production of collective information. Further, I 
suggest that modification, co-optation and appropriation in this case were important for 
our understanding of heedful interrelating. Rather than thinking about resistance as a 
unified force, heedful interrelated allows for critical making to be performed in 
meaningful micropolitical and fluid ways. Like little bubbles under the water, critical 
makers can materialize and reveal surface-level tensions.  
Previous literature has extended heedful interrelating within organization-specific 
contexts (Weick, 2001); however, this study applies heedful interrelating to activities that 
span beyond organizational or institutional boundaries. In fact, we see heedful 
interrelating from medical professionals and biohackers in this case. We also see heedful 
interrelating across materialities through the use and deployment of both medical and 
nonmedical materials. DIY makers heed techno-logics and medico-logics to produce 
concepts that attempt to solve problems of price and access by resisting dominant logics 
of medical production. 
Thus, this study can extend conceptualization of maktivism as both ongoing and 
momentary and emerging as needed, over time, through modes of “material showing.” In 
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other words, maktivism allows for an emphasis on storytelling and solution-frames 
through artifacts of resistance rather than structuration—instantiation rather than 
institutionalization. Taken this way, maktivism “pops up” through counter-production. 
Rather than competing against dominant capitalist logics of new production and 
manufacturing, DIY makers in this case simply redeployed old techno-logics, in new and 
meaningful ways. Said another way, DIY makers made visible the discursive debate that 
was circulating within the crisis. Rather than relying on the diffusion of historical 
knowledge about alternative methods of epinephrine administration, they reconstituted 
old logics through new productions and, in doing so, further problematized the dominant 
discourse. Unlike traditional capitalist logics, DIY makers in this case re-presented old 
knowledge in new ways, thereby demystifying both technology and medico-
administrative logics. Taken this way, DIY makers harken back and point forward 
through their making. Maktivism “pops up,” contributes through material showing, then 
dissolves to leave behind revealed truths and micropolitical artifacts of resistance.  
 Pop-up maktivism as bricolage. To better understand pop-up maktivism as a 
process, I turn to the concept of bricolage. In organizational communication literature, 
bricolage is a process of sensemaking (Weick, 2001). Quite fittingly, a bricoleur is a 
tinkerer, and bricolage is colloquially defined as a do-it-yourself cognitive process. More 
precisely, however, bricoleur emerges from the Levi-Strauss conceptualization of “a 
means to use whatever resources and repertoire one has to perform whatever task one 
faces” (Weick, 2001, p. 62). Bricolage, thus, allows the bricoleur to create/produce 
something new from whatever materials and resources are available, a kind of 
improvisation that sensitizes others to the “possibility that there are many more potential 
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resources” (p. 62) than currently seem available. Taken in this context, DIY makers in 
this case were bricoleurs of old medical logics who repurposed materialities to solve new 
social problems. 
Bricolage can help explain how “crucial uncertainties” came to be addressed, 
particularly in terms of how DIY makers challenged the relationship between dominant 
domains of knowledge, normalized protocols, and economic market subjectivities. While 
they did not produce meaningful socio-behavioral change through their material 
productions, they engaged in micropolitically demystifying the dominant techno- and 
medico-logics of epinephrine administration, which contributed to the larger public 
discourse of price and access. These material redeployments make the unseen seen again 
or, said another way, allow them to pop up in the collective social mind. Pop-up 
maktivism is a conceptual-theoretical interpretation meant to consider the larger 
implications of resistance across and within dominant domains. The following section 
attempts to interpretively consider the meaningful role pop-up maktivism can play in 
social action. 
Boundaries of Contestation: Toward a Conceptual Model 
The biopolitical boundaries outlined in this case (i.e., who can and cannot 
participate in medicine, where expertise lies, how hygienic protocols become embedded 
in everyday life, etc.) were established over time through various discursive and material 
(re)enactments. Discourses are social systems that produce domains of knowledge and 
meaning. As discourses become more widely adopted and circulated, they become 
embedded, normalized, and produce forms of subjectivity (power relations). Discursive 
logic, too, becomes seen as rational, factual, and true. Dominant discourses also circulate 
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within and along various contiguities/boundaries that often overlap with and cross 
various other systems of power. For example, in this case, discursive domains of 
capitalism, governmentality, and medical knowledge are prevalent. Discursive spheres 
also produce institutions of power and authority that attempt to preserve power and, in 
many cases, extend into new territories. Discursive logics are the hidden and embedded 
rules that make knowledge seem value-neutral and preferred. However, logics are 
political, and they become enacted in formal and informal policies and protocols.  
Deleuze and Guattari (1988) suggest that power is akin to the travel of water—
moving toward available spaces, trickling downwards and into new spaces, carving new 
territories by seeping into fissures and gaps, and slowly eroding that which might stand in 
its way. Metaphorizing power as water is a useful illustration for explaining how power 
moves to claim new territories or boundaries. As previously discussed, the power of 
power is in its invisibility, its seeming objectivity and value neutrality, and its movement 
into the governance of everyday thoughts and behaviors. Thus, dominant discourses 
continually attempt to extend their reach into other systems. These borders exert power 
throughout discursive and material spaces. (See Figure 21.) Deleuze and Guattari (1988) 
suggest that capitalism, for example, has gained power by shifting the flow of wealth in 
society, and state sovereignty has increased in power by extending its boundaries through 
military technologies of air and naval power. Biopower, too, functions as an example for 
expanding hidden boundaries of power for economic-political sovereignty by governing 
health through biopolitical and anatamo-political means (Lemke, 2011; Nadesan, 2008). 
We can see examples of all three types of power in this case. Simply put, power 
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structures are not confined to traditional spaces or modes of power and discipline. I 
created Figure 22 to visually illustrate.  
 
Figure 22. Illustration of dominant discursive formations present in this case.  
Organizational communication scholars have a rich history of investigating 
resistance to dominant modes within organizations (Alvesson & Willmott, 1992; Bain & 
Taylor, 2000; Ball & Wilson, 2000; Contu, 2008; Fleming & Spicer, 2003; Knights & 
MaCabe, 2000). However, organizational or institutional contexts are built within 
discursive realms. Therefore, this study illustrates broader territories of resistance 
(Munro, 2016). 
DIY making is arguably, at best, a form of micropolitical resistance in this study. 
It emerges within dominant discourses and deploys/repurposes the discursive logics of 
the dominant while simultaneously existing on the fringe/periphery. The kind of 
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resistance enacted by biohackers in this case requires a nuanced perspective about 
whether dominant discursive power can truly be contested or whether contestation is 
always situated within dominant logics. If we conclude the latter, then scholarship on 
resistance might seem by some to be futile. Deleuze and Guattari’s (1988) conception of 
power, in part, insinuates such a futility. They suggest that power emerges through nodes 
that reject chronology and traditional conceptions of organizing. Nodes of power (i.e., 
where power makes itself seen and felt) can be “deterritorialized” (or broken off) through 
contestation and resistance; however, they argue that power continues to exist under the 
surface and eventually appears again through other nodes. That is, power is rhizomatic 
Deleuze & Guattari, 1988), sprouting up in new and seemingly disconnected spaces but 
always connected under the surface, and making that which interacts with it part of its 
“reproductive apparatus” (p. 9). This proverbial power whack-a-mole presents a 
challenge for scholarship on resistance and social action. 
If nodes of power reject chronology and organizing in predictable ways, perhaps 
we might consider that pop-up maktivism is just another example of predictable but 
somewhat futile resistance. However, I believe that, instead, there is another lesson 
available about power.  
What can we learn from a study on contested logics and boundaries? This 
case utilizes the notion of “rupture point” as a methodological concept (LeGreco & 
Tracy, 2009). However, we might also think of rupture more discursively. Rather than 
relying on notions of resistance as supplanting or subverting dominant discursive logics, I 
propose we might reconsider the goal and function of contestation and resistance. 
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As documented in the chapters 4 and 5, maktivists in this case are subjected to 
both neoliberal entrepreneurial imperatives and medical logics. Thus, maktivism is 
inherently situated in dominant discourses. Perhaps, however, it is worth considering that 
maktivism is as much a subjectivity as a kind of peripheral activity that borrows from and 
repurposes dominant logics to draw new edges, carve out, or cut notches into the 
boundaries of various discursive formations. If and when dominant logics become 
noticeable, as was the case with pharmaceutical pricing, and creates a “rupture”—a crisis 
or a noticing—resistance has the ability to “hold the line” so to speak, even if 
temporarily, of those discursive logics. Additionally, because maktivism is always 
peripheral in nature, discursive and material enactments and productions function as 
deviance, even when borrowing from dominant logics. Taken this way, maktivism can 
point to problems in the dominant logic but also reveal inconsistencies and resist taken-
for-granted assumptions.  
Resistance through participation can reveal certain boundaries of power. 
Maktivism can attempt to carve small ruts in the edges where institutional discipline 
circulates. Further, micropolitical contestations like this might provide researchers and 
makers with a new perspective about how contestation and resistance become successful. 
Just as dominant discourses of power circulate and (re)emerge over time, so too do 
opportunities for micropolitical resistance and making. These spaces of contestation 
function to dot the landscape and more visibly trace and reveal the cracks in the hidden 
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surface of power, something I visually depict in Figure 23. 
 
Figure 23. Illustration of points of peripheral contestation and resistance to dominant 
discourses. This visual should be considered in tandem with that above (as a close-up of 
one section of the bottom left part of Figure 1.  
 
In this case, maktivists and DIY makers were able to deconstruct and reconstruct certain 
techno- and medico-administrative logics into new forms. That is, through their 
production, DIY makers materialized logics.  
Reconceptualizing Successful Maktivism 
Some critical organizational communication scholars (see Deetz, 2008) argue that 
orientations toward studies of power bifurcate the relationship between oppressor and 
oppressed. Others suggest that scholarship routinely masculinizes notions of power and 
success (see Nadesan & Trethewey, 2000; Jamieson, 2015; Martin, 1990). Indeed, after a 
close reading of this study, one might conclude that Four Thieves Vinegar, in creating an 
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EpiPencil, just reconstituted the neoliberal capitalistic logics of the EpiPen. Similarly, 
one might argue that a failure to dismantle power structures limits the effectiveness of 
biohackers in this case. Further, one might wonder whether anyone even used the 
EpiPencil. Indeed, I had that question myself. 
When I asked Laufer whether he knew of anyone making the EpiPencil or 
advertising that they had used one, he responded that none of the feedback nor kind notes 
he had received clearly indicated that anyone actually replaced their EpiPen with an 
EpiPencil. He noted that the goal was not to replace EpiPens but to give people options.  
I would argue that actions that result in people “having options” is an important 
aspect of successful resistance. Certainly, dominant neoliberal logics present success as 
growth-type measures (e.g., yield, production, volume, consuming, and adoption). 
However, a study that similarly conceptualizes success in these same terms may well be 
contributing to privileged and masculinized notions of success. Instead, this study asks us 
to consider an alternative conceptualization of success, one that is antithetical to 
dominant interpretations. This mode rests in alternative notions of participation as a 
function of resistance and contestation. Thus, this study asks us to consider what we can 
learn by reconceptualizing participation and mirroring dominant logics as micropolitical 
forms of resistance. 
 Ratto and Boler (2014) note that activism and hacktivism have largely moved 
from the virtual and digital world to the material world. Maktivism is both the literal and 
physical enactment of taking matters into one’s own hands to address political, civil, and 
social issues (Jacka, 2003). Sociomateriality provides a lens by which to consider the 
“constitutive entanglement of the social and the material” (Orlikowski, 2007, p. 1438) by 
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focusing on how human bodies, physical objects, and technologies come to be entangled 
with language, interaction, and human activity (Jarzabkowski & Pinch, 2013). This 
dissertation is, in part, a study of the (re)production of materialities that challenge various 
embedded scripts and meanings in material things, most notably medicalized 
technologies.  
This study analyzed the role of “alternative possibilities” through the 
rearrangement and assembly of medical materials and, thereby, produced new technical 
affordances and made visible historically embedded meanings. This study contributes to 
research on sociomateriality by considering how DIY maker devices constituted new 
(and old) material meanings, by intentionally and unintentionally deconstructing and 
reconstructing material scripts through reproduction. This study takes a new perspective 
toward sociomaterial production by considering how material meanings are 
simultaneously resisted and recodified through the repurposing of materials and open-
source instructions. I argue that this kind of resistance is successful because it uses 
dominant logics to evidence power, and it constitutes the rational possibility for more 
meaningful social action. The next section more fully explicates these ideas. 
Introducing Mirrored Materiality 
At first glance, one might consider the Four Thieves Vinegar EpiPencil “hack” to 
lack sophistication or nuance. The EpiPencil was merely a parts list consisting of already-
available medical-grade components. Their instructions told users to use the components 
as they were intended (e.g., syringes and needles are meant to store drugs and inject them 
into the body). Even the label design was borrowed from Mylan—the company Four 
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Thieves Vinegar was claiming to contest. However, the EpiPencil became a symbol of 
resistance, an artifact of fear. How can we explain this?  
I argue that through their participation in (re)constructing a medical device, Four 
Thieves Vinegar was able to co-opt the social meanings and institutional logics 
embedded within the medical material components. And in doing so, they were able to 
reframe the material axiological values and epistemological logics of the device. Said 
more specifically, by merely repurposing medical materials for use in new ways, fringe 
participation revealed otherwise hidden aspects of power within those materialities. 
Broadly, DIY makers in this case also similarly participated in solving issues of 
price and access by repurposing materials to produce meaningful alternatives, including 
the use of both medical and non-medical components (e.g., 3D printed dispensers, 
repurposed toothbrush holders). Other biohacking groups, too, chose to modify medico-
administrative logics (i.e., injection protocols that modified the order of steps and 
physical forms of auto-injectors). These approaches are also effective at revealing issues 
of power (in this case, by contesting logics of price by revealing cheaper manufacturing 
solutions). That said, the difference between Four Thieves Vinegar’s approach and other 
do-it-yourself “hacks” is important: Four Thieves Vinegar participated in resistance that 
closely mirrored dominant logics through their redeployment of normalized injection 
protocols. Four Thieves Vinegar was able to effectively “deterritorialize” certain aspects 
of power—like manufacturing and cost of goods—by deterritorializing medical 
knowledge and contesting boundaries of production and participation. 
Issues of price and access circulated throughout the dominant narrative, as did 
demand for intervention and market alternatives. By offering a fringe alternative, the 
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EpiPencil problematizes certain dominant logics and, in doing so, both participates and 
contests.  
Table 3  
Aspects of Mirrored Materiality Present in This Study 
Logics of the EpiPen Discursive Politics of (the 
Mirrored Materiality of) the 
EpiPen Alternatives 
Revealed 
Incongruity 
Price of EpiPen ($600) Alternative can be produced for 
$35 
Incongruity of 
value 
EpiPens are made of 
patented technology and 
materials; EpiPens are 
patented and protected 
technology and materials 
Materials that comprise EpiPens 
are easily purchasable, readily 
available online, and simple to 
construct at home (open-
technology) 
Incongruity of 
techno-logics 
(demystifying 
technology);  
Incongruity of 
ownership 
Justification by Mylan that 
the cost is associated with 
specialized manufacturing 
Can be assembled (co-opted) using 
just five off-the-shelf parts 
currently used in other healthcare 
contexts 
Incongruity of 
complexity 
(deconstruction) 
Alternative devices pose a 
risk to safety; EpiPens have 
been approved by the FDA 
EpiPencil uses medical-grade 
parts, already available and 
approved for medical use; Still 
requires a doctor prescription; 
Administration and application are 
similar/same 
Incongruity of 
access (public 
good); 
Incongruity of 
medical authority 
 
To more fully flesh out this concept, I borrow from the notion of perspective by 
incongruity (Burke, 1959). Perspective by incongruity traditionally explains how the 
juxtaposition of unfamiliar or opposed terms, metaphors, or images serve to sense-break 
familiar patterns and shift power through a kind of “intellectual vertigo.” However, 
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perspective by incongruity functions to resist power by jarring that which is expected but 
is somehow different.  
Much the same way one finds new wrinkles when looking in the mirror and 
expecting the same face as we had years ago, incongruities can reveal otherwise taken-
for-granted wrinkles in material power. Thus, the power of the mirrored materiality lies 
in its material (re)form. Materialities gain power through their (re)construction and 
(re)production over time. Mirrored materiality, then, occurs within dominant structures 
regularly. We even see this within the logics (e.g., administration, design, protocols) of 
the EpiPen. However, I argue that mirrored materiality can also contest dominant logics 
when it gives perspective by incongruity. By borrowing from or (re)producing parts of 
dominant logics while resisting others, mirrored materiality can also be used to reveal or 
problematize materials of power, and their modes of discipline. 
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Mirrored Materiality 	 	 Incongruities (e.g., 
value, manufacturing, 
access, medical 
ownership) 	 	  
	 	 
 
Figure 24 (left). Historical image of AtroPen. Adapted from Meridian Auto-Injectors, in 
BuyEmp.com, n.d. Retrieved January 20, 2019 from 
https://www.buyemp.com/product/meridian-auto-injectors. In the public domain. 
Figure 25 (center-left and center-right). Examples of EpiPen versions. Adapted from 
Dove Press, 2017. Retrieved January 20, 2019 from https://www.dovepress.com/update-
on-the-usage-and-safety-of-epinephrine-auto-injectors-2017-peer-reviewed-fulltext-
article-DHPS. In the public domain. 
Figure 26 (right). EpiPencil. Image courtesy of Matt Donovan. 
  
143 
The EpiPen, in this case, is embedded with (material, political, medical, etc.) 
logics and values, which have been historically constructed. Biohackers, although 
operating within the dominant problem-solution frame, (re)created alternative DIY at-
home epinephrine auto-injectors as a form of contestation. Biohackers attempted to resist 
certain dominant discourses (e.g., affordability, medical gatekeeping, etc.); however, they 
also situated their (re)creating within other dominant logics and values. Biohackers’ 
social activity and discursive logics of contestation were imbued within a new material 
production that embedded some new social meanings while reflecting other more 
dominant meanings. Taken together, the final product was a mirrored materiality that 
evidenced/illuminated flaws in the techno-logics of the dominant discourse. By mirroring 
through co-opting, appropriation, and even subjectivity, the absurdity and difference in 
the politic of EpiPens and EpiPencil is actually amplified and brought to light.   
In organizational communication research and critical post-structural 
perspectives, notions of resistance often center on qualities of “opposition” and 
“difference.” Literature on resistance tends to focus on “fixed identities and normalized 
conflict that preclude meaningful ways forward” (Deetz, 2008, p. 389). Scholars have 
historically argued that forms or acts of reproduction usually contribute to, reify, and 
further substantiate power. In fact, critical organizational communication scholars 
exploring the often complex and usually contradictory ways employee identities become 
implicated in tensions of power have often suggested that power and identity are 
mutually defining (Putnam, 2015) and that efforts to articulate resistance often result in 
the reproduction of existing power relations and forms of control (Ashcraft, 2005; 
Fleming & Spicer, 2003; Trethewey, 2001). 
144 
participation and resistance as dialectic, this study highlights how one side of a seemingly 
opposing activity (in this case, participation) can be enacted as a means to achieve the 
other (e.g., resistance) (Tracy, 2004). Biohackers constantly oscillate between discursive 
acts that are both participatory and resistant, revealing how participation can function as a 
form of resistance, while also reifying other dominant power structures. This case 
illuminates how power and forms of resistance to it are in constant tension. By 
highlighting these tensions, we can begin to see the recursive nature and structure of 
these tensions in context. 
Whereas previous studies have focused on the ways the (re)production or 
mirroring of dominant logics reifies hegemonic power structures, this study suggests that 
(re)production can also reveal power tensions in certain contexts. This mirroring or re-
presentation of that which is being resisted or opposed reveals embedded sociomaterial 
meanings within new material productions and original (mimicked) materialities. 
Mirrored materiality as resistance provides a lens by which sociomaterial engagement 
can problematize and (re)politicize various discourses through their production. Critical 
theory asks how things come to exist, (co)exist, and interrelate in the (re)production of 
organizing. This study helps us consider how matter comes to absorb certain aspects of 
preferred knowledge, how protocols and behaviors come to be seen/felt as naturalized, 
and how discursive power suppresses other possibilities (possibilities for alternatives). 
Epinephrine auto-injectors, in this case, function as sociomaterial artifacts and 
archetypes of power and resistance. In resisting, biohackers created an artifact (“objects 
to share with”) that, through its production, attempted to bring change at the local level, 
contribute to new knowledge and logics, and provide value to the populace through 
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material function (a viable, usable medical alternative and an artifact that constituted new 
meanings and creating alternative discursive logics about dominant techno-logics). 
Therefore, do-it-yourself alternative devices functioned simultaneously as resistance in 
physical form (i.e., an artifact to make a public statement) and participation through 
tangible contributions (i.e., objects that solve a problem).  
Critical making as both participation and resistance reveals the sociomaterial 
potentiality of technologies. In other words, material artifacts challenge both what is 
possible and where possibilities for change might exist, not only by creating new objects 
but also by mobilizing and evidencing new domains of knowledge and establishing new 
archetypes (social constructs). Thus, biohacker alternative devices in this case also serve 
as sociomaterial archetypes (i.e., as representations, models, and prototypes that are 
repeated and reconstructed as a visage of the original). Mirrored materialities illuminate 
how material meanings are inherited by the sociomaterial constructs that produce them. 
Epinephrine auto-injectors function, in this case, as the archetype from which new copies 
can be made and shows how newer models and meanings can disrupt taken-for-granted 
patterns of behavior situated within historical objects. 
Limitations and Future Directions 
Organizational communication scholarship concerns itself with communication 
processes and social dynamics that influence perceptions, attitudes, and beliefs about 
various technologies. These attitudes, in turn, affect how technologies are used and 
adopted. As such, one goal of organizational communication scholarship is to give 
attention to matters that come to matter, particularly in contexts that demand social 
146 
action. This particular case suggests that maktivism can more capability and 
meaningfully produce technologies that solve real-world problems.  
One limitation of this study is that it was focused on discursive constructs and 
sociomateriality, broadly. However, this study could very easily include more micro-level 
discursive analysis. I made a number of assumptions about individuals who use EpiPens 
that relied on second-hand data. However, to more fully substantiate maktivism as an 
activity for greater citizenry, this study should consider incorporating more representative 
and individual data to create more multivocality. By understanding the concerns and 
needs of individuals who would benefit from medical alternatives, future studies on this 
topic could further elucidate how alternative medico-logics are (or are not) embedded 
into the public psyche. 
 Second, this research limited its scope by placing parameters on the case. 
Therefore, it excluded a variety of discursive moves, particularly related to political and 
capitalistic engagement and policy. Following studies could usefully begin to fill these 
gaps by focusing more closely on the relationship between economic-political 
sovereignty. For example, tracing the historic interactions and political maneuvers 
enacted between biohackers and government agencies can help provide greater context of 
the governmentality of biohackers through various apparatuses of security.  
Third, this case included instances of both institutional and non-institutional 
actors as DIY makers. Although this study did not set out to compare the tactics of 
critical making across institutional “experts” and “non-experts,” this case provides 
interesting possibilities for considering the role of medical professionals as within-
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institution maktivists. Further research should consider how institutional experts and 
medical gatekeepers influence issues of contestation, participation, and resistance.  
 Fourth, this research topic deals with issues of risk—medical, social, political, and 
more. However, risk was not a primary focus of this study. Future studies should consider 
an analysis of this topic through the lens of risk analysis and risk literature. Similarly, 
there are natural research extensions to health policy and health communication research. 
Health communication policy research can benefit from this topic by focusing on how 
knowledge is constructed across multiple systems and structures (Canary & McPhee, 
2009).  
 Finally, this study did not include an analysis of the organizing of biohacker actor 
groups. Biohackers and biohacker groups organize in similar ways to other alternative 
organizations but different in others. Heedful interrelating describes how DIY makers 
function more as a sort of connective cooperation or co-arising activity rather than a 
traditionally collective action. Future studies should valuably consider contributions to 
notions of alternative organizing in the context of biohacker groups as social connective 
activity. 
Resonance and Significance 
 As with much applied research, this case study uses various theoretical 
frameworks as a lens by which to potentially explain a particular phenomenon in context. 
Further, the findings are valuable to providing rich and detailed context to an important 
social issue beyond traditional surface-level explanations. This study aims to create 
resonance (Tracy, in press) by offering new and meaningful connections or transferability 
to issues of public health policy, medical consumerism, or the discusrive formation of 
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medicalized topics. Although this study examined pharmaceutical pricing in the specific 
historical and rhetorical context of EpiPens and epinephrine, the problem of 
pharmaceutical pricing continues. Insulin, for example, has emerged as the next 
pharmaceutical crisis, leading new biohacker coalitions find ways to produce insulin 
outside of traditional laboratory or manufacturing sites (Open Insulin Project, n.d.). 
Therefore, the historically and culturally situated knowledge within this study can 
provide transferability to future problems in similar contexts.  
Conclusion 
This study aims to continue to add to a growing body of research and literature 
attempting to shift institutional logics that stand in the way of providing affordable access 
to healthcare in the United States. By focusing on research that demonstrates key areas of 
contestation and exposes the strategies long-employed by pharmaceutical companies, 
research on pharmaceutical pricing is important. Studies like this are also relevant as 
pharmaceutical pricing continues to be an issue in other contexts.  
Recently, rising prices have led to difficulties in access within the United States. 
Further, groups like Four Thieves Vinegar have larger missions of contributing to do-it-
yourself medicine and moving from device technology to the at-home manufacturing of 
pharmacological drugs. As more institutional logics continue to be contested in the 
future, more research should examine the implications of biohacker communities. 
Organizational communication scholars stand to provide substantial utility to these 
important efforts.  
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Actor Data Type Example Data Sources 
Government Patents Original Epinephrine Patent US730,136 
 
Survival Technologies Auto-injector Patent 
US3,882,863  
 
Survival Technologies Patent US4,031,893 
 
EpiPen Patent US7,449,012 
 
Meridian Medical Technologies Patent 
US7,449,023 
 Device Safety 
Texts 
Pralidoxime Nerve Agent Auto-Injector Label 
and Safety Instructions 
 
FDA Guidance for Staff: Technology 
Considerations for Pens, Jets, Injectors 
 
FDA Press Release - FDA Approves first 
Generic Version of EpiPen (2018) 
 
Department of Defense Annual Industrial 
Capabilities Report (2000) 
 Agency Policy 
Documents 
NASBE Press Release: NASBE Launches 
Epinephrine Policy Initiative 
 
2013 Emergency Access to Epinephrine Law 
(EpiPen Law) 
 
FDA Policies for Drug-Device Combinations 
 
Press Release: President Obama Signs new 
EpiPen Law to Protect Children with Asthma 
 Congressional 
Oversight Texts 
Reviewing the Rising Price of EpiPens – 
Congressional Hearing with FDA and Mylan 
 
Congressional Letter to Robert M. Califf, FDA 
 
Congressional Letter to Heather Bresch/Mylan 
 
Cummins & Sanders Investigation into 
Staggering Generic Drug Price Increases 
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Pharmaceutical 
Industry 
Mylan Texts EpiPen Administration Instructions (2000s) 
 
Archival EpiPen Labels (1990s, 2000s, 2010s) 
 
Company Mission 
 
Citizen Petition against Teva Pharmaceuticals 
 
Press Release: Mylan Launches First Generic 
for EpiPen 
 
Press Release: Mylan Taking Immediate Action 
to Further Enhance Access to EpiPen 
 
Understanding the Pharmaceutical Supply 
Chain 
 Other 
Pharmaceutical 
Manufacturer 
Texts 
Antidote Treatment (AtroPen & Pralidoxime 
ComboPen) Guide – Meridian Technologies 
 
Intelliject NDA Submission to FDA (2011) 
 
CVS Press Release: CVS Health Offers Patients 
Lowest Cash Price in the Market for Generic 
EpiPen 
 Consumer 
Watchdog Texts 
Fact Checking Mylan Claims they Raised the 
EpiPen Price because of Improvements 
(American Council on Science and Health) 
 
The EpiPen Problem: Analyzing Unethical 
Drug Price Increases and the Need for Greater 
Government Regulation 
 
Mylan Pricing Summary: A Case Study in 
Increases (PolicyMed) 
 
The Lack of EpiPen Competitors is the FDA’s 
Fault (Mises Institute) 
 
EpiPens and the Sale of Fear (Hastings Center) 
 Patient/Consumer 
Advocacy Group 
Texts 
Understanding Anaphylaxis (Asthma & Allergy 
Network) 
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Personal Communication: Emails from Food 
Allergy Research and Education (FARE) 
 
Epinephrine: Answers to Key Questions on 
Alternatives, Expiration, and Needs (FARE) 
 
Epinephrine Assistance Resources (FARE) 
 
ACAAI Statement on EpiPen Pricing 
Medical 
Industry 
Medical 
Professional 
Maker Texts 
Pre-filled Syringe using Straws to Prevent 
Inadvertent Plunging Instructions – Altman MD 
 
DIY*EpiPen [video] 
 
3D Printed Epi Injector – Dr. Thomas 
McClellan [video] 
 EMT/EMS Texts KS Board of EMS Emergency Epinephrine 
Administration Training Materials 
 
Treating Anaphylactic Sticker Shock (EKU 
School of Emergency Medical Care) 
 
Check and Inject Kit Design and Instructions 
 
King County (Wash.) EMS Saves $334,000 
Annually by Switching to IM Delivery of epi by 
EMTs 
 Medical Group 
Texts 
Mythbuster: Why Homemade Epinephrine Kits 
should not be used (Children’s Mercy) 
 
Infectious Disease Society Letter to Turing 
Pharmaceuticals 
News Reporting Media Texts An Anarchist is Teaching Patients to Make their 
own Medicine (Scientific American) 
 
A DIY Pharmaceutical Revolution is Coming – 
If it Doesn’t Kill us First (Gizmodo) 
 
Don’t Only Blame Mylan for $600 EpiPens 
(Fortune) 
 
Mylan CEO on EpiPens: The System Rewards 
Higher Prices (CNBC) 
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US FDA Warns Against $30 DIY Alternative to 
Mylan’s EpiPen 
 
EpiPens Have Become so Expensive People are 
Using Riskier DIY Alternatives (Scientific 
American) 
 
Please Do Not Hack Your Own EpiPen 
 
Absurdly Expensive EpiPens are Driving 
Families to Dangerous Lengths (CNN) 
Biohacker Formal 
Interviews 
DIYBio Interviews (4) 
 
Expert Interview – Michael Laufer (Four 
Thieves Vinegar) 
 DIY epinephrine 
autoinjector 
materials 
EpiPencil Instructions, FAQ, Parts List, Label 
 
Introducing the EpiPencil [video] 
 
EpiPencil Update/FAQ [video] 
 
Michael Laufer Twitter Posts (1,500) 
 
Four Thieves Vinegar Twitter Posts (1,500) 
 
Drug Delivery Device (3D CAD) specs from 
GrabCAD 
 
Stratasys Drug Delivery Device (3D CAD) 
specs from Shapeways 
 
3D Prototype from ProgressTH 
 
EpiPen Alternative Housing Design for 3D 
Printing [3D CAD] – TinkerCAD 
 
How to Make your Own EpiPen – Treat Outside 
the Box [video] 
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Additional Context about U.S. Drug-Pricing 
 
All prices listed in the table below are variable. Data on EpiPen wholesale pricing 
(i.e., the price the distributor sells a drug to another entity) and out-of-pocket cost (i.e., 
the cost a patient must pay out of their own pocket after formulary price, insurance rates, 
rebates, and coupons are applied) were gathered from various sources and cross-
referenced for accuracy. If a cited source used an estimated cost, I report the estimate. In 
some cases, prices listed in this study were based off of first-hand accounts. In those 
instances, I report those prices. At the time of this writing, prescription prices in the US 
are highly variable and depend on a number of factors. Because this is not an in-depth 
study of pharmaceutical pricing, the following is a simplified explanation for some of the 
reasons related to price variability. This explanation is meant to illuminate the highly 
complex ways pharmaceutical drugs are priced in America.  
In America, the price of pharmaceutical medication is not regulated by the federal 
government. Nearly all other developed nations have specific policies that limit 
pharmaceutical companies’ abilities to price-gouge the government or citizens through 
drug sales. Many countries have price controls, regulations, and health-based outcome 
pricing models that ensure a fair price is being charged for medications. In those 
countries, the government is also the primary or sole buyer of medications for the 
country, and therefore the State negotiates the prices of all medications sold within the 
country. Because pharmaceutical companies operating in those countries only negotiate 
with a single government entity, they have less negotiating power. In the United States, 
however, various for-profit and nonprofit entities buy pharmaceutical drugs specifically 
for their consumers. Insurance groups and hospitals, pharmacies, health plans, and 
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retailers might individually negotiate prices for the drugs they buy, resulting in 
sometimes different and unregulated pricing. Antitrust laws in American prevent 
negotiated prices from being shared, limiting the negotiating power of buyers to buy at a 
fair or competitive price. In cases where medications are protected by patent, and thus no 
generic alternative(s) on the market, pharmaceutical manufacturers have the ability to 
freely set the price point for their drugs. However, in recent years concern of the rise of 
high-cost generics has become central to this debate. 
To further complicate the issue, most health insurance plans and pharmacy benefit 
plans include out-of-pocket costs such as co-pays (i.e., a fixed amount of money a patient 
must pay in exchange for their medication). In some cases, individuals on the same health 
insurance plan may pay different prices for the same drug depending on variables such as 
what pharmacy they choose to fill their prescription with. Pharmaceutical manufacturers 
have recently started offering coupons and rebates to lower the out-of-pocket costs for 
consumers; however, the amounts of rebates are often kept hidden from consumers, and 
rebates are not always passed onto consumers. In some cases, the amount an individual 
has to pay for a prescription drug can be higher when using their insurance than when 
buying the medication without using insurance. This may be due to the fact that the 
pharmacy has negotiated a better retail price for the medication than the individual’s 
health insurance plan, or the result of the pharmacy using a manufacturer rebate to be 
reimbursed a portion of the prescription cost. Coupons and rebates ultimately do little to 
offset or lower the actual cost of drugs in America; they do however help lower the 
impact felt at the counter when a patient goes to pick up their medication from a 
pharmacy. In the US, drug prescribing and dispensing are highly regulated, sometimes 
176 
leaving customers with few options for medication selection, alternatives, and price. In 
cases where there are multiple products for the same drug, (e.g., generics or therapeutic 
equivalents), there are times when a pharmacy cannot substitute a cheaper alternative for 
a more expensive one. One factor is whether the prescribing doctor writes a prescription 
allowing a generic alternative (e.g., today a doctor who writes a prescription for an 
“EpiPen” (brand name), as opposed to an “Epinephrine auto-injector” (generic 
alternative) will result in a patient receiving the brand name product. Another factor is 
whether a patient’s pharmacy coverage (or lack thereof) includes particular drugs on their 
formulary (a list of drugs, their prices, and conditions related to whether certain drugs can 
or cannot be substituted for others). In some cases, another drug may be available on the 
market, but an individual’s insurance does not cover it. Ultimately the ability to know the 
true cost of a medication is systematically unavailable and necessarily complicated. 
Because Americans have little-to-no price transparency, thus limited options to shop by 
price, drug prices in the US remain disproportionately higher than anywhere else in the 
world. In fact, Americans on average pay 2-6 times more for prescription drugs than the 
rest of the world (International Federation of Health Plans). 
 
  
 
 
 
 
Table 4 
 
Chronological Ordering of EpiPen Pricing and DIY Biohacker Activity 
 
Date List of Historically Relevant Events Price of EpiPen* 
1903 • Japanese biochemist Jokichi Takamine is granted US patent for the development of 
synthetic epinephrine 
• Takamine licenses his patent to Parke-Davis (a pharmaceutical firm) for epinephrine 
manufacturing. Epinephrine is only available for emergency medical use in hospitals 
and by medical professionals 
 
1971 • Hollister-Stier Laboratories releases Ana-kit as a bee-sting kit for consumer use. Ana-
kit includes a single dose of epinephrine in a pre-filled syringe 
 
1973-
1977 
• Pentagon contracts Survival Technologies to develop a “hypodermic injection device” 
for soldiers to quickly self-administer nerve agent antidotes in battle 
 
1983 • Scientists at Meridian Medical extend injection device technology to applications in 
the consumer market, patent epinephrine auto-injector device 
 
179 
 1987 • FDA approves Meridian Medical epinephrine auto-injector device for commercial 
use 
• EpiPen first released to the market 
$35 ($99 
today, 
adjusted for 
inflation) 
2007 
 
• Mylan purchases rights to EpiPen marketing and distribution through acquisition of 
Merck Generics (MGKB) for $6.6B 
$100 
(wholesale) 
2009 • Mylan applies for EpiPen patent protection extension by modifying/adding a bright 
orange cap (added as a “safety feature”) to EpiPen design, and updating the 
instructions on the label. 
 
2011 • Mylan began selling EpiPens exclusively in two-packs. Mylan also reduced the 
expiration period for its EpiPens from two years to one year, requiring customers to 
purchase them twice as frequently 
$163 
2012 • Mylan launches EpiPens4Schools initiative. Partners with the National Association of 
State Boards of Education (NASBE) to promote adoption of state and federal laws 
encouraging or requiring schools nationwide to keep a stock of EpiPen devices 
nationwide 
• Teva Pharmaceuticals and Mylan report reaching “confidential agreement” which 
includes a decision for Teva to delay the release of its epinephrine auto-injector 
alternative device until 2015 
$219 (July) 
2013 • Mylan successfully lobbies 10 states to pass legislation requiring EpiPens be stocked 
in hotels, restaurants, and other public locations 
• (November) H.R. 2094 – School Access to Emergency Epinephrine Act – passed as 
federal law 
$265 (July) 
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 2014 • First media report(s) about rising cost of EpiPens appear in online, fringe media 
outlets 
• The rising price of EpiPens led several local fire departments in Washington and 
Kentucky to re-train EMTs to administer epinephrine via syringe. Some departments 
created kits that mirrored Ana-kits 
$350 (May) 
$380 (Sept) 
2015 
 
• Mylan introduces lawsuit to prevent generic (Teva) from being approved by the FDA 
• Mylan uses FDA review process to file a “citizen petition” citing safety concerns, 
discourages FDA approval of Teva device 
• FDA rejects Mylan’s citizen petition, but ultimately rejects Teva application for 
commercial use  
• (August) American doctor (sponsored by Mylan) publishes article in the American 
Journal of Medicine advocating for the EpiPen to be added to the federal preventative 
drug list 
• (October) Mylan claims it performed post-market tests on EpiPens to ensure “quality 
standards.” The company suggests these Research and Development (R&D) efforts 
contribute to rising device costs 
• Minor market epinephrine auto-injector competitor (Avi-Q) institutes complete recall 
of all products, reducing market competition 
• (November) Consumer advocacy groups and doctors (compensated by Mylan) 
advocate for EpiPen to be added to Affordable Care Act federal preventative drug list 
$461 (May) 
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 2016 
 
 
• Business Insider published one of the first mainstream articles on EpiPen pricing 
titled “EpiPens have become so expensive some people are using riskier DIY 
alternatives” 
• Medical professionals (allergists and EMTs) begin returning to lower-cost 
alternatives including the use of syringe and vial delivery. Some create their own do-
it-yourself alternatives 
------ RUPTURE POINT ------ 
• (August) VT Senator Bernie Sanders posts “There’s no reason an EpiPen, which 
costs Mylan just a few dollars to make should cost families more than $600” on 
social media 
• MT Senator Amy Klobuchar calls for Federal Trade Commission and Senate 
Judiciary Committee to investigate EpiPen prices 
• Mylan Specialty spokesperson resigns, pens open letter criticizing Mylan for EpiPen 
prices 
• US House Committee on Energy and Commerce send FDA Commissioner official 
letter of inquiry related to the lack of epinephrine auto-injector generic alternatives on 
the market 
• Dr. Ryan Neuhofel (licensed allergist) releases instructions on how to build a DIY 
epinephrine auto-injector 
• (September) FARE (Food Allergy & Research Education) consumer advocacy group 
responds to risks of “DIY” EpiPen alternatives 
• Four Thieves Vinegar biohacker collective releases DIY “Epipencil” (including open-
source instructions, how-to video on YouTube, and manifesto) for $35 
• MIT Technology Review is the first to report on Epipencil 
• Philippines-based biohacker group ProgressTH respond to EpiPencil release, 
announces plans to release instructions and specs for 3D printing Epipencil parts to 
lower cost of device to $3 USD 
• Other DIY “hacks” appear online with various at-home epinephrine auto-injector 
solutions 
$609 (May) 
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 • Silicon Valley engineers deconstruct EpiPen, suggest cost to manufacture is less than 
$10 
• FDA and Mylan testify to US House Committee on Oversight & Government Reform 
for questions related to EpiPen pricing 
• FDA warns public against using Epipencil 
• (October) Four Thieves Vinegar releases Epipencil “Update and FAQ” video on 
YouTube 
• DIY hacker “Treat Outside the Box” releases instructions for DIY epinephrine auto-
injector on YouTube 
• (December) Mylan releases its own generic EpiPen alternative 
• Mylan offers manufacturers coupon to lower out-of-pocket costs 
$340 EpiPen 
Generic,  
$650 
otherwise 
2017 • (January) CVS, largest retail pharmacy network in US, announces it is offering 
authorized generic of alternative epinephrine auto-injector Adrenaclick to patients 
($110) 
• (December) Four Thieves Vinegar Epipencil video removed from YouTube for 
violating community guidelines (“content that encourages or promotes violent or 
dangerous acts that have inherent risk of serious physical harm or death”) 
 
2018 • (May) FDA declares supply chain shortage for EpiPen, claims shortage is due to 
manufacturing delays from Pfizer. To address the shortage, the FDA extended EpiPen 
expiration dates four months 
• (August) FDA approves first therapeutic equivalent (directly substitutable) generic 
alternative epinephrine auto-injector from Teva Pharmaceuticals 
• (September) FDA approves pre-filled epinephrine syringe alternative, Symjepi 
• CMS (Centers for Medicare & Medicaid Services) issues press release proposing 
future legislation requiring pharmaceutical manufacturers disclose drug prices in TV 
advertisements 
EpiPen: $379 
($150 out-of-
pocket with 
manufacturer 
coupon) 
2025 • Mylan patent protection for EpiPen expires  
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